10-Q 1 axaeq3q1810q.htm 10-Q Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549  
 
FORM 10-Q

(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2018 
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             

Commission File Number 000-20501
AXA Equitable Life Insurance Company
(Exact name of registrant as specified in its charter) 
New York
 
13-5570651
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
1290 Avenue of the Americas, New York, New York
 
10104
(Address of principal executive offices)
 
(Zip Code)
(212) 554-1234
(Registrant’s telephone number, including area code)

Not applicable
(Former name, former address, and former fiscal year if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an “emerging growth company”. See definition of “accelerated filer,” “large accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer
 
¨
  
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
x  
  
Smaller reporting company
 
¨
 
 
 
 
 
 
 
Emerging growth company
 
¨
 
 
 
 
 
 
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ¨
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
As of November 13, 2018, 2,000,000 shares of the registrant’s Common Stock were outstanding.
REDUCED DISCLOSURE FORMAT:
AXA Equitable Life Insurance Company meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q and is therefore filing this Form 10-Q in the reduced disclosure format.



AXA EQUITABLE LIFE INSURANCE COMPANY
FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2018
TABLE OF CONTENTS

 
 
 
 
  
 
 
Page
 
 
 
 
 
 
 
 
 
•
 
•
 
•
 
•
 
•
 
•
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


3

FORWARD-LOOKING STATEMENTS
Certain of the statements included or incorporated by reference in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expects,” “believes,” “anticipates,” “intends,” “seeks,” “aims,” “plans,” “assumes,” “estimates,” “projects,” “should,” “would,” “could,” “may,” “will,” “shall” or variations of such words are generally part of forward-looking statements. Forward-looking statements are made based on management’s current expectations and beliefs concerning future developments and their potential effects upon AXA Equitable Life Insurance Company (“AXA Equitable”) and its consolidated subsidiaries. “We,” “us” and “our” refer to AXA Equitable and its consolidated subsidiaries, unless the context refers only to AXA Equitable as a corporate entity. There can be no assurance that future developments affecting AXA Equitable will be those anticipated by management. Forward-looking statements include, without limitation, all matters that are not historical facts.
These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements, including, among others: (i) conditions in the financial markets and economy, including equity market declines and volatility, interest rate fluctuations, impacts on our goodwill and changes in liquidity and access to and cost of capital; (ii) operational factors, including indebtedness, elements of our business strategy not being effective in accomplishing our objectives, protection of confidential customer information or proprietary business information, information systems failing or being compromised and strong industry competition; (iii) credit, counterparties and investments, including counterparty default on derivative contracts, failure of financial institutions, defaults, errors or omissions by third parties and affiliates and gross unrealized losses on fixed maturity and equity securities; (iv) our reinsurance and hedging programs; (v) our products, structure and product distribution, including variable annuity guaranteed benefits features within certain of our products, complex regulation and administration of our products, variations in statutory capital requirements, financial strength and claims-paying ratings and key product distribution relationships; (vi) estimates, assumptions and valuations, including risk management policies and procedures, potential inadequacy of reserves, actual mortality, longevity and morbidity experience differing from pricing expectations or reserves, amortization of deferred acquisition costs and financial models; (vii) our Investment Management and Research segment, including fluctuations in assets under management, the industry-wide shift from actively-managed investment services to passive services and potential termination of investment advisory agreements; (viii) legal and regulatory risks, including federal and state legislation affecting financial institutions, insurance regulation and tax reform; and (ix) risks related to our controlling stockholder, including conflicts of interest, waiver of corporate opportunities and costs associated with separation and rebranding; and (x) remediation of our material weaknesses.
Forward-looking statements should be read in conjunction with the other cautionary statements, risks, uncertainties and other factors included in AXA Equitable’s Annual Report on Form 10-K for the year ended December 31, 2017, including in the section entitled “Risk Factors,” and elsewhere in this Quarterly Report on Form 10-Q. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.


4

PART I FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED BALANCE SHEETS
 
September 30,
2018
 
December 31,
2017
 
(Unaudited)
 
 
 
(in millions, except share amounts)
ASSETS
 
 
 
Investments:
 
Fixed maturities available for sale, at fair value (amortized cost of $40,542 and $34,831)
$
39,754

 
$
36,358

Mortgage loans on real estate (net of valuation allowance of $7 and $8)
12,053

 
10,935

Real estate held for production of income(1)
54

 
390

Policy loans
3,269

 
3,315

Other equity investments(1)
1,321

 
1,351

Trading securities, at fair value
14,760

 
12,628

Other invested assets(1)
1,844

 
3,121

Total investments
73,055

 
68,098

Cash and cash equivalents(1)
3,317

 
3,409

Cash and securities segregated, at fair value
1,263

 
825

Broker-dealer related receivables
2,224

 
2,158

Deferred policy acquisition costs
5,011

 
4,492

Goodwill and other intangible assets, net
3,687

 
3,709

Amounts due from reinsurers
3,069

 
5,079

Loans to affiliates
800

 
703

GMIB reinsurance contract asset, at fair value
1,571

 
10,488

Current and deferred income taxes
456

 
—

Other assets(1)
3,182

 
4,432

Separate Accounts assets
123,869

 
122,537

Total Assets
$
221,504

 
$
225,930

 
 
 
 
LIABILITIES
 
 
 
Policyholders’ account balances
$
46,508

 
$
43,805

Future policy benefits and other policyholders liabilities
28,325

 
29,070

Broker-dealer related payables
395

 
764

Securities sold under agreements to repurchase
1,900

 
1,887

Customer related payables
2,781

 
2,229

Amounts due to reinsurers
78

 
134

Short-term and long-term debt(1)
398

 
769

Current and deferred income taxes
—

 
1,954

Other liabilities(1)
2,205

 
2,663

Separate Accounts liabilities
123,869

 
122,537



5
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED BALANCE SHEETS - CONTINUED


 
September 30,
2018
 
December 31,
2017
 
(Unaudited)
 
 
Total Liabilities
$
206,459

 
$
205,812

Redeemable noncontrolling interest(1)
$
143

 
$
626

Commitments and contingent liabilities
—

 
—

 
 
 
 
EQUITY
 
 
 
AXA Equitable's Equity
 
 
 
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding
$
2

 
$
2

Capital in excess of par value
7,771

 
6,859

Retained earnings
4,988

 
8,938

Accumulated other comprehensive income (loss)
(867
)
 
598

Total AXA Equitable's equity
11,894

 
16,397

Noncontrolling interest
3,008

 
3,095

Total Equity
14,902

 
19,492

Total Liabilities, Redeemable Noncontrolling Interest and Equity
$
221,504

 
$
225,930

______________
(1)    See Note 2 for details of balances with variable interest entities.

See Notes to Consolidated Financial Statements (Unaudited).


6
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(UNAUDITED)


 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
REVENUES
 
 
 
 
 
 
 
Policy charges and fee income
900

 
852

 
$
2,644

 
$
2,516

Premiums
217

 
208

 
657

 
665

Net derivative gains (losses)
(2,006
)
 
(368
)
 
(3,106
)
 
1,048

Net investment income (loss)
652

 
677

 
1,748

 
1,993

Investment gains (losses), net:
 
 
 
 
 
 
 
Total other-than-temporary impairment losses
(4
)
 
—

 
(4
)
 
(13
)
Other investment gains (losses), net
(5
)
 
(8
)
 
77

 
4

Total investment gains (losses), net
(9
)
 
(8
)
 
73

 
(9
)
Investment management and service fees
1,093

 
1,019

 
3,227

 
2,974

Other income
13

 
32

 
47

 
68

Total revenues
860

 
2,412

 
5,290

 
9,255

BENEFITS AND OTHER DEDUCTIONS
 
 
 
 
 
 
 
Policyholders’ benefits
206

 
856

 
1,987

 
3,184

Interest credited to policyholders’ account balances
259

 
233

 
754

 
681

Compensation and benefits (includes $34, $33, $101 and $101 of deferred policy acquisition costs, respectively)
467

 
436

 
1,459

 
1,324

Commissions and distribution related payments (includes $119, $101, $331 and $332 of deferred policy acquisition costs, respectively)
371

 
362

 
1,119

 
1,133

Interest expense
12

 
9

 
34

 
20

Amortization of deferred policy acquisition costs (net of capitalization of $153, $134, $432 and $433 of deferred policy acquisition costs, respectively)
(239
)
 
—

 
(129
)
 
42

Other operating costs and expenses (includes $1, $2, $2 and $5 of deferred policy acquisition costs, respectively)
341

 
462

 
3,267

 
992

Total benefits and other deductions
1,417

 
2,358

 
8,491

 
7,376

Income (loss) from continuing operations, before income taxes
(557
)
 
54

 
(3,201
)
 
1,879

Income tax (expense) benefit
175

 
89

 
782

 
(198
)
Net income (loss)
(382
)
 
143

 
(2,419
)
 
1,681

Less: net (income) loss attributable to the noncontrolling interest
(129
)
 
(122
)
 
(439
)
 
(353
)
Net income (loss) attributable to AXA Equitable
$
(511
)
 
$
21

 
$
(2,858
)
 
$
1,328


See Notes to Consolidated Financial Statements (Unaudited).


7
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
COMPREHENSIVE INCOME (LOSS)
 
 
 
 
 
 
 
Net income (loss)
$
(382
)
 
$
143

 
$
(2,419
)
 
$
1,681

Other comprehensive income (loss) net of income taxes:

 

 

 

Foreign currency translation adjustment
1

 
6

 
(11
)
 
20

Change in unrealized gains (losses), net of reclassification adjustment
(404
)
 
(71
)
 
(1,456
)
 
336

Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment
(3
)
 
(3
)
 
(8
)
 
(2
)
Total other comprehensive income (loss), net of income taxes
(406
)
 
(68
)
 
(1,475
)
 
354

Comprehensive income (loss)
(788
)
 
75

 
(3,894
)
 
2,035

Less: Comprehensive (income) loss attributable to noncontrolling interest
(126
)
 
(154
)
 
(429
)
 
(372
)
Comprehensive income (loss) attributable to AXA Equitable
$
(914
)
 
$
(79
)
 
$
(4,323
)
 
$
1,663


See Notes to Consolidated Financial Statements (Unaudited).



8
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF EQUITY
(UNAUDITED)

 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Equity attributable to AXA Equitable:
 
 
 
Common stock, at par value, beginning and end of period
$
2

 
$
2

 
 
 
 
Capital in excess of par value, beginning of year
$
6,859

 
$
5,339

Changes in capital in excess of par value
912

 
22

Capital in excess of par value, end of period
$
7,771

 
$
5,361

 
 
 
 
Retained earnings, beginning of year
$
8,938

 
$
6,095

   Impact of adoption of revenue recognition standard ASC 606
8

 
—

Net earnings (loss)
(2,858
)
 
1,328

Stockholder dividends
(1,100
)
 
—

Retained earnings, end of period
$
4,988

 
$
7,423

 
 
 
 
Accumulated other comprehensive income (loss), beginning of year
$
598

 
$
(4
)
Other comprehensive income (loss)
(1,465
)
 
335

Accumulated other comprehensive income (loss), end of period
(867
)
 
331

Total AXA Equitable's equity, end of period
$
11,894

 
$
13,117

 
 
 
 
Noncontrolling interest, beginning of year
$
3,095

 
$
3,096

Impact of adoption of revenue recognition standard ASC 606
25

 
—

Repurchase of AB Holding units
(59
)
 
(96
)
Net earnings (loss) attributable to noncontrolling interest
418

 
311

Dividends paid to noncontrolling interest
(468
)
 
(347
)
Other comprehensive income (loss) attributable to noncontrolling interest
(10
)
 
19

Other changes in noncontrolling interest
7

 
(14
)
Noncontrolling interest, end of period
3,008

 
2,969

Total Equity, End of Period
$
14,902

 
$
16,086


See Notes to Consolidated Financial Statements (Unaudited).



9
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)


 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Net income (loss)
(2,419
)
 
1,681

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
Interest credited to policyholders’ account balances
754

 
681

Policy charges and fee income
(2,644
)
 
(2,516
)
(Income) loss related to derivative instruments
3,106

 
(1,048
)
Investment (gains) losses, net
(73
)
 
9

Realized and unrealized (gains) losses on trading securities
206

 
(188
)
Amortization of deferred compensation
13

 
27

Amortization of deferred sales commission
17

 
25

Other depreciation and amortization
(60
)
 
(67
)
Amortization of deferred cost of reinsurance asset
1,884

 
111

Distribution from joint ventures and limited partnerships
63

 
94

Cash received on the recapture of captive reinsurance
1,099

 
—

Changes in:
 
 
 
Net broker-dealer and customer related receivables/payables
414

 
(56
)
Reinsurance recoverable
20

 
(361
)
Segregated cash and securities, net
(438
)
 
157

Deferred policy acquisition costs
(129
)
 
42

Future policy benefits
(58
)
 
1,146

Current and deferred income taxes
(264
)
 
640

Other, net
123

 
617

Net cash provided by (used in) operating activities
$
1,614

 
$
994

 
 
 
 
Cash flows from investing activities:
 
 
 
Proceeds from the sale/maturity/prepayment of:
 
 
 
Fixed maturities, available for sale
$
5,942

 
$
3,873

Mortgage loans on real estate
375

 
695

Trading account securities
6,913

 
6,565

Other
344

 
58

Payment for the purchase/origination of:


 
 
Fixed maturities, available for sale
(6,422
)
 
(3,721
)
Mortgage loans on real estate
(1,485
)
 
(1,534
)
Trading account securities
(8,103
)
 
(9,307
)
Other
(146
)
 
(207
)
Purchase of business, net of cash acquired
—

 
(133
)
Cash settlements related to derivative instruments
(584
)
 
(929
)
Increase in loans to affiliates
(1,100
)
 
—

Decrease in loans to affiliates
700

 
—

Change in short-term investments
350

 
(266
)
Investment in capitalized software, leasehold improvements and EDP equipment
(79
)
 
(67
)


10
AXA EQUITABLE LIFE INSURANCE COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS-CONTINUED
(UNAUDITED)


 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Other, net
305

 
(258
)
Net cash provided by (used in) investing activities
$
(2,990
)
 
$
(5,231
)
 
 
 
 
Cash flows from financing activities:
 
 
 
Policyholders’ account balances:
 
 
 
Deposits
$
7,852

 
$
5,871

Withdrawals
(4,014
)
 
(2,574
)
Transfer (to) from Separate Accounts
(338
)
 
1,617

Change in short-term financings
(168
)
 
(216
)
Change in collateralized pledged assets
(62
)
 
724

Change in collateralized pledged liabilities
279

 
664

 Increase (decrease) in overdrafts payable
(39
)
 
66

Shareholder dividend paid
(1,100
)
 
—

Repurchase of AB Holding units from noncontrolling interest
(59
)
 
—

Redemption of noncontrolling interests of consolidated VIEs, net
(519
)
 
(52
)
Distribution to noncontrolling interests in consolidated subsidiaries
(468
)
 
(347
)
Increase (decrease) in securities sold under agreement to repurchase
13

 
(159
)
Purchases of AB Holding Units to fund long-term incentive compensation plan awards, net
(83
)
 
(134
)
Other, net
(1
)
 
—

Net cash provided by (used in) financing activities
$
1,293

 
$
5,460

Effect of exchange rate changes on cash and cash equivalents
(9
)
 
17

Change in cash and cash equivalents
(92
)
 
1,240

Cash and cash equivalents, beginning of year
3,409

 
2,950

Cash and Cash Equivalents, end of period
$
3,317

 
$
4,190

 
 
 
 
Non-cash transactions during the period(1)
 
 
 
(Settlement) issuance of long-term debt
$
(202
)
 
$
202

Transfer of assets to reinsurer
$
(604
)
 
$
—

Repayment of loan to affiliates
$
300

 
$
—

_______________
(1)     See Note 11 for significant non-cash transactions related to the GMxB unwind and related merger of AXA RE Arizona.


See Notes to Consolidated Financial Statements (Unaudited)


11
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


1)    ORGANIZATION
AXA Equitable Life Insurance Company (“AXA Equitable” and, collectively with its consolidated subsidiaries, the “Company”) is a diversified financial services company. The Company is an indirect, wholly-owned subsidiary of AXA Equitable Holdings, Inc. (“Holdings”). Prior to May 14, 2018, Holdings was a direct wholly-owned subsidiary of AXA S.A. (“AXA”), a French holding company for the AXA Group, a worldwide leader in life, property and casualty and health insurance and asset management. On May 14, 2018, Holdings completed an initial public offering in which AXA sold a minority stake to the public. The accompanying consolidated financial statements represent the consolidated results and financial position of AXA Equitable and not the consolidated results and financial position of Holdings.
The Company conducts operations in four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Company’s management evaluates the performance of each of these segments independently.
•
The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.
•
The Group Retirement segment offers tax-deferred investment and retirement plans sponsored by educational entities, municipalities and not-for-profit entities as well as small and medium-sized businesses.
•
The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels—Institutional, Retail and Private Wealth Management—and distributes its institutional research products and solutions through Bernstein Research Services. The Investment Management and Research segment reflects the business of AllianceBernstein Holding L.P. (“AB Holding”), AllianceBernstein L.P. (“ABLP”) and their subsidiaries (collectively, “AB”).
•
The Protection Solutions segment includes the Company’s life insurance and group employee benefits businesses. The life insurance business offers a variety of variable universal life, indexed universal life and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of life, short- and long-term disability, dental and vision insurance products to small and medium-size businesses across the United States.
The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes: the closed block of life insurance (the “Closed Block”), run-off group pension business, run-off health business, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Investment Management and Research segment. Accordingly, Corporate and Other does not include any items applicable to AB.
At September 30, 2018 and September 30, 2017, respectively, AXA Equitable’s economic interest in AB was approximately 29% and approximately 29%. At September 30, 2018 and September 30, 2017, respectively, Holdings’ economic interest in AB was approximately 65% and approximately 65%. The general partner of AB, AllianceBernstein Corporation (the “General Partner”), is a wholly-owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods.
In March 2018, AXA contributed its 0.5% minority interest in AXA Financial, Inc. (“AXA Financial”) to Holdings so that Holdings now owns 100% of AXA Financial. On October 1, 2018 AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity. See Note 16 for further information.


12
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


Basis of Presentation
The Unaudited Interim Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Intercompany balances and transactions have been eliminated.
In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended December 31, 2017 (the “2017 Form 10-K”).
The terms “third quarter 2018” and “third quarter 2017” refer to the three months ended September 30, 2018 and 2017, respectively. The terms “first nine months of 2018” and “first nine months of 2017” refer to the nine months ended September 30, 2018 and 2017, respectively.
2)    SIGNIFICANT ACCOUNTING POLICIES
Adoption of New Accounting Pronouncements
Standard
Description
Effect on the Financial Statement or Other Significant Matters
ASU 2014-09
Revenue from Contracts with Customers (Topic 606)
This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP and IFRS.
On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. Adoption did not change the amounts or timing of the Company’s revenue recognition for base investment management and advisory fees, distribution revenues, shareholder servicing revenues, and broker-dealer revenues. Some performance-based fees and carried-interest distributions that were recognized prior to adoption when no risk of reversal remained, in certain instances may now be recognized earlier if it is probable that significant reversal will not occur.

On January 1, 2018, the Company recognized a cumulative effect adjustment, net of tax, to increase opening equity attributable to AXA Equitable and the noncontrolling interest by approximately $8 million and $25 million, respectively, reflecting the impact of carried-interest distributions previously received by AB of approximately $78 million, net of revenue sharing payments to investment team members of approximately $43 million, for which it is probable that significant reversal will not occur and for which incremental tax is provided at AXA Equitable.


13
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Standard
Description
Effect on the Financial Statement or Other Significant Matters
ASU 2016-01
Financial Instruments - Overall (Subtopic 825-10)
This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value currently are reported in AOCI.
On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in no material reclassification adjustment from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $13 million common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option.
ASU 2016-15 Statement of Cash Flows (Topic 230 )
This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method.
Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
ASU 2017-07
Compensation - Retirement Benefits (Topic 715)
This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement.
On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance.
ASU 2017-09
Compensation - Stock Compensation (Topic 718)
This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award.
Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements.
Future Adoption of New Accounting Pronouncements
Standard
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2018-14
Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20)
This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. Amendments in ASU 2018-14 remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements.
Effective for fiscal years ending after December 15, 2020, for public business entities. Early adoption is permitted. Amendments should be applied on a retrospective basis to all periods presented.
Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations.


14
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Standard
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2018-13
Fair Value Measurement (Topic 820)
This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU modify disclosure requirements in Topic 820, including the removal of certain disclosure requirements, modification of certain disclosures, and the addition of new requirements.
Effective for fiscal years beginning after December 15, 2019, for public business entities. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional requirements delayed until their effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively.
Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations.


15
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Standard
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2018-12
Financial Services - Insurance (Topic 944)
This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including:
–
Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts.  Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield.
–
Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk.  The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI.
–
Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts.  Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing.
–
Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, separate account liabilities and deferred acquisition costs.  Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement.
Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020.  Early adoption is permitted.
–
For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods.  Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception.  The same adoption method must be used for deferred acquisition costs.
–
For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented.
–
For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts.
Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on our consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls.


16
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Standard
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2018-07 Compensation - Stock Compensation (Topic 718)
This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees.
Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted.
The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements.

ASU 2018-02
Income Statement - Reporting Comprehensive Income

This ASU contains new guidance that permits, but does not require, entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, these stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits.
Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. Election can be made either to apply the new guidance retrospectively to each period in which the effect of the Tax Reform Act is recognized or in the period of adoption.
Management currently is evaluating the options provided for adopting this guidance and the potential impacts on the Company’s consolidated financial statements.
ASU 2017-12
Derivatives and Hedging (Topic 815)
The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results.
Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early application permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption.
Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements.
ASU 2017-08 Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20)
This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments.
Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis.
Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements.
ASU 2016-13
Financial Instruments - Credit Losses (Topic 326)
This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination.
Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, for public business entities. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective.
Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.


17
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Standard
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2016-02
Leases (Topic 842)
This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model.
Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach, which includes optional practical expedients that entities may elect to apply.
The Company expects to adopt ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB, when it becomes effective on January 1, 2019. The Company identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company expects to implement new accounting processes and internal controls to meet the requirements for financial reporting and disclosures of its leases. The Company expects these evaluation and implementation activities will continue throughout 2018 prior to the effective date of adoption on January 1, 2019. The Company plans to elect the optional modified retrospective transition method to apply the provisions of the new standard, which will result in a cumulative-effect adjustment to opening retained earnings in the period of adoption. Under this transition method, the Company would not recast prior financial statements.
Revenue Recognition
Investment Management and Service Fees and Related Expenses
Reported as Investment management and service fees in the Company’s consolidated statements of income (loss) are investment advisory and service fees, distribution revenues, and institutional research services revenues principally emerging from the Investment Management and Research segment. Also included are investment management and administrative service fees earned by AXA Equitable Funds Management Group, LLC (“AXA Equitable FMG”) and reported in the Individual Retirement, Group Retirement and Protection Solutions segments as well as certain asset-based fees associated with insurance contracts.
Investment management, advisory, and service fees
AB provides asset management services by managing customer assets and seeking to deliver returns to investors. Similarly, AXA Equitable FMG provides investment management and administrative services, such as fund accounting and compliance services, to AXA Premier VIP Trust (“VIP Trust”), EQ Advisors Trust (“EQAT”) and 1290 Funds as well as two private investment trusts established in the Cayman Islands, AXA Allocation Funds Trust and AXA Offshore Multimanager Funds Trust (collectively, the “Other AXA Trusts”). The contracts supporting these revenue streams create a distinct, separately identifiable performance obligation for each day the assets are managed for the performance of a series of services that are substantially the same and have the same pattern of transfer to the customer. Accordingly, these investment management, advisory, and administrative service base fees are recorded over time as services are performed and entitle the Company to variable consideration. Base fees, generally calculated as a percentage of assets under management (“AUM”), are recognized as revenue at month-end when the transaction price no longer is variable and the value of the consideration is determined. These fees are not subject to claw back and there is minimal probability that a significant reversal of the revenue recorded will occur.
Certain investment advisory contracts of AB, including those associated with hedge funds or other alternative investments, provide for a performance-based fee (including carried interest), in addition to a base advisory fee,


18
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

calculated either as a percentage of absolute investment results or a percentage of investment results in excess of a stated benchmark over a specified period of time. These performance-based fees are forms of variable consideration and therefore, are excluded from the transaction price until it becomes probable there will not be significant reversal of the cumulative revenue recognized. At each reporting date, the Company evaluates constraining factors surrounding the variable consideration to determine the extent to which, if any, revenues associated with the performance-based fee can be recognized. Constraining factors impacting the amount of variable consideration included in the transaction price include contractual claw-back provisions, the length of time of the uncertainty, the number and range of possible amounts, the probability of significant fluctuations in the fund’s market value, and the level in which the fund’s value exceeds the contractual threshold required to earn such a fee and the materiality of the amount being evaluated. Prior to adoption of the new revenue recognition guidance on January 1, 2018, the Company recognized performance-based fees at the end of the applicable measurement period when no risk of reversal remained, and carried-interest distributions received as deferred revenues until no risk of reversal remained.
Sub-advisory and sub-administrative expenses associated with these services are calculated and recorded as the related services are performed in Other operating costs and expense in the consolidated statements of income (loss) as the Company is acting in a principal capacity in these transactions and, as such, reflects these revenues and expenses on a gross basis.
Research services
Research services revenue principally consists of brokerage transaction charges received by Sanford C. Bernstein & Co. LLC (“SCB LLC”), Sanford C. Bernstein Limited (“SCBL”) and AB’s other sell side subsidiaries for providing equity research services to institutional clients. Brokerage commissions for trade execution services and related expenses are recorded on a trade-date basis when the performance obligations are satisfied. Generally, the transaction price is agreed upon at the point of each trade and based upon the number of shares traded or the value of the consideration traded. Research revenues are recognized when the transaction price is quantified, collectability is assured, and significant reversal of such revenue is not probable.
Distribution services
Revenues from distribution services include fees received as partial reimbursement of expenses incurred in connection with the sale of certain AB sponsored mutual funds and the 1290 Funds and for the distribution primarily of EQAT and VIP Trust shares to separate accounts in connection with the sale of variable life and annuity contracts. The amount and timing of revenues recognized from performance of these distribution services often is dependent upon the contractual arrangements with the customer and the specific product sold as further described below.
Most open-end management investment companies, such as U.S. funds and the EQAT and VIP Trusts and the 1290 Funds, have adopted a plan under Rule 12b-1 of the Investment Company Act that allows for certain share classes to pay out of assets, distribution and service fees for the distribution and sale of its shares (“12b-1 Fees”). These open-end management investment companies have such agreements with the Company, and the Company has selling and distribution agreements pursuant to which it pays sales commissions to the financial intermediaries that distribute the shares. These agreements may be terminated by either party upon notice (generally 30 days) and do not obligate the financial intermediary to sell any specific amount of shares.
The Company records 12b-1 fees monthly based upon a percentage of the net asset value (“NAV”) of the funds. At month-end, the variable consideration of the transaction price is no longer constrained as the NAV can be calculated and the value of consideration is determined. These services are separate and distinct from other asset management services as the customer can benefit from these services independently of other services. The Company accrues the corresponding 12b-1 fees paid to sub-distributors monthly as the expenses are incurred. The Company is acting in a principal capacity in these transactions; as such, these revenues and expenses are recorded on a gross basis in the consolidated statements of income (loss).
AB sponsored mutual funds offer back-end load shares in limited instances and charge the investor a contingent deferred sales charge (“CDSC”) if the investment is redeemed within a certain period. The variable consideration for these


19
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

contracts is contingent upon the timing of the redemption by the investor and the value of the sales proceeds. Due to these constraining factors, the Company excludes the CDSC fee from the transaction price until the investor redeems the investment. Upon redemption, the cash consideration received for these contractual arrangements is recorded as a reduction of unamortized deferred sales commissions.
AB’s Luxembourg subsidiary, the management company for most of its non-U.S. funds earns a management fee which is accrued daily and paid monthly, at an annual rate, based on the average daily net assets of the fund. With respect to certain share classes, the management fee also may contain a component paid to distributors and other financial intermediaries and service providers to cover shareholder servicing and other administrative expenses (also referred to as an “All-in-Fee”). Based on the conclusion that asset management is distinct from distribution, the Company allocates a portion of the investment and advisory fee to distribution revenues for the servicing component based on standalone selling prices.
Other revenues
Also reported as Investment management and service fees in the Company’s consolidated statements of income (loss) are other revenues from contracts with customers, primarily consisting of shareholder servicing fees, mutual fund reimbursements, and other brokerage income.
Shareholder services, including transfer agency, administration, and record-keeping are provided by AB to company-sponsored mutual funds. The consideration for these services is based on a percentage of the NAV of the fund or a fixed-fee based on the number of shareholder accounts being serviced. The revenues are recorded at month-end when the constraining factors involved with determining NAV or the numbers of shareholders’ accounts are resolved.
Other income
Revenues from contracts with customers reported as Other Income in the Company’s consolidated statements of income (loss) primarily consist of advisory account fees and brokerage commissions from the Company’s subsidiary broker-dealer operations and sales commissions from the Company’s general agent for the distribution of non-affiliate insurers’ life insurance and annuity products. These revenues are recognized at month-end when constraining factors, such as AUM and product mix, are resolved and the transaction pricing no longer is variable such that the value of consideration can be determined.
Contract assets and liabilities
The Company applies the practical expedient for contracts that have an original duration of one year or less. Accordingly, the Company accrues the incremental costs of obtaining a contract when incurred and does not consider the time value of money. At September 30, 2018 there are no material balances of contract assets and contract liabilities; as such, no further disclosures are necessary.
Accounting and Consolidation of Variable Interest Entities (“VIEs”)
At September 30, 2018, the Company held approximately $1.2 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds, and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $166.1 billion, and the Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.2 billion at September 30, 2018. Except for approximately $748 million of unfunded commitments


20
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

at September 30, 2018, the Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.
At September 30, 2018, the Company consolidated one real estate joint venture for which it was identified as primary beneficiary under the VIE model. The consolidated entity is jointly owned by AXA Equitable and AXA France and holds an investment in a real estate venture. Included in the Company’s consolidated balance sheets at September 30, 2018, are total assets of $37 million related to this VIE, primarily resulting from the consolidated presentation of $37 million of real estate held for production of income. In addition, real estate held for production of income reflects $17 million as related to two non-consolidated joint ventures at September 30, 2018.
Included in the Company’s consolidated balance sheets at September 30, 2018 are assets of $202 million, liabilities of $6 million and redeemable non-controlling interest of $80 million associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets at September 30, 2018 are assets of $121 million, liabilities of $3 million and redeemable non-controlling interest of $21 million from consolidation of AB-sponsored investment funds under the VOE model. The assets of these consolidated funds are presented within Other invested assets and cash and cash equivalents, and liabilities of these consolidated funds are presented with other liabilities on the face of the Company’s consolidated balance sheets at September 30, 2018; ownership interests not held by the Company relating to consolidated VIEs and VOEs are presented either as redeemable or non-redeemable noncontrolling interest, as appropriate.
As of September 30, 2018, the net assets of AB-sponsored investment products that are non-consolidated VIEs are approximately $58.2 billion, and the Company’s maximum risk of loss is its investment of $6 million in these VIEs and its advisory fee receivables from these VIEs, which are not material.
Assumption Updates and Model Changes
In 2018, the Company began conducting its annual review of our assumptions and models during the third quarter, consistent with industry practice. The annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for our insurance business, liabilities for future policyholder benefits, DAC and deferred sales inducement assets. As a result of this review, some assumptions were updated, resulting in increases and decreases in the carrying values of these product liabilities and assets.
The net impact of assumption changes in the third quarter of 2018 decreased Policy charges and fee income by $12 million, decreased Policyholders’ benefits by $684 million, increased Net derivative losses by $1,065 million, and decreased the Amortization of DAC, net by $165 million. This resulted in a decrease in Income (loss) from operations, before income taxes of $228 million and decreased Net income (loss) by approximately $187 million.
Revision of Prior Period Financial Statements
As previously reported, during the preparation of the second quarter 2018 financial statements, management identified errors in its previously issued financial statements related to: (a) a misclassification between interest credited and net derivative gains/losses, (b) an error in an actuarial model used to determine the deferred acquisition cost asset and related amortization for a specific group of insurance products issued by the Company, and (c) the understatement of a charge from Holdings related to partial settlement of a pension plan obligation. The impact of these errors to the Company’s consolidated financial statements for the three months ended March 31, 2018, the nine months ended September 30, 2017, the six months ended June 30, 2017, the three months ended March 31, 2017 and the years ended December 31, 2017 and 2016 were not considered to be material.
In addition, during the preparation of its third quarter 2018 financial statements, management identified errors in its previously issued financial statements. These errors primarily relate to the calculation of policyholders’ benefit reserves for the Company’s life and annuity products and the calculation of net derivative gains (losses) and DAC amortization for certain variable and interest sensitive life products. The impact of these errors were not considered to be material to the consolidated financial statements as of and for the three months ended March 31, 2018, the three and six months


21
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

ended June 30, 2018, the three and nine months ended September 30, 2017, the three and six months ended June 30, 2017, the three months ended March 31, 2017 and the years ended December 31, 2017, 2016 and 2015. However, in order to improve the consistency and comparability of the financial statements, management has determined to revise the Company’s consolidated financial statements for the three and six months ended March 31, 2018 and June 30, 2018, respectively, as well as the three, six and nine months ended March 31, 2017, June 30, 2017 and September 30, 2017, respectively and for the years ended December 31, 2017, 2016 and 2015.
See Note 15 for details of the revisions.
3)    INVESTMENTS
Fixed Maturities
The following tables provide information relating to fixed maturities classified as AFS. As a result of the adoption of the Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities (ASU 2016-01) standard on January 1, 2018 (see Note 2), equity securities are no longer classified and accounted for as available-for-sale securities.
Available-for-Sale Securities by Classification 
 
Amortized
Cost
 
Gross Unrealized
Gains
 
Gross Unrealized
Losses
 
Fair
Value
 
OTTI
in AOCI (3)
 
(in millions)
September 30, 2018:
 
 
 
 
 
 
 
 
 
Fixed Maturities:
 
 
 
 
 
 
 
 
 
Corporate
$
24,796

 
$
397

 
$
591

 
$
24,602

 
$
—

U.S. Treasury, government and agency
13,621

 
58

 
728

 
12,951

 
—

States and political subdivisions
409

 
43

 
1

 
451

 
—

Foreign governments
431

 
17

 
10

 
438

 
—

Residential mortgage-backed(1)
200

 
8

 
—

 
208

 
—

Asset-backed(2)
613

 
1

 
6

 
608

 
2

Redeemable preferred stock
472

 
31

 
7

 
496

 
—

Total at September 30, 2018
$
40,542

 
$
555

 
$
1,343

 
$
39,754

 
$
2

 


22
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Amortized
Cost
 
Gross Unrealized
Gains
 
Gross Unrealized
Losses
 
Fair
Value
 
OTTI
in AOCI (3)
 
(in millions)
December 31, 2017:
 
 
 
 
 
 
 
 
 
Fixed Maturities:
 
 
 
 
 
 
 
 
 
Corporate
$
20,596

 
$
942

 
$
56

 
$
21,482

 
$
—

U.S. Treasury, government and agency
12,644

 
676

 
185

 
13,135

 
—

States and political subdivisions
414

 
67

 
—

 
481

 
—

Foreign governments
387

 
27

 
5

 
409

 
—

Residential mortgage-backed(1)
236

 
15

 
—

 
251

 
—

Asset-backed(2)
93

 
3

 
—

 
96

 
2

Redeemable preferred stock
461

 
44

 
1

 
504

 
—

Total Fixed Maturities
$
34,831

 
$
1,774

 
$
247

 
$
36,358

 
$
2

Equity securities
157

 
—

 
—

 
157

 
—

Total at December 31, 2017
$
34,988

 
$
1,774

 
$
247

 
$
36,515

 
$
2

_____________
(1)
Includes publicly traded agency pass-through securities and collateralized obligations.
(2)
Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
(3)
Amounts represent OTTI losses in AOCI, which were not included in income (loss) in accordance with current accounting guidance.

The contractual maturities of AFS fixed maturities at September 30, 2018 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Available-for-Sale Fixed Maturities
Contractual Maturities at September 30, 2018 
 
Amortized
Cost
 
Fair Value
 
(in millions)
Due in one year or less
$
1,908

 
$
1,915

Due in years two through five
7,755

 
7,816

Due in years six through ten
12,941

 
12,719

Due after ten years
16,653

 
15,992

Subtotal
$
39,257

 
$
38,442

Residential mortgage-backed securities
200

 
208

Asset-backed securities
613

 
608

Redeemable preferred stock
472

 
496

Total
$
40,542

 
$
39,754



23
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the three and nine months ended September 30, 2018 and 2017: 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Proceeds from sales
$
973

 
$
1,287

 
$
4,774

 
$
1,822

Gross gains on sales
$
6

 
$
5

 
$
140

 
$
34

Gross losses on sales
$
(4
)
 
$
(2
)
 
$
(59
)
 
$
(29
)
 
 
 
 
 
 
 
 
Total OTTI
$
(4
)
 
$
—

 
$
(4
)
 
$
(13
)
Non-credit losses recognized in OCI
—

 
—

 
—

 
—

Credit losses recognized in net income (loss)
$
(4
)
 
$
—

 
$
(4
)
 
$
(13
)
The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts:
Fixed Maturities - Credit Loss Impairments 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Balances, beginning of period
$
(9
)
 
$
(115
)
 
$
(10
)
 
$
(190
)
Previously recognized impairments on securities that matured, paid, prepaid or sold
—

 
32

 
1

 
120

Recognized impairments on securities impaired to fair value this period(1)
—

 
—

 
—

 
—

Impairments recognized this period on securities not previously impaired
(4
)
 
—

 
(4
)
 
(13
)
Additional impairments this period on securities previously impaired
—

 
—

 
—

 
—

Increases due to passage of time on previously recorded credit losses
—

 
—

 
—

 
—

Accretion of previously recognized impairments due to increases in expected cash flows
—

 
—

 
—

 
—

Balances at September 30
$
(13
)
 
$
(83
)
 
$
(13
)
 
$
(83
)
_______________
(1)     Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.



24
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated:
 
September 30,
2018
 
December 31, 2017
 
(in millions)
AFS Securities:
 
 
 
Fixed maturities:
 
 
 
With OTTI loss
$
1

 
$
1

All other
(789
)
 
1,526

Net Unrealized Gains (Losses)
$
(788
)
 
$
1,527

Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized and all other:
Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses
 
Net
Unrealized
Gains
(Losses) on
Investments
 
DAC
 
Policyholders’
Liabilities
 
Deferred
Income
Tax Asset
(Liability)
 
AOCI Gain
(Loss) Related
to Net
Unrealized
Investment
Gains (Losses)
 
(in millions)
Balance, July 1, 2018
$
1

 
$
—

 
$
—

 
$
—

 
$
1

Net investment gains (losses) arising during the period
—

 
—

 
—

 
—

 
—

Reclassification adjustment:
 
 
 
 
 
 
 
 
 
Included in Net income (loss)
—

 
—

 
—

 
—

 
—

Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
—

 
—

 
—

 
—

Deferred income taxes
—

 
—

 
—

 
—

 
—

Policyholders’ liabilities
—

 
—

 
—

 
—

 
—

Balance, September 30, 2018
$
1

 
$
—

 
$
—

 
$
—

 
$
1

 
 
 
 
 
 
 
 
 
 
Balance, July 1, 2017
$
(6
)
 
$
2

 
$
1

 
$
1

 
$
(2
)
Net investment gains (losses) arising during the period
(5
)
 
—

 
—

 
—

 
(5
)
Reclassification adjustment:
 
 
 
 
 
 
 
 
 
Included in Net income (loss)
11

 
—

 
—

 
—

 
11

Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
(1
)
 
—

 
—

 
(1
)
Deferred income taxes
—

 
—

 
—

 
(1
)
 
(1
)
Policyholders’ liabilities
—

 
—

 
(1
)
 
—

 
(1
)
Balance, September 30, 2017
$
—

 
$
1

 
$
—

 
$
—

 
$
1



25
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

____________
(1)
Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in income (loss) for securities with no prior OTTI loss.


 
Net
Unrealized
Gains
(Losses) on
Investments
 
DAC
 
Policyholders’
Liabilities
 
Deferred
Income
Tax Asset
(Liability)
 
AOCI Gain
(Loss) Related
to Net
Unrealized
Investment
Gains (Losses)
 
(in millions)
Balance, January 1, 2018
$
1

 
$
1

 
$
(1
)
 
$
(5
)
 
$
(4
)
Net investment gains (losses) arising during the period
—

 
—

 
—

 
—

 
—

Reclassification adjustment:
 
 
 
 
 
 
 
 
 
Included in Net income (loss)
—

 
—

 
—

 
—

 
—

Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
(1
)
 
—

 
—

 
(1
)
Deferred income taxes
—

 
—

 
—

 
5

 
5

Policyholders’ liabilities
—

 
—

 
1

 
—

 
1

Balance, September 30, 2018
$
1

 
$
—

 
$
—

 
$
—

 
$
1

 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2017
$
19

 
$
(1
)
 
$
(10
)
 
$
(3
)
 
$
5

Net investment gains (losses) arising during the period
—

 
—

 
—

 
—

 
—

Reclassification adjustment:
 
 
 
 
 
 
 
 
 
Included in Net income (loss)
(19
)
 
—

 
—

 
—

 
(19
)
Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
2

 
—

 
—

 
2

Deferred income taxes
—

 
—

 
—

 
3

 
3

Policyholders’ liabilities
—

 
—

 
10

 
—

 
10

Balance, September 30, 2017
$
—

 
$
1

 
$
—

 
$
—

 
$
1

____________
(1)
Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in income (loss) for securities with no prior OTTI loss.


26
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

All Other Net Unrealized Investment Gains (Losses) in AOCI
 
Net
Unrealized
Gains
(Losses) on
Investments
 
DAC
 
Policyholders’
Liabilities
 
Deferred
Income
Tax Asset
(Liability)
 
AOCI Gain
(Loss) Related
to Net
Unrealized
Investment
Gains (Losses)
 
(in millions)
Balance, July 1, 2018
$
(245
)
 
$
11

 
$
(110
)
 
$
(27
)
 
$
(371
)
Net investment gains (losses) arising during the period
(554
)
 
—

 
—

 
—

 
(554
)
Reclassification adjustment:
 
 
 
 
 
 
 
 
—

Included in Net income (loss)
10

 
—

 
—

 
—

 
10

Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
72

 
—

 
—

 
72

Deferred income taxes
—

 
—

 
—

 
112

 
112

Policyholders’ liabilities
—

 
—

 
(62
)
 
—

 
(62
)
Balance, September 30, 2018
$
(789
)
 
$
83

 
$
(172
)
 
$
85

 
$
(793
)
 
 
 
 
 
 
 
 
 
 
Balance, July 1, 2017
$
1,145

 
$
(200
)
 
$
(191
)
 
$
(263
)
 
$
491

Net investment gains (losses) arising during the period
18

 
—

 
—

 
—

 
18

Reclassification adjustment:
 
 
 
 
 
 
 
 

Included in Net income (loss)
(2
)
 
—

 
—

 
—

 
(2
)
Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
(48
)
 
—

 


 
(48
)
Deferred income taxes
—

 
—

 
—

 
29

 
29

Policyholders’ liabilities
—

 
—

 
(53
)
 


 
(53
)
Balance, September 30, 2017
$
1,161

 
$
(248
)
 
$
(244
)
 
$
(234
)
 
$
435

_______________
(1)
Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss.


27
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


 
Net
Unrealized
Gains
(Losses) on
Investments
 
DAC
 
Policyholders’
Liabilities
 
Deferred
Income
Tax Asset
(Liability)
 
AOCI Gain
(Loss) Related
to Net
Unrealized
Investment
Gains (Losses)
 
(in millions)
Balance, January 1, 2018
$
1,526

 
$
(315
)
 
$
(232
)
 
$
(300
)
 
$
679

Net investment gains (losses) arising during the period
(2,240
)
 
—

 
—

 
—

 
(2,240
)
Reclassification adjustment:
 
 
 
 
 
 
 
 
—

Included in Net income (loss)
(75
)
 
—

 
—

 
—

 
(75
)
Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC
—

 
398

 
—

 
—

 
398

Deferred income taxes
—

 
—

 
—

 
385

 
385

Policyholders’ liabilities
—

 
—

 
60

 
—

 
60

Balance, September 30, 2018
$
(789
)
 
$
83

 
$
(172
)
 
$
85

 
$
(793
)
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2017
$
428

 
$
(104
)
 
$
(188
)
 
$
(47
)
 
$
89

Net investment gains (losses) arising during the period
705

 
—

 
—

 
—

 
705

Reclassification adjustment:
 
 
 
 
 
 
 
 

Included in Net income (loss)
28

 
—

 
—

 
—

 
28

Excluded from Net income (loss)(1)
—

 
—

 
—

 
—

 
—

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 

DAC
—

 
(144
)
 
—

 
—

 
(144
)
Deferred income taxes
—

 
—

 
—

 
(187
)
 
(187
)
Policyholders’ liabilities
—

 
—

 
(56
)
 
—

 
(56
)
Balance, September 30, 2017
$
1,161

 
$
(248
)
 
$
(244
)
 
$
(234
)
 
$
435

____________
(1)
Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss.



28
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables disclose the fair values and gross unrealized losses of the 1,461 issues at September 30, 2018 and the 620 issues at December 31, 2017 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
 
Less Than 12 Months
 
12 Months or Longer
 
Total
 
Fair
Value
 
Gross
Unrealized
Losses
 
Fair
Value
 
Gross
Unrealized
Losses
 
Fair
Value
 
Gross
Unrealized
Losses
 
(in millions)
September 30, 2018:
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturities:
 
 
 
 
 
 
 
 
 
 
 
Corporate
$
12,410

 
$
466

 
$
2,006

 
$
125

 
$
14,416

 
$
591

U.S. Treasury, government and agency
8,316

 
251

 
2,952

 
477

 
11,268

 
728

States and political subdivisions
19

 
1

 
—

 
—

 
19

 
1

Foreign governments
68

 
2

 
73

 
8

 
141

 
10

Residential mortgage-backed
13

 
—

 
—

 
—

 
13

 
—

Asset-backed
399

 
6

 
—

 
—

 
399

 
6

Redeemable preferred stock
177

 
6

 
12

 
1

 
189

 
7

Total
$
21,402

 
$
732


$
5,043


$
611


$
26,445


$
1,343

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017:
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturities:
 
 
 
 
 
 
 
 
 
 
 
Corporate
$
2,102

 
$
17

 
$
1,163

 
$
39

 
$
3,265

 
$
56

U.S. Treasury, government and agency
2,150

 
6

 
3,005

 
179

 
5,155

 
185

States and political subdivisions
20

 
—

 
—

 
—

 
20

 
—

Foreign governments
11

 
—

 
73

 
5

 
84

 
5

Residential mortgage-backed
18

 
—

 
—

 
—

 
18

 
—

Asset-backed
7

 
—

 
2

 
—

 
9

 
—

Redeemable preferred stock
7

 
—

 
12

 
1

 
19

 
1

Total
$
4,315

 
$
23

 
$
4,255

 
$
224

 
$
8,570

 
$
247

The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of AXA Equitable, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.5% of total investments. The largest exposures to a single issuer of corporate securities held at September 30, 2018 and December 31, 2017 were $200 million and $182 million, respectively.
Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium grade), 4 or 5 (below investment grade) or 6 (in or near default). At September 30, 2018 and December 31, 2017, respectively, approximately $1,280 million and $1,309 million, or 3.2% and 3.8%, of the $40,542 million and $34,831 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized gains and (losses) of $(11) million and $5 million at September 30, 2018 and December 31, 2017, respectively.
At September 30, 2018 and December 31, 2017, respectively, the $611 million and $224 million of gross unrealized losses of twelve months or more were concentrated in corporate and U.S. Treasury, government and agency securities.


29
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

In accordance with the policy described in Note 2, the Company concluded that an adjustment to income for OTTI for these securities was not warranted at either September 30, 2018 or 2017. At September 30, 2018 and December 31, 2017, the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis.
The Company does not originate, purchase or warehouse residential mortgages and is not in the mortgage servicing business. At September 30, 2018, the carrying value of fixed maturities that were non-income producing for the twelve months preceding that date was $2 million.
For the three and nine months ended September 30, 2018 and 2017, investment income is shown net of investment expenses of $17 million, $49 million, $11 million and $40 million respectively.
At September 30, 2018 and December 31, 2017, the fair values of the Company’s trading account securities were $14,760 million and $12,628 million, respectively. Also at September 30, 2018 and December 31, 2017, trading securities included the General Account’s investment in Separate Accounts, which had carrying values of $52 million and $49 million, respectively.
Net unrealized and realized gains (losses) on trading account equity securities are included in Net investment income (loss) in the Consolidated Statements of Income (Loss). The table below shows a breakdown of Net investment income from trading account securities during the three and nine months ended September 30, 2018 and 2017:
Net Investment Income (Loss) from Trading Securities 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period
$
(20
)
 
$
45

 
$
(192
)
 
$
153

Net investment gains (losses) recognized on securities sold during the period
$
(5
)
 
$
10

 
(14
)
 
35

Unrealized and realized gains (losses) on trading securities arising during the period
(25
)
 
55

 
(206
)
 
188

Interest and dividend income from trading securities
82

 
54

 
228

 
143

Net investment income (loss) from trading securities
$
57

 
$
109

 
$
22

 
$
331

Mortgage Loans
At September 30, 2018 and December 31, 2017, the carrying values of problem commercial mortgage loans on real estate that had been classified as nonaccrual loans were $19 million and $19 million, respectively.


30
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Valuation Allowances for Mortgage Loans:
Allowance for credit losses for mortgage loans for the nine months ended September 30, 2018 and 2017 are as follows:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Allowance for credit losses:
 
 
 
Beginning balance, January 1
$
8

 
$
8

Charge-offs
—

 
—

Recoveries
(1
)
 
—

Provision
—

 
—

Ending balance, September 30,
$
7

 
$
8

 
 
 
 
September 30, Individually Evaluated for Impairment
$
7

 
$
8


There were no allowances for credit losses for agricultural mortgage loans for the nine months ended September 30, 2018 and 2017.
The following tables provide information relating to the loan to value and debt service coverage ratios for commercial and agricultural mortgage loans at September 30, 2018 and December 31, 2017.

Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
September 30, 2018
 
Debt Service Coverage Ratio(1)
 
 
Loan-to-Value Ratio:(2)
Greater than 2.0x
 
1.8x to 2.0x
 
1.5x to 1.8x
 
1.2x to 1.5x
 
1.0x to 1.2x
 
Less than 1.0x
 
Total Mortgage
Loans
 
(in millions)
Commercial Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
806

 
$
21

 
$
351

 
$
24

 
$
—

 
$
—

 
$
1,202

50% - 70%
4,739

 
649

 
1,192

 
603

 
151

 
—

 
7,334

70% - 90%
221

 
110

 
169

 
298

 
27

 
—

 
825

90% plus
—

 
—

 
27

 
—

 
—

 
—

 
27

Total Commercial Mortgage Loans
$
5,766

 
$
780

 
$
1,739

 
$
925

 
$
178

 
$
—

 
$
9,388

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agricultural Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
271

 
$
142

 
$
257

 
$
555

 
$
322

 
$
33

 
$
1,580

50% - 70%
127

 
53

 
231

 
378

 
235

 
49

 
1,073

70% - 90%
—

 
—

 
—

 
19

 
—

 
—

 
19

90% plus
—

 
—

 
—

 
—

 
—

 
—

 
—

Total Agricultural Mortgage Loans
$
398

 
$
195

 
$
488

 
$
952

 
$
557

 
$
82

 
$
2,672



31
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Debt Service Coverage Ratio(1)
 
 
Loan-to-Value Ratio:(2)
Greater than 2.0x
 
1.8x to 2.0x
 
1.5x to 1.8x
 
1.2x to 1.5x
 
1.0x to 1.2x
 
Less than 1.0x
 
Total Mortgage
Loans
 
(in millions)
Total Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
1,077

 
$
163

 
$
608

 
$
579

 
$
322

 
$
33

 
$
2,782

50% - 70%
4,866

 
702

 
1,423

 
981

 
386

 
49

 
8,407

70% - 90%
221

 
110

 
169

 
317

 
27

 
—

 
844

90% plus
—

 
—

 
27

 
—

 
—

 
—

 
27

Total Mortgage Loans
$
6,164

 
$
975

 
$
2,227

 
$
1,877

 
$
735

 
$
82

 
$
12,060

_______________
(1)
The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
(2)
The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.

Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
December 31, 2017
 
Debt Service Coverage Ratio(1)
 
 
Loan-to-Value Ratio:(2)
Greater than 2.0x
 
1.8x to 2.0x
 
1.5x to 1.8x
 
1.2x to 1.5x
 
1.0x to 1.2x
 
Less than 1.0x
 
Total Mortgage Loans
 
(in millions)
Commercial Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
742

 
$
—

 
$
320

 
$
74

 
$
—

 
$
—

 
$
1,136

50% - 70%
4,088

 
682

 
1,066

 
428

 
145

 
—

 
6,409

70% - 90%
169

 
110

 
196

 
272

 
50

 
—

 
797

90% plus
—

 
—

 
27

 
—

 
—

 
—

 
27

Total Commercial Mortgage Loans
$
4,999

 
$
792

 
$
1,609

 
$
774

 
$
195

 
$
—

 
$
8,369

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agricultural Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
272

 
$
149

 
$
275

 
$
515

 
$
316

 
$
30

 
$
1,557

50% - 70%
111

 
46

 
227

 
359

 
221

 
49

 
1,013

70% - 90%
—

 
—

 
—

 
4

 
—

 
—

 
4

90% plus
—

 
—

 
—

 
—

 
—

 
—

 
—

Total Agricultural Mortgage Loans
$
383

 
$
195

 
$
502

 
$
878

 
$
537

 
$
79

 
$
2,574

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
1,014

 
$
149

 
$
595

 
$
589

 
$
316

 
$
30

 
$
2,693

50% - 70%
4,199

 
728

 
1,293

 
787

 
366

 
49

 
7,422

70% - 90%
169

 
110

 
196

 
276

 
50

 
—

 
801

90% plus
—

 
—

 
27

 
—

 
—

 
—

 
27

Total Mortgage Loans
$
5,382

 
$
987

 
$
2,111

 
$
1,652

 
$
732

 
$
79

 
$
10,943

______________
(1)
The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.


32
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

(2)
The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.

The following table provides information relating to the aging analysis of past due mortgage loans at September 30, 2018 and December 31, 2017, respectively.
Age Analysis of Past Due Mortgage Loan
 
30-59 Days
 
60-89 Days
 
90 Days
or More
 
Total
 
Current
 
Total Financing Receivables
 
Recorded Investment 90 Days or More and Accruing
 
 
 
 
 
 
 
(in millions)
 
 
 
 
September 30, 2018
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
$
—

 
$
—

 
$
27

 
$
27

 
$
9,361

 
$
9,388

 
$
—

Agricultural
5

 
12

 
57

 
74

 
2,598

 
2,672

 
57

Total Mortgage Loans
$
5

 
$
12

 
$
84

 
$
101

 
$
11,959

 
$
12,060

 
$
57

December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
$
27

 
$
—

 
$
—

 
$
27

 
$
8,342

 
$
8,369

 
$
—

Agricultural
49

 
3

 
22

 
74

 
2,500

 
2,574

 
22

Total Mortgage Loans
$
76

 
$
3

 
$
22

 
$
101

 
$
10,842

 
$
10,943

 
$
22

The following table provides information relating to impaired mortgage loans at September 30, 2018 and December 31, 2017, respectively:
Impaired Mortgage Loans
 
Recorded
Investment
 
Unpaid
Principal
Balance
 
Related
Allowance
 
Average
Recorded
Investment(1)
 
Interest
Income
Recognized
 
(in millions)
September 30, 2018:
 
 
 
 
 
 
 
 
 
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Agricultural mortgage loans
—

 
—

 
—

 
—

 
—

Total
$
—

 
$
—

 
$
—

 
$
—

 
$
—

With related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
27

 
$
27

 
$
(7
)
 
$
27

 
$
—

Agricultural mortgage loans
—

 
—

 
—

 
—

 
—

Total
$
27

 
$
27

 
$
(7
)
 
$
27

 
$
—

 
 
 
 
 
 
 
 
 
 
December 31, 2017:
 
 
 
 
 
 
 
 
 
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Agricultural mortgage loans
—

 
—

 
—

 
—

 
—

Total
$
—

 
$
—

 
$
—

 
$
—

 
$
—

With related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
27

 
$
27

 
$
(8
)
 
$
27

 
$
2

Agricultural mortgage loans
—

 
—

 
—

 
—

 
—

Total
$
27

 
$
27

 
$
(8
)
 
$
27

 
$
2



33
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

_______________
(1)
Represents a three-quarter average of recorded amortized cost.

Types of Derivative Instruments and Derivative Strategies
The Company utilizes various derivative instruments and strategies to manage its risk. Commonly used derivative instruments include, but are not necessarily limited to, exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options credit and foreign exchange derivatives as well as bond and repo transactions to support the hedging. The Company also uses foreign exchange derivatives to reduce exposure to currency fluctuations that may arise from non-U.S.-dollar denominated financial instruments. The Company had a currency swap contract with AXA to hedge foreign exchange exposure from affiliated loans, which matured in March 2018.
For detailed information on these derivative instruments and strategies, see Note 3 to the consolidated financial statements included in the 2017 Form 10-K.
The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.
Derivative Instruments by Category
 
At September 30, 2018
 
Gains (Losses)
Reported In Net
Earnings (Loss)
Nine Months Ended September 30, 2018
 
 
 
Fair Value
 
 
Notional
Amount
 
Asset
Derivatives
 
Liability
Derivatives
 
 
(in millions)
Freestanding derivatives:
 
 
 
 
 
 
 
Equity contracts:(1,4)
 
 
 
 
 
 
 
Futures
$
7,307

 
$
1

 
$
1

 
$
(487
)
Swaps
7,900

 
12

 
189

 
(488
)
Options
24,248

 
4,119

 
1,619

 
674

Interest rate contracts:(1,4)
 
 
 
 
 
 
 
Swaps
25,761

 
330

 
653

 
(1,012
)
Futures
17,172

 
—

 
—

 
52

Credit contracts:(1,4)
 
 
 
 
 
 
 
Credit default swaps
1,935

 
28

 
3

 
3

Other freestanding contracts:(1,4)
 
 
 
 
 
 
 
Foreign currency contracts
2,110

 
75

 
9

 
60

Margin
—

 
27

 
—

 
—

Collateral
—

 
65

 
2,135

 
—

Embedded derivatives:
 
 
 
 
 
 
 
GMIB reinsurance contracts(4)
—

 
1,571

 
—

 
(1,488
)
GMxB derivative features liability(2,4)
—

 
—

 
4,157

 
394

SCS, SIO, MSO and IUL indexed features(3,4)
—

 
—

 
2,357

 
(814
)
Total
$
86,433

 
$
6,228

 
$
11,123

 
$
(3,106
)
_______________
(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.


34
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

(3)
SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in the Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.
(4)
Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
 
At December 31, 2017
 
Gains (Losses)
Reported In Net
Earnings (Loss)
Nine Months Ended September 30, 2017
 
 
 
Fair Value
 
 
Notional
Amount
 
Asset
Derivatives
 
Liability
Derivatives
 
 
(in millions)
Freestanding derivatives:
 
 
 
 
 
 
 
Equity contracts:(1,4)
 
 
 
 
 
 
 
Futures
$
3,113

 
$
1

 
$
3

 
$
(512
)
Swaps
4,655

 
3

 
126

 
(596
)
Options
20,630

 
3,334

 
1,426

 
831

Interest rate contracts:(1,4)
 
 
 
 
 
 
 
Swaps
19,032

 
320

 
191

 
523

Futures
11,032

 
—

 
—

 
28

Swaptions
—

 
—

 
—

 
—

Credit contracts:(1,4)
 
 
 
 
 
 
 
Credit default swaps
2,131

 
35

 
3

 
16

Other freestanding contracts:(1,4)
 
 
 
 
 
 
 
Foreign currency contracts
1,423

 
19

 
10

 
(40
)
Margin
—

 
24

 
—

 
—

Collateral
—

 
4

 
1,855

 
—

Embedded derivatives:
 
 
 
 
 
 
 
GMIB reinsurance contracts(4)
—

 
10,488

 
—

 
500

GMxB derivative features liability(2,4)
—

 
—

 
4,256

 
1,169

SCS, SIO, MSO and IUL indexed features(3,4)
—

 
—

 
1,698

 
(871
)
Total
$
62,016

 
$
14,228

 
$
9,568

 
$
1,048

_______________
(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(3)
SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in the Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.
(4)
Reported in Net derivative gains (losses) in the consolidated statements of income (loss).

Equity-Based and Treasury Futures Contracts Margin
All outstanding equity-based and treasury futures contracts at September 30, 2018 are exchange-traded and net settled daily in cash. At September 30, 2018, the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000, and Emerging Market indices, having initial margin requirements of $203 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $53 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200, and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $21 million.


35
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Collateral Arrangements
The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At September 30, 2018 and December 31, 2017, respectively, the Company held $2,135 million and $1,855 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in Other invested assets. The Company posted collateral of $65 million and $3 million at September 30, 2018 and December 31, 2017, respectively, in the normal operation of its collateral arrangements.
Securities Repurchase and Reverse Repurchase Transactions
Securities repurchase and reverse repurchase transactions are conducted by the Company under a standardized securities industry master agreement, amended to suit the requirements of each respective counterparty. The Company’s securities repurchase and reverse repurchase agreements are accounted for as secured borrowing or lending arrangements, respectively and are reported in the consolidated balance sheets on a gross basis. At September 30, 2018 and December 31, 2017, the balance outstanding under securities repurchase transactions was $1,900 million and $1,887 million, respectively. The Company utilized these repurchase and reverse repurchase agreements for asset liability and cash management purposes. For other instruments used for asset liability management purposes, see “Obligation under funding agreements” included in Note 13.
The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at September 30, 2018.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At September 30, 2018
 
Gross Amounts
Recognized
 
Gross Amounts
Offset in the Balance Sheets
 
Net Amounts
Presented in the
Balance Sheets
 
(in millions)
ASSETS(1)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
4,132

 
$
1,810

 
$
2,322

Interest rate contracts
330

 
653

 
(323
)
Credit contracts
28

 
3

 
25

Currency
75

 
8

 
67

Margin
27

 
—

 
27

Collateral
65

 
2,134

 
(2,069
)
Total Derivatives, subject to an ISDA Master Agreement
$
4,657

 
$
4,608

 
$
49

Other financial instruments
1,795

 
—

 
1,795

Other invested assets
$
6,452

 
$
4,608

 
$
1,844



36
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Gross Amounts
Recognized
 
Gross Amounts
Offset in the Balance Sheets
 
Net Amounts
Presented in the
Balance Sheets
 
(in millions)
LIABILITIES(2)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
1,810

 
$
1,810

 
$
—

Interest rate contracts
653

 
653

 
—

Credit contracts
3

 
3

 
—

Currency
9

 
9

 
—

Margin
—

 
—

 
—

Collateral
2,135

 
2,135

 
—

Total Derivatives, subject to an ISDA Master Agreement
4,610

 
4,610

 
—

Other financial liabilities
2,205

 
—

 
2,205

Other liabilities
$
6,815

 
$
4,610

 
$
2,205

Securities sold under agreement to repurchase(3)
$
1,891

 
$
—

 
$
1,891

_______________
(1)
Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)
Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)
Excludes expense of $9 million in securities sold under agreement to repurchase.

The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at September 30, 2018.
Collateral Amounts Not Offset in the Consolidated Balance Sheets
At September 30, 2018
 
Fair Value of Assets
 
Collateral (Received)/Held
 
 
 
Financial
Instruments
 
Cash
 
Net
Amounts
 
(in millions)
ASSETS:(1)
 
 
 
 
 
 
Total derivatives
$
2,091

 
$
—

 
$
(2,042
)
 
$
49

Other financial instruments
1,795

 
—

 
—

 
1,795

Other invested assets
$
3,886

 
$
—

 
$
(2,042
)
 
$
1,844

LIABILITIES:(2)
 
 
 
 
 
 

Securities sold under agreement to repurchase(3)
$
1,891

 
$
(1,891
)
 
$
—

 
$
—

______________
(1)
Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)
Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)
Excludes expense of $9 million in securities sold under agreement to repurchase.



37
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at September 30, 2018.
Repurchase Agreement Accounted for as Secured Borrowings
At September 30, 2018
 
Remaining Contractual Maturity of the Agreements
 
Overnight and
Continuous
 
Up to 30
days
 
30–90
days
 
Greater Than
90 days
 
Total
 
(in millions)
Securities sold under agreement to repurchase(1)
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency securities
$
—

 
$
1,891

 
$
—

 
$
—

 
$
1,891

Total
$
—

 
$
1,891

 
$
—

 
$
—

 
$
1,891

______________
(1)
Excludes expense accrual of $9 million included in securities sold under agreements to repurchase on the consolidated balance sheets.

The following table presents information about the Company’s offsetting financial assets and liabilities and derivative instruments at December 31, 2017.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2017
 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheets
 
Net Amounts Presented in the Balance Sheets
 
(in millions)
ASSETS(1)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
3,338

 
$
1,555

 
$
1,783

Interest rate contracts
320

 
191

 
129

Credit contracts
35

 
3

 
32

Currency
19

 
10

 
9

Collateral
4

 
1,855

 
(1,851
)
Margin
24

 
—

 
24

Total Derivatives, subject to an ISDA Master Agreement
$
3,740

 
$
3,614

 
$
126

Other financial instruments
2,995

 
—

 
2,995

Other invested assets
$
6,735

 
$
3,614

 
$
3,121



38
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Gross Amounts Recognized
 
Gross Amounts Offset in the Balance Sheets
 
Net Amounts Presented in the Balance Sheets
 
(in millions)
LIABILITIES(2)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
1,555

 
$
1,555

 
$
—

Interest rate contracts
191

 
191

 
—

Credit contracts
3

 
3

 
—

Currency
10

 
10

 
—

Margin
—

 
—

 
—

Collateral
1,855

 
1,855

 
—

Total Derivatives, subject to an ISDA Master Agreement
$
3,614

 
$
3,614

 
$
—

Other financial liabilities
2,663

 
—

 
2,663

Other liabilities
$
6,277

 
$
3,614

 
$
2,663

Securities sold under agreement to repurchase(3)
$
1,882

 
$
—

 
$
1,882

_____________
(1)
Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)
Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)
Excludes expense of $5 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2017.
Collateral Amounts Not Offset in the Consolidated Balance Sheets
At December 31, 2017  
 
Net Amounts Presented in the Balance Sheets
 
Collateral (Received)/Held
 
 
 
Financial
Instruments
 
Cash
 
Net
Amounts
 
(in millions)
Assets:(1)
 
 
 
 
 
 
 
Total Derivatives
$
1,954

 
$
—

 
$
(1,828
)
 
$
126

Other financial instruments
2,995

 
—

 
—

 
2,995

Other invested assets
$
4,949

 
$
—

 
$
(1,828
)
 
$
3,121

Liabilities:(2)
 
 
 
 
 
 
 
Other financial liabilities
$
2,663

 
$
—

 
$
—

 
$
2,663

Other liabilities
$
2,663

 
$
—

 
$
—

 
$
2,663

 
 
 
 
 
 
 
 
Securities sold under agreement to repurchase(3)
$
1,882

 
$
(1,988
)
 
$
(21
)
 
$
(127
)
______________
(1)
Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)
Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)
Excludes expense of $5 million in securities sold under agreement to repurchase.



39
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2017.
Repurchase Agreement Accounted for as Secured Borrowings
At December 31, 2017
 
Remaining Contractual Maturity of the Agreements
 
Overnight and Continuous
 
Up to 30 days
 
30–90 days
 
Greater Than 90 days
 
Total
 
(in millions)
Securities sold under agreement to repurchase:(1)
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency securities
$
—

 
$
1,882

 
$
—

 
$
—

 
$
1,882

Total
$
—

 
$
1,882

 
$
—

 
$
—

 
$
1,882

______________
(1)
Excludes expense of $5 million in securities sold under agreement to repurchase on the consolidated balance sheets.

4)    CLOSED BLOCK
Summarized financial information for the Company’s Closed Block is as follows:
 
September 30,
2018
 
December 31,
2017
 
(in millions)
CLOSED BLOCK LIABILITIES:
 
 
 
Future policy benefits, policyholders’ account balances and other
6,788

 
6,958

Policyholder dividend obligation
—

 
19

Other liabilities
48

 
271

Total Closed Block liabilities
6,836

 
7,248

ASSETS DESIGNATED TO THE CLOSED BLOCK:
 
 
 
Fixed maturities, available for sale, at fair value (amortized cost of $3,681 and $3,923)
3,669

 
4,070

Mortgage loans on real estate
1,902

 
1,720

Policy loans
745

 
781

Cash and other invested assets
39

 
351

Other assets
187

 
182

Total assets designated to the Closed Block
6,542

 
7,104

Excess of Closed Block liabilities over assets designated to the Closed Block
294

 
144

Amounts included in accumulated other comprehensive income (loss):
 
 
 
Net unrealized investment gains (losses), net of policyholder dividend obligation of $0 and $19
(2
)
 
138

Maximum Future Earnings To Be Recognized From Closed Block Assets and Liabilities
292

 
282



40
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The Company’s Closed Block revenues and expenses are as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
REVENUES:
 
 
 
 
 
 
 
Premiums and other income
44

 
52

 
144

 
167

Net investment income (loss)
72

 
82

 
218

 
244

Net investment gains (losses)
—

 
(2
)
 
1

 
(18
)
Total revenues
116

 
132

 
363

 
393

BENEFITS AND OTHER DEDUCTIONS:
 
 
 
 
 
 
 
Policyholders’ benefits and dividends
123

 
132

 
372

 
416

Other operating costs and expenses
1

 
1

 
3

 
2

Total benefits and other deductions
124

 
133

 
375

 
418

Net revenues (loss) before income taxes
(8
)
 
(1
)
 
(12
)
 
(25
)
Income tax (expense) benefit
2

 
1

 
2

 
9

Net revenues (losses)
(6
)
 
—

 
(10
)
 
(16
)
A reconciliation of the Company’s policyholder dividend obligation follows:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Balances, beginning of year
$
19

 
$
52

Unrealized investment gains (losses), net of DAC
(19
)
 
(5
)
Balances, end of period
$
—

 
$
47

5)    INSURANCE LIABILITIES
Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features
The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:
•
Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals);
•
Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals);
•
Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages;
•
Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or
•
Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life.


41
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following table summarizes the direct GMDB and GMIB without a no-lapse guarantee rider (“NLG”) feature liabilities, before reinsurance ceded, reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities:
 
GMDB
 
GMIB
 
Total
 
(in millions)
Balance at January 1, 2018
$
4,054

 
$
4,754

 
$
8,808

Paid guarantee benefits
(291
)
 
(108
)
 
(399
)
Other changes in reserve
755

 
(1,041
)
 
(286
)
Balance at September 30, 2018
$
4,518

 
$
3,605

 
$
8,123

 
 
 
 
 
 
Balance at January 1, 2017
$
3,159

 
$
3,808

 
$
6,967

Paid guarantee benefits
(272
)
 
(102
)
 
(374
)
Other changes in reserve
1,058

 
749

 
1,807

Balance at September 30, 2017
$
3,945

 
$
4,455

 
$
8,400

The following table summarizes the ceded GMDB liabilities, reflected in the consolidated balance sheets in Amounts due from reinsurers:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Balance, beginning of year
$
2,030

 
$
1,558

Paid guarantee benefits
(67
)
 
(132
)
Other changes in reserve
(1,860
)
 
555
Balance, end of period
$
103

 
$
1,981

The GMIB reinsurance contract asset is considered to be an insurance derivative and is reported at fair value. The fair value of the GMIB reinsurance contract asset at September 30, 2018 and December 31, 2017 is $1,571 million and $10,488 million, respectively.
The September 30, 2018 values for direct variable annuity contracts in-force on such date with GMDB and GMIB features are presented in the following table. For contracts with the GMDB feature, the net amount at risk in the event of death is the amount by which the GMDB exceed related account values. For contracts with the GMIB feature, the net amount at risk in the event of annuitization is the amount by which the present value of the GMIB benefits exceeds related account values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB guarantees may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive:


42
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


Direct Variable Annuity Contract Values
 
September 30, 2018
 
Return of
Premium
 
Ratchet
 
Roll-Up
 
Combo
 
Total
 
(Dollars in millions)
GMDB:
 
 
 
 
 
 
 
 
 
Account values invested in:
 
 
 
 
 
 
 
 
 
General Account
$
14,046

 
$
102

 
$
62

 
$
188

 
$
14,398

Separate Accounts
$
47,293

 
$
9,522

 
$
3,418

 
$
35,066

 
$
95,299

Net amount at risk, gross
$
162

 
$
53

 
$
1,892

 
$
16,098

 
$
18,205

Net amount at risk, net of amounts reinsured
$
162

 
$
50

 
$
1,305

 
$
16,098

 
$
17,615

Average attained age of policyholders
51.6
 
66.8
 
73.4
 
68.8
 
55.5
Percentage of policyholders over age 70
9.9
%
 
42.2
%
 
64.9
%
 
49.1
%
 
18.7
%
Range of contractually specified interest rates
N/A

 
N/A

 
3% - 6%

 
3% - 6.5%

 
3% - 6.5%

 
 
 
 
 
 
 
 
 
 
GMIB:
 
 
 
 
 
 
 
 
 
Account values invested in:
 
 
 
 
 
 
 
 
 
General Account
N/A

 
N/A

 
$
21

 
$
274

 
$
295

Separate Accounts
N/A

 
N/A

 
$
21,549

 
$
39,729

 
$
61,278

Net amount at risk, gross
N/A

 
N/A

 
$
753

 
$
5,793

 
$
6,546

Net amount at risk, net of amounts reinsured
N/A

 
N/A

 
$
236

 
$
5,272

 
$
5,508

Average attained age of policyholders
N/A

 
N/A

 
70.5
 
69.1
 
69.2
Weighted average years remaining until annuitization
N/A

 
N/A

 
1.6
 
0.5
 
0.6
Range of contractually specified interest rates
N/A

 
N/A

 
3% - 6%

 
3% - 6.5%

 
3% - 6.5%

Separate Account Investments by Investment Category Underlying GMDB and GMIB Features
The total account values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is backed by the assets in the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB guarantees. The investment performance of the assets impacts the related account values and, consequently, the net amount of risk associated with the GMDB and GMIB benefits and guarantees. Because variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive.
Investment in Separate Account Investment Options
 
September 30,
2018
 
December 31, 2017 (1)
 
(in millions)
GMDB:
 
 
 
Equity
$
42,675

 
$
41,658

Fixed income
5,274
 
5,469
Balanced
46,504
 
46,577
Other
846
 
968
Total
$
95,299

 
$
94,672



43
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
September 30,
2018
 
December 31, 2017 (1)
 
(in millions)
GMIB:
 
 
 
Equity
$
19,512

 
$
19,928

Fixed income
2,924

 
3,150
Balanced
38,540

 
38,890
Other
302

 
318
Total
$
61,278

 
$
62,286

_______________
(1)
Amounts previously reported were as follows in millions: (a) GMDB: Equity $78,069, Fixed Income $2,234, Balanced $14,084, and Other $283; (b) GMIB: Equity $50,429, Fixed Income $1,568, Balanced $10,165, and Other $124.

Hedging Programs for GMDB, GMIB, GIB and Other Features
Beginning in 2003, the Company established a program intended to hedge certain risks associated first with the GMDB feature and, beginning in 2004, with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. At September 30, 2018, the total account value and net amount at risk of the hedged variable annuity contracts were $69,997 million and $ 16,706 million, respectively, with the GMDB feature and $59,052 million and $6,602 million, respectively, with the GMIB and GIB feature. A hedge program is also used to manage certain capital markets risks associated with the products the Company has assumed that have GMDB and GMIB features.
These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net derivative gains (losses) in the period in which they occur, and may contribute to income (loss) volatility.
Variable and Interest-Sensitive Life Insurance Policies - NLG
The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements.
The following table summarizes the NLG liabilities reflected in the General Account in Future policy benefits and other policyholders’ liabilities, the related reinsurance reserve ceded, reflected in Amounts due from reinsurers and deferred cost of reinsurance, reflected in Other assets in the consolidated balance sheets:
 
Direct
Liability
 
Reinsurance
Ceded
 
Net
 
(in millions)
Balance at January 1, 2018
$
692

 
$
(664
)
 
$
28

Paid Guaranteed Benefits
(13
)
 
—

 
(13
)
Other changes in reserves
76

 
(53
)
 
23

Balance at September 30, 2018
$
755

 
$
(717
)
 
$
38



44
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Direct
Liability
 
Reinsurance
Ceded
 
Net
 
(in millions)
Balance at January 1, 2017
$
1,182

 
$
(606
)
 
$
576

Other changes in reserves
218

 
(68
)
 
150

Balance at September 30, 2017
$
1,400

 
$
(674
)
 
$
726


6)    REINSURANCE AGREEMENTS
Effective February 1, 2018, the Company entered into a coinsurance reinsurance agreement (the “Coinsurance Agreement”) to cede 90% of its single premium deferred annuities (SPDA) products issued between 1978-2001 and its Guaranteed Growth Annuity (GGA) single premium deferred annuity products issued between 2001-2014. As a result of this agreement, the Company transferred securities with a market value of $604 million and cash of $31 million to equal the statutory reserves of approximately $635 million. As the risks transferred by the Company to the reinsurer under the Coinsurance Agreement are not considered insurance risks and therefore do not qualify for reinsurance accounting, the Company applied deposit accounting. Accordingly, the Company recorded the transferred assets of $635 million as a deposit asset recorded in Other assets, net of the ceding commissions paid to the reinsurer.

7)    FAIR VALUE DISCLOSURES
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance established a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
Level 1
Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2
Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.
Level 3
Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.
The Company uses unadjusted quoted market prices to measure the fair value of instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.
Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent


45
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.
Assets and liabilities measured at fair value on a recurring basis are summarized below. At September 30, 2018 and December 31, 2017, no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period.
Fair Value Measurements at September 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Assets:
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
Fixed maturities, available-for-sale:
 
 
 
 
 
 
 
Corporate
$
—

 
$
23,468

 
$
1,134

 
$
24,602

U.S. Treasury, government and agency
—

 
12,951

 
—

 
12,951

States and political subdivisions
—

 
413

 
38

 
451

Foreign governments
—

 
438

 
—

 
438

Residential mortgage-backed(1)
—

 
208

 
—

 
208

Asset-backed(2)
—

 
71

 
537

 
608

Redeemable preferred stock
172

 
324

 
—

 
496

Total fixed maturities, available-for-sale
172

 
37,873

 
1,709

 
39,754

Other equity investments
12

 
—

 
—

 
12

Trading securities
519

 
14,241

 
—

 
14,760

Other invested assets:
 
 
 
 
 
 
 
Short-term investments
—

 
418

 
—

 
418

Assets of consolidated VIEs/VOEs
86

 
214

 
28

 
328

Swaps
—

 
(433
)
 
—

 
(433
)
Credit Default Swaps
—

 
25

 
—

 
25

Futures
—

 
—

 
—

 
—

Options
—

 
2,500

 
—

 
2,500

Total other invested assets
86

 
2,724

 
28

 
2,838



46
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Cash equivalents
2,441

 
—

 
—

 
2,441

Segregated securities
—

 
1,263

 
—

 
1,263

GMIB reinsurance contract asset
—

 
—

 
1,571

 
1,571

Separate Accounts assets
120,529

 
2,706

 
367

 
123,602

Total Assets
$
123,759

 
$
58,807

 
$
3,675

 
$
186,241

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
GMxB derivative features’ liability
$
—

 
$
—

 
$
4,157

 
$
4,157

SCS, SIO, MSO and IUL indexed features’ liability
—

 
2,357

 
—

 
2,357

Liabilities of consolidated VIEs/VOEs
1

 
3

 
—

 
4

Contingent payment arrangements
—

 
—

 
11

 
11

Total Liabilities
$
1

 
$
2,360

 
$
4,168

 
$
6,529

___________________
(1)
Includes publicly traded agency pass-through securities and collateralized obligations.
(2)
Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

Fair Value Measurements at December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Assets:
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
Fixed maturities, available-for-sale:
 
 
 
 
 
 
 
Corporate
$
—

 
$
20,343

 
$
1,139

 
$
21,482

U.S. Treasury, government and agency
—

 
13,135

 
—

 
13,135

States and political subdivisions
—

 
441

 
40

 
481

Foreign governments
—

 
409

 
—

 
409

Residential mortgage-backed(1)
—

 
251

 
—

 
251

Asset-backed(2)
—

 
88

 
8

 
96

Redeemable preferred stock
180

 
324

 
—

 
504

Total fixed maturities, available-for-sale
180

 
34,991

 
1,187

 
36,358

Other equity investments
13

 
—

 
1

 
14

Trading securities
467

 
12,161

 
—

 
12,628

Other invested assets:
 
 
 
 
 
 
 
Short-term investments
—

 
768

 
—

 
768

Assets of consolidated VIEs/VOEs
1,060

 
215

 
27

 
1,302

Swaps
—

 
15

 
—

 
15

Credit Default Swaps
—

 
33

 
—

 
33

Futures
(2
)
 
—

 
—

 
(2
)
Options
—

 
1,907

 
—

 
1,907

Total other invested assets
1,058

 
2,938

 
27

 
4,023



47
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Cash equivalents
2,360

 
—

 
—

 
2,360

Segregated securities
—

 
825

 
—

 
825

GMIB reinsurance contract asset
—

 
—

 
10,488

 
10,488

Separate Accounts’ assets
118,983

 
2,983

 
349

 
122,315

Total Assets
$
123,061

 
$
53,898

 
$
12,052

 
$
189,011

Liabilities:
 
 
 
 
 
 
 
GMxB derivative features’ liability
$
—

 
$
—

 
$
4,256

 
$
4,256

SCS, SIO, MSO and IUL indexed features’ liability
—

 
1,698

 
—

 
1,698

Liabilities of consolidated VIEs/VOEs
670

 
22

 
—

 
692

Contingent payment arrangements
—

 
—

 
11

 
11

Total Liabilities
$
670

 
$
1,720

 
$
4,267

 
$
6,657

________________
(1)
Includes publicly traded agency pass-through securities and collateralized obligations.
(2)
Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

The Company’s corporate fixed maturities includes both public and private issues.
The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security.
The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made.
The net fair value of the Company’s freestanding derivative positions as disclosed in Note 3, are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from


48
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security.
Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Account assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less, and are carried at cost as a proxy for fair value measurement due to their short-term nature.
Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets.
Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors.
Certain Company products such as the SCS and EQUI-VEST variable annuity product, and in the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have 1, 3, 5, or 6 year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers.
The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated


49
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

to market observable data. The Company applies various due diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, mortgage- and asset-backed securities are classified as Level 3.
The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base.  The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base.  The GMAB feature increases the contract account value at the end of a specified period to a GMAB base.  The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base.
Level 3 also includes the GMIB reinsurance contract asset and liabilities which are accounted for as derivative contracts.  The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios.
The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity separate account funds.  The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements.  Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities to reflect change in the claims-paying ratings of counterparties and the Company an adjustment to the swap curve for non-performance risk to reflect the claims-paying rating of the Company.   Equity and fixed income volatilities were modeled to reflect current market volatilities.  Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations.
After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $107 million and $69 million at September 30, 2018 and December 31, 2017, respectively, to recognize incremental counterparty non-performance risk.
Lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected.
The Company’s Level 3 liabilities include contingent payment arrangements associated with acquisitions in 2010, 2013 and 2014 by AB. At each reporting date, AB estimates the fair values of the contingent consideration expected to be paid based upon probability-weighted AUM and revenue projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy.
The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, primarily corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities.


50
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

During the nine months ended September 30, 2018, AFS fixed maturities with fair values of $28 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $65 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.6% of total equity at September 30, 2018.
During the nine months ended September 30, 2017, AFS fixed maturities with fair values of $7 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $6 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.1% of total equity at September 30, 2017.
The tables below presents a reconciliation for all Level 3 assets and liabilities for the three and nine months ended September 30, 2018 and 2017, respectively:
Level 3 Instruments Fair Value Measurements
 
Corporate
 
State and
Political
Sub-
divisions
 
Commercial
Mortgage-
backed
 
Asset-
backed
 
(in millions)
Balance, July 1, 2018
$
1,152

 
$
38

 
$
—

 
$
538

Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
Net investment income (loss)
3

 
—

 
—

 
(1
)
Investment gains (losses), net
(4
)
 
—

 
—

 
—

Subtotal
(1
)
 
—

 
—

 
(1
)
Other comprehensive income (loss)
(1
)
 
—

 
—

 
1

Purchases
36

 
—

 
—

 
—

Sales
(52
)
 
—

 
—

 
(1
)
Settlements
—

 
—

 
—

 
—

Transfers into Level 3(1)
—

 
—

 
—

 
—

Transfers out of Level 3(1)
—

 
—

 
—

 
—

Balance, September 30, 2018
$
1,134

 
$
38

 
$
—

 
$
537

Balance, July 1, 2017
$
1,068

 
$
42

 
$
290

 
$
12

Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
Net investment income (loss)
2

 
—

 
—

 
—

Investment gains (losses), net
—

 
—

 
(9
)
 
—

Subtotal
2

 
—

 
(9
)
 
—

Other comprehensive income (loss)
6

 
—

 
8

 
(3
)
Purchases
196

 
—

 
—

 
—

Sales
(119
)
 
(1
)
 
(40
)
 
(1
)
Settlements
—

 
—

 
—

 
—

Transfers into Level 3(1)
—

 
—

 
—

 
—

Transfers out of Level 3(1)
(7
)
 
—

 
(1
)
 
—

Balance, September 30, 2017
$
1,146

 
$
41

 
$
248

 
$
8

____________
(1)
Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.


51
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Corporate
 
State and
Political
Sub-
divisions
 
Commercial
Mortgage-
backed
 
Asset-
backed
 
(in millions)
Balance, January 1, 2018
$
1,139

 
$
40

 
$
—

 
$
8

Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
Net investment income (loss)
8

 
—

 
—

 
(1
)
Investment gains (losses), net
(4
)
 
—

 
—

 
—

Subtotal
4

 
—

 
—

 
(1
)
Other comprehensive income (loss)
(15
)
 
(1
)
 
—

 
—

Purchases
236

 
—

 
—

 
533

Sales
(267
)
 
(1
)
 
—

 
(3
)
Settlements
—

 
—

 
—

 
—

Transfers into Level 3(1)
65

 
—

 
—

 
—

Transfers out of Level 3(1)
(28
)
 
—

 
—

 
—

Balance, September 30, 2018
$
1,134

 
$
38

 
$
—

 
$
537

Balance, January 1, 2017
$
845

 
$
42

 
$
349

 
$
24

Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
Net investment income (loss)
6

 
—

 
1

 
—

Investment gains (losses), net
—

 
—

 
(29
)
 
15

Subtotal
6

 
—

 
(28
)
 
15

Other comprehensive income (loss)
—

 
—

 
27

 
(10
)
Purchases
518

 
—

 
—

 
—

Sales
(224
)
 
(1
)
 
(99
)
 
(20
)
Settlements
—

 
—

 
—

 
—

Transfers into Level 3(1)
6

 
—

 
—

 
—

Transfers out of Level 3(1)
(5
)
 
—

 
(1
)
 
(1
)
Balance, September 30, 2017
$
1,146

 
$
41

 
$
248

 
$
8

____________
(1)
Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.



52
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Redeemable
Preferred
Stock
 
Other
Equity
Investments(2)
 
GMIB
Reinsurance
Asset
 
Separate
Accounts
Assets
 
GMxB Derivative Features Liability
 
Contingent
Payment
Arrangement
 
(in millions)
Balance, July 1, 2018
$
—

 
$
29

 
$
1,825

 
$
361

 
$
(3,534
)
 
$
(11
)
Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
 
 
 
 
Net investment income (loss)
—

 
—

 
—

 
—

 
—

 
—

Investment gains (losses), net
—

 
—

 
—

 
6

 
—

 
—

Net derivative gains (losses)
—

 
—

 
(255
)
 
—

 
(534
)
 
—

Subtotal
—

 
—

 
(255
)
 
6

 
(534
)
 
—

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
—

 
—

Purchases(2)
—

 
1

 
12

 
1

 
(96
)
 
—

Sales(3) 
—

 
(1
)
 
(11
)
 
—

 
7

 
—

Settlements(4,5)
—

 
—

 
—

 
(1
)
 
—

 
—

Activity related to consolidated VIEs
—

 
(1
)
 
—

 
—

 
—

 
—

Transfers into Level 3(1)
—

 
—

 
—

 
—

 
—

 
—

Transfers out of Level 3(1)
—

 
—

 
—

 
—

 
—

 
—

Balance, September 30, 2018
$
—

 
$
28

 
$
1,571

 
$
367

 
$
(4,157
)
 
$
(11
)
Balance, July 1, 2017
$
1

 
$
8

 
$
11,260

 
$
333

 
$
(4,889
)
 
$
17

Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
 
 
 
 
Net investment income (loss)
—

 
—

 
—

 
—

 
—

 
—

Investment gains (losses), net
—

 
(4
)
 
—

 
4

 
—

 
—

Net derivative gains (losses)
—

 
—

 
(393
)
 
—

 
396

 
—

Subtotal
—

 
(4
)
 
(393
)
 
4

 
396

 
—

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
—

 
—

Purchases(3)
—

 
—

 
55

 
1

 
(100
)
 
—

Sales(4)
—

 
(1
)
 
(22
)
 
—

 
3

 
—

Settlements(5)
—

 
—

 
—

 
(1
)
 
—

 
(5
)
Activity related to consolidated VIEs
—

 
—

 
—

 
—

 
—

 
—

Transfers into Level 3(1)
—

 
—

 
—

 
—

 
—

 
—

Transfers out of Level 3(1)
—

 
—

 
—

 
—

 
—

 
—

Balance, September 30, 2017
1

 
3

 
10,900

 
337

 
(4,590
)
 
12

____________
(1)
Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.
(2)
For the GMIB reinsurance contract asset, and the GMxB derivative features liability, represents attributed fee.


53
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

(3)
For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid.
(4)
For contingent payment arrangements, it represents payments under the arrangement.
(5)
For GMIB Reinsurance Asset, it represents the settlement of the captive reinsurance transaction.

 
Redeemable Preferred Stock
 
Other
Equity
Investments(2)
 
GMIB Reinsurance Asset
 
Separate Accounts Assets
 
GMxB Derivative Features Liability
 
Contingent Payment Arrangement
 
(in millions)
Balance, January 1, 2018
$
—

 
$
28

 
$
10,488

 
$
349

 
$
(4,256
)
 
$
(11
)
Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
 
 
 
 
Net investment income (loss)
—

 
—

 
—

 
—

 
—

 
—

Investment gains (losses), net
—

 
(1
)
 
—

 
19

 
—

 
—

Net derivative gains (losses)
—

 
—

 
(1,488
)
 
—

 
394

 
—

Subtotal
—

 
(1
)
 
(1,488
)
 
19

 
394

 
—

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
—

 
—

Purchases(2)
—

 
7

 
83

 
4

 
(305
)
 
—

Sales(3) 
—

 
(3
)
 
(49
)
 
(1
)
 
10

 
—

Settlements(4,5)
—

 
—

 
(7,463
)
 
(4
)
 
—

 
—

Activity related to consolidated VIEs
—

 
(3
)
 
—

 
—

 
—

 
—

Transfers into Level 3(1)
—

 
5

 
—

 
—

 
—

 
—

Transfers out of Level 3(1)
—

 
(5
)
 
—

 
—

 
—

 
—

Balance, September 30, 2018
$
—

 
$
28

 
$
1,571

 
$
367

 
$
(4,157
)
 
$
(11
)
Balance, January 1, 2017
$
1

 
$
11

 
$
10,313

 
$
313

 
$
(5,473
)
 
$
18

Total gains (losses), realized and unrealized, included in:
 
 
 
 
 
 
 
 
 
 
 
Income (loss) as:
 
 
 
 
 
 
 
 
 
 
 
Net investment income (loss)
—

 
—

 
—

 
—

 
—

 
—

Investment gains (losses), net
—

 
(4
)
 
—

 
22

 
—

 
—

Net derivative gains (losses)
—

 
—

 
500

 
—

 
1,169

 
—

Subtotal
—

 
(4
)
 
500

 
22

 
1,169

 
—

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
—

 
—

Purchases(3)
—

 
5

 
165

 
7

 
(290
)
 
—

Sales(4) 
—

 
(3
)
 
(79
)
 
(2
)
 
4

 
—

Settlements(5)
—

 
—

 
—

 
(4
)
 
—

 
(6
)
Activity related to consolidated VIEs
—

 
(7
)
 
—

 
—

 
—

 
—

Transfers into Level 3(1)
—

 
1

 
—

 
1

 
—

 
—

Transfers out of Level 3(1)
—

 
—

 
—

 
—

 
—

 
—

Balance, September 30, 2017
$
1

 
$
3

 
$
10,900

 
$
337

 
$
(4,590
)
 
$
12

____________
(1)
Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.


54
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

(2)
For the GMIB reinsurance contract asset, and the GMxB derivative features liability, represents attributed fee.
(3)
For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid.
(4)
For contingent payment arrangements, it represents payments under the arrangement.
(5)
For GMIB Reinsurance Asset, it represents the settlement of the captive reinsurance transaction.

The table below details changes in unrealized gains (losses) for the nine months ended September 30, 2018 and 2017 by category for Level 3 assets and liabilities still held at September 30, 2018 and 2017, respectively:
 
Income (Loss)
 
 
Investment
Gains
(Losses),
Net
 
Net Derivative Gains (losses)
 
OCI
 
(in millions)
Level 3 Instruments
 
 
 
 
 
Nine months ended September 30, 2018
 
 
 
 
 
Held at September 30, 2018:
 
 
 
 
 
Change in unrealized gains (losses):
 
 
 
 
 
Fixed maturities, available-for-sale:
 
 
 
 
 
Corporate
$
—

 
$
—

 
$
(13
)
State and political subdivisions
—

 
—

 
(1
)
Commercial mortgage-backed
—

 
—

 
—

Asset-backed
—

 
—

 
—

Subtotal
—

 
—

 
(14
)
GMIB reinsurance contracts
—

 
(1,488
)
 
—

Separate Accounts’ assets(1)
19

 
—

 
—

GMxB derivative features’ liability
—

 
394

 
—

Total
$
19

 
$
(1,094
)
 
$
(14
)
____________
(1)
There is an investment expense that offsets this investment gain (loss).



55
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


 
Income (Loss)
 
 
 
Investment
Gains
(Losses),
Net
 
Net Derivative Gains (losses)
 
OCI
 
(in millions)
Level 3 Instruments
 
 
 
 
 
Nine months ended September 30, 2017
 
 
 
 
 
Held at September 30, 2017:
 
 
 
 
 
Change in unrealized gains (losses):
 
 
 
 
 
Fixed maturities, available-for-sale:
 
 
 
 
 
Commercial mortgage-backed
$
—

 
$
—

 
$
26

Asset-backed
—

 
—

 
(9
)
Subtotal
—

 
—

 
17

GMIB reinsurance contracts
—

 
500

 
—

Separate Accounts’ assets(1)
—

 
—

 
—

GMxB derivative features’ liability
—

 
1,169

 
—

Total
$
—

 
$
1,669

 
$
17

____________
(1)
There is an investment expense that offsets this investment gain (loss).



56
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of September 30, 2018 and December 31, 2017, respectively.

Quantitative Information about Level 3 Fair Value Measurements at September 30, 2018
 
 
Fair
Value
 
Valuation
Technique
 
Significant
Unobservable Input
 
Range
 
Weighted Average
 
 
(in millions)
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 
 
Fixed maturities, available-for-sale:
 
 
 
 
 
 
 
 
 
 
Corporate
 
39

 
Matrix pricing model
 
Spread over the industry-specific benchmark yield curve
 
50 - 565 bps
 
194 bps
 
 
755

 
Market com-parable 
companies
 
EBITDA multiples
Discount rate
Cash flow multiples
 
4.2x - 37.3x
7.2% - 16.5%
9.0x - 17.7x
 
13.8x
11.1%
13.1x
Separate Accounts assets
 
345

 
Third party appraisal
 
Capitalization rate
Exit capitalization rate
Discount rate
 
4.4%
5.6%
6.5%
 
 
 
 
1

 
Discounted cash flow
 
Spread over U.S. Treasury curve
Discount factor
 
228 bps
4.8%
 
 
GMIB reinsurance contract asset
 
1,571

 
Discounted cash flow
 
Lapse Rates
Withdrawal Rates
Utilization Rates
Non-performance risk
Volatility rates - Equity
Mortality Rates(1):
Ages 0-40
Ages 41-60
Ages 60-115
 
1.0% - 6.3%
0.0 - 8.0%
0.0% - 16.0%
0.5% - 1.3%
6.0% - 31.0%

0.01% - 0.18%
0.07% - 0.54%
0.42% - 42.0%
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
GMIBNLG
 
4,163

 
Discounted cash flow
 
GMIB valuation spread
Lapse Rates
Withdrawal Rates
Utilization Rates
Non-performance risk
NLG Forfeiture Rates
Long-term equity Volatility
Mortality Rates(1):
Ages 0-40
Ages 41-60
Ages 60-115
 
0.9%
0.8% - 26.2%
0.0% - 12.4%
0.0% - 100.0%
0% - 1.4%
0.8% - 1.2%
20.0%

0.01% - 0.19%
0.06% - 0.53%
0.41% - 41.2%
 
 
GWBL/GMWB
 
77

 
Discounted cash flow
 
Lapse Rates
Withdrawal Rates
Utilization Rates
Volatility rates - Equity
 
0.5% - 5.7%
0.0% - 7.0%
100% after delay
6.0% - 31.0%
 
 
GIB
 
(84
)
 
Discounted cash flow
 
Lapse Rates
Withdrawal Rates
Utilization Rates
Volatility rates - Equity
 
0.5% - 5.7%
0.0% - 8.0%
0.0% - 38.0%
6.0% - 31.0%
 
 
GMAB
 
1

 
Discounted cash flow
 
Lapse Rates
Volatility rates - Equity
 
0.5% - 11.0%
6.0% - 31.0%
 
 
____________
(1)
Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.


57
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


Quantitative Information about Level 3 Fair Value Measurements at December 31, 2017
 
 
Fair
Value
 
Valuation
Technique
 
Significant
Unobservable Input
 
Range
 
Weighted Average
 
 
(in millions)
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 
 
Fixed maturities, available-for-sale:
 
 
 
 
 
 
 
 
 
 
Corporate
 
53

 
Matrix pricing model
 
Spread over the industry-specific benchmark yield curve
 
0 -565 bps
 
125 bps
 
 
789

 
Market comparable companies
 
EBITDA multiples
Discount Rate
Cash flow Multiples
 
5.3x-27.9x
7.2% - 17.0%
9.0x - 17.7x
 
12.9x
11.1%
13.1x
Separate Accounts’ assets
 
326

 
Third party appraisal
 
Capitalization rate
Exit capitalization rate
Discount rate
 
4.6%
5.6%
6.6%
 
 
 
 
1

 
Discounted cash flow
 
Spread over U.S. Treasury curve
Discount factor
 
243 bps
4.4%
 
 
GMIB reinsurance contract asset
 
10,488

 
Discounted cash flow
 
Lapse Rates
Withdrawal rates
GMIB Utilization Rates
Non-performance risk
Volatility rates - Equity
Mortality Rates(1):
Ages 0-40
Ages 41-60
Ages 60-115
 
1.0% - 6.3%
0.0% - 8.0%
0.0% - 16.0%
5bps - 10bps
9.9%- 30.9%

0.01% - 0.18%
0.07% - 0.54%
0.42% - 42.0%
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
GMIBNLG
 
4,149

 
Discounted cash flow
 
Non-performance Risk
Lapse Rates
Withdrawal Rates
Utilization Rates
NLG Forfeiture Rates
Long-term equity Volatility
Mortality Rates(1):
Ages 0-40
Ages 41-60
Ages 60-115
 
1.0%
0.8% - 26.2%
0.0% - 12.4%
0.0% - 16.0%
0.6% - 2.1%
20.0%

0.01% - 0.19%
0.06% - 0.53%
0.41% - 41.2%
 
 
GWBL/GMWB
 
130

 
Discounted cash flow
 
Lapse Rates
Withdrawal Rates
Utilization Rates
Volatility rates - Equity
 
0.9% - 5.7%
0.0% - 7.0%
100% after delay
9.0% - 30.9%
 
 
GIB
 
(27
)
 
Discounted cash flow
 
Lapse Rates
Withdrawal Rates
Utilization Rates
Volatility rates - Equity
 
0.9% - 5.7%
0.0% - 7.0%
0.0% - 16.0%
9.9% - 30.9%
 
 
GMAB
 
5

 
Discounted cash flow
 
Lapse Rates
Volatility rates - Equity
 
0.5% - 11.0%
9.9% - 30.9%
 
 
____________
(1)
Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.

Excluded from the tables above at September 30, 2018 and December 31, 2017, respectively, are approximately $964 million and $395 million of Level 3 fair value measurements of investments for which the underlying quantitative


58
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments.
The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities.
Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. There were no Residential mortgage backed securities included in the tables above at September 30, 2018 and December 31, 2017, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities.
Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. There were no Asset-backed securities included in the tables above at September 30, 2018 and December 31, 2017, there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would result in significantly lower (higher) fair value measurements.
Included in other equity investments classified as Level 3 are reporting entities’ venture capital securities in the Technology, Media and Telecommunications industries. The fair value measurements of these securities include significant unobservable inputs including an enterprise value to revenue multiples and a discount rate to account for liquidity and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would result in a significantly lower (higher) fair value measurement.
Separate Account assets classified as Level 3 in the table at September 30, 2018 and December 31, 2017, primarily consist of a private real estate fund and mortgage loans. A third-party appraisal valuation technique is used to measure the fair value of the private real estate investment fund, including consideration of observable replacement cost and sales comparisons for the underlying commercial properties, as well as the results from applying a discounted cash flow approach. Significant increase (decrease) in isolation in the capitalization rate and exit capitalization rate assumptions used in the discounted cash flow approach to the appraisal value would result in a higher (lower) measure of fair value. With respect to the fair value measurement of mortgage loans a discounted cash flow approach is applied, a significant increase (decrease) in the assumed spread over U.S. Treasury securities would produce a lower (higher) fair value measurement. Changes in the discount rate or factor used in the valuation techniques to determine the fair values of these private equity investments and mortgage loans generally are not correlated to changes in the other significant unobservable inputs. Significant increase (decrease) in isolation in the discount rate or factor would result in significantly lower (higher) fair value measurements. These fair value measurements are determined using substantially the same valuation techniques as earlier described above for the Company’s General Account investments in these securities.
Significant unobservable inputs with respect to the fair value measurement of the Level 3 GMIB reinsurance contract asset and the Level 3 liabilities identified in the table above are developed using the Company data. Validations of


59
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

unobservable inputs are performed to the extent the Company has experience. When an input is changed the model is updated and the results of each step of the model are analyzed for reasonableness.
The significant unobservable inputs used in the fair value measurement of the Company’s GMIB reinsurance contract asset are lapse rates, withdrawal rates and GMIB utilization rates. Significant increases in GMIB utilization rates or decreases in lapse or withdrawal rates in isolation would tend to increase the GMIB reinsurance contract asset.
Fair value measurement of the GMIB reinsurance contract asset and liabilities includes dynamic lapse and GMIB utilization assumptions whereby projected contractual lapses and GMIB utilization reflect the projected net amount of risks of the contract. As the net amount of risk of a contract increases, the assumed lapse rate decreases and the GMIB utilization increases. Increases in volatility would increase the asset and liabilities.
The significant unobservable inputs used in the fair value measurement of the Company’s GMIBNLG liability are lapse rates, withdrawal rates, GMIB utilization rates, adjustment for Non-performance risk and NLG forfeiture rates.  NLG forfeiture rates are caused by excess withdrawals above the annual GMIB accrual rate that cause the NLG to expire.   Significant decreases in lapse rates, NLG forfeiture rates, adjustment for non-performance risk and GMIB utilization rates would tend to increase the GMIBNLG liability, while decreases in withdrawal rates and volatility rates would tend to decrease the GMIBNLG liability.
The significant unobservable inputs used in the fair value measurement of the Company’s GMWB and GWBL liability are lapse rates and withdrawal rates. Significant increases in withdrawal rates or decreases in lapse rates in isolation would tend to increase these liabilities. Increases in volatility would increase these liabilities.
During 2017, AB made the final contingent consideration payment relating to its 2014 acquisition and recorded a change in estimate and wrote off the remaining contingent consideration payable relating to its 2010 acquisition. As of September 30, 2018 and December 31, 2017, one acquisition-related contingent consideration liability of $11 million remains relating to AB’s 2016 acquisition, which was valued using a revenue growth rate of 31.0% and a discount rate ranging from 1.4% to 2.3%.
The carrying values and fair values at September 30, 2018 and December 31, 2017 for financial instruments not otherwise disclosed in Note 3 are presented in the table below. Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations.
 
Carrying Value
 
Fair Value
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
September 30, 2018:
 
 
 
 
 
 
 
 
Mortgage loans on real estate
$
12,053

 
$
—

 
$
—

 
$
11,659

 
$
11,659

Loans to affiliates
800

 
—

 
804

 
—

 
804

Policyholders’ liabilities: Investment contracts
2,020

 
—

 
—

 
2,052

 
2,052

Funding Agreements
3,012

 
—

 
2,926

 
—

 
2,926

Policy loans
3,269

 
—

 
—

 
3,946

 
3,946

Short-term debt
398

 
—

 
398

 
—

 
398

Separate Accounts liabilities
8,231

 
—

 
—

 
8,231

 
8,231



60
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Carrying Value
 
Fair Value
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
December 31, 2017:
 
 
 
 
 
 
 
 

Mortgage loans on real estate
$
10,935

 
$
—

 
$
—

 
$
10,895

 
$
10,895

Loans to affiliates
703

 
—

 
700

 
—

 
700

Policyholders’ liabilities: Investment contracts
2,068

 
—

 
—

 
2,170

 
2,170

Funding Agreements
3,014

 
—

 
3,020

 
—

 
3,020

Policy loans
3,315

 
—

 
—

 
4,210

 
4,210

Short-term and Long-term debt
769

 
—

 
768

 
—

 
768

Separate Accounts liabilities
7,537

 
—

 
—

 
7,537

 
7,537


Fair values for commercial and agricultural mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived from taking the appropriate U.S. Treasury rate with a like term to the remaining term of the loan and adding a spread reflective of the risk premium associated with the specific loan. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower.
Fair values for the Company’s long-term debt related to real estate joint ventures is determined by a third-party appraisal and assessed for reasonableness. The Company’s short-term debt primarily includes commercial paper issued by AB with short-term maturities and book value approximates fair value. The fair values of the Company’s borrowing and lending arrangements with AXA affiliated entities are determined from quotations provided by brokers knowledgeable about these securities and internally assessed for reasonableness, including matrix pricing models for debt securities and discounted cash flow analysis for mortgage loans.
The fair value of policy loans is calculated by discounting expected cash flows based upon the U.S. treasury yield curve and historical loan repayment patterns.
The fair values of the Company's funding agreements are determined by discounted cash flow analysis based on the indicative funding agreement rates published by the FHLB.
The fair values for the Company’s association plans contracts, supplementary contracts not involving life contingencies (“SCNILC”), deferred annuities and certain annuities, which are included in Policyholders’ account balances and liabilities for investment contracts with fund investments in Separate Accounts are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as Access Accounts and Escrow Shield Plus product reserves are held at book value.
8)    REVENUE RECOGNITION
See “Revenue Recognition” in Note 2 for descriptions of revenues presented in the table below. The adoption of ASC 606 had no significant impact on revenue recognition during the first nine months of 2018, except for the recognition of $49 million of performance fees from two hedge funds in liquidation that is not probable of significant reversal, that under the previous revenue accounting standard would not be recognized until final liquidation.
The table below presents the revenues recognized during the three and nine months ended September 30, 2018 and 2017, disaggregated by category:


61
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

    
 
Three Months Ended
September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
2017
2018
 
2017
 
(in millions)
Investment management, advisory and service fees:
 
 
 
 
 
 
 
Base fees
$
740

 
$
701

 
$
2,188

 
$
2,018

Performance-based fees
42

 
4

 
83

 
25

Research services
103

 
109

 
324

 
331

Distribution services
183

 
175

 
545

 
511

Other revenues:
 
 
 
 
 
 
 
Shareholder services
20

 
19

 
58

 
56

Other
4

 
5

 
16

 
13

Total investment management and service fees
$
1,092

 
$
1,013

 
$
3,214

 
$
2,954

 
 
 
 
 
 
 
 
Other income
$
7

 
$
9

 
$
24

 
$
25

9)    SHARE-BASED COMPENSATION PROGRAMS
AXA and Holdings sponsor various share-based compensation plans for eligible employees, financial professionals and non-officer directors of the Company. AB also sponsors its own equity compensation plan for certain of its employees.
Compensation costs for the three and nine months ended September 30, 2018 and 2017 for share-based payment arrangements as further described herein are as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Performance Shares(1)
$
4.3

 
$
2.6

 
$
9.9

 
$
15.6

Stock Options
0.6

 
0.4

 
1.1

 
1.1

Restricted Stock Unit Awards(2)
14.9

 
5.6

 
22.4

 
26.9

Other Compensation Plans(3)
0.7

 
1.5

 
1.8

 
1.5

Total Compensation Expenses
$
20.5

 
$
10.1

 
$
35.2

 
$
45.1

 ______________
(1)
Reflects change to performance share retirement rules. Specifically, individuals who retire at any time after the grant date will continue to vest in their 2017 performance shares while individuals who retire prior to March 1, 2019 will forfeit all 2018 performance shares.
(2)
Reflects a $10.9 million adjustment for awards with graded vesting, service-only conditions from the graded to the straight-line attribution method.
(3)
Includes Stock Appreciation Rights and Employee Stock Purchase Plans.



62
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Awards Linked to Holdings’ Common Stock
As described below, Holdings made various grants of equity awards linked to the value of Holdings’ common stock in the second quarter of 2018. For awards with graded vesting schedules and service-only vesting conditions, including Holdings restricted stock units (“Holdings RSUs”) and other forms of share-based payment awards, the Company applies a straight-line expense attribution policy for the recognition of compensation cost. Estimated and/or actual forfeitures with respect to the 2018 grants were considered immaterial in the recognition of compensation cost for the third quarter of 2018.
Holdings adopted the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan (the “Omnibus Plan”) on April 25, 2018. All grants discussed in this section were made under this Omnibus Plan with the exception of the Holdings RSUs granted to financial professionals. Also, all grants discussed in the section will be settled in shares of Holdings’ common stock except for the RSUs granted to financial professionals which will be settled in cash. As of September 30, 2018, the common stock reserved and available for issuance under the Omnibus Plan was 5.9 million shares.
Restricted Stock Units
In May 2018, Holdings made several grants of Holdings RSUs. The market price of a Holdings’ share is used as the basis for the fair value measure of a Holdings RSU. For purposes of determining compensation cost for stock-settled Holdings RSUs, fair value is fixed at the grant date until settlement, absent modification to the terms of the award. For liability-classified cash-settled Holdings RSUs, fair value is remeasured at the end of each reporting period. If Holdings pays any ordinary dividend in cash, all outstanding Holdings RSUs will accrue dividend equivalents in the form of additional Holdings RSUs to be settled or forfeited consistent with the terms of the related award.
Transaction Incentive Awards
On May 9, 2018, coincident with the IPO, Holdings granted one-time “Transaction Incentive Awards” to executive officers and certain other employees in the form of 0.6 million Holdings RSUs. fifty percent of the Holdings RSUs will vest based on service over a two year period from the IPO date (the “Service Units”), and fifty percent will vest based on service and a market condition (the “Performance Units”). The market condition is based on share price growth of at least 130% or 150% within a two or five year period, respectively. If the market condition is not achieved, 50% of the Performance Units may still vest based on five years of continued service and the remaining Performance Units will be forfeited. The $6.3 million aggregate grant-date fair value of the 0.3 million Service Units was measured at the $20 IPO price of a Holdings’ share and will be charged to compensation expense over the stated requisite service periods.
The grant-date fair value of half of the Performance Units, or 0.2 million Holdings RSUs, was also measured at the $20 IPO price for a Holdings’ share as employees are still able to vest in these awards even if the share price growth targets are not achieved. The resulting $3.2 million for these awards will be charged to compensation expense over the five-year requisite service period. The grant-date fair value of $16.47 was used to value the remaining half of the Performance Units that are subject to risk of forfeiture for non-achievement of the Holdings’ share price conditions. The grant date fair value was measured using a Monte Carlo simulation from which a five-year requisite service period was derived, representing the median of the distribution of stock price paths on which the market condition is satisfied, over which the total $2.6 million compensation expense will be recognized. In the third quarter of 2018, the Company recognized compensation expense associated with the Transaction Incentive Awards of approximately $2.2 million.
Employee Awards
Also on May 9, 2018, Holdings made an employee grant of 0.2 million Holdings RSUs, or 50 restricted stock units to each eligible individual, that cliff vest on November 9, 2018. The grant-date fair value of the award was measured using the $20 IPO price for a Holdings’ share and the resulting $4.8 million will be recognized as compensation expense over the six-month service period. In the third quarter of 2018, the Company recognized expense associated with the employee award of approximately $1.7 million.


63
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

2018 Annual Awards
On May 17, 2018, Holdings granted 0.8 million Holdings RSUs to employees that vest ratably in equal annual installments over a three-year period on each of the first three anniversaries of March 1, 2018. The fair value of the award was measured using the $21.68 closing price of the Holdings’ share on the grant date, and the resulting $17.8 million will be recognized as compensation expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. Similarly, on May 17, 2018, the Company granted an award of 0.5 million cash-settled Holdings RSUs to certain eligible financial professionals that vest ratably in equal installments over a three-year period on each of the first three anniversaries of March 1, 2018. The cash payment for each RSU will equal the average closing price for a Holdings’ share on the NYSE over the 20 trading days immediately preceding the vesting date. These awards are liability-classified and require fair value remeasurement based upon the price of a Holdings’ share at the close of each reporting period. In the third quarter of 2018, the Company recognized expense associated with the annual awards of approximately $1.8 million.
Performance Shares
Also on May 17, 2018, Holdings approved a grant of 0.4 million unearned Performance Shares to employees, subject to performance conditions and a cliff-vesting term ending March 1, 2021. If Holdings pays any ordinary dividend, outstanding Performance Shares will accrue dividend equivalents in the form of additional Performance Shares to be settled or forfeited consistent with the terms of the related award. The Performance Shares consist of two distinct tranches; one based on the Holdings’ return-on-equity targets (the “ROE Performance Shares”) and the other based on the Company’s relative total shareholder return targets (the “TSR Performance Shares”), each comprising approximately one-half of the award. Participants may receive from 0% to 200% of unearned Performance Shares granted.
The grant-date fair value of the ROE Performance Shares will be established once the 2019 and 2020 Non-GAAP ROE target are determined and approved. The grant-date fair value of the TSR Performance Shares was measured at $23.17 using a Monte Carlo approach. Under the Monte Carlo approach, stock returns were simulated for Holdings and the selected peer companies to estimate the payout percentages established by the conditions of the award. The resulting $4.0 million aggregate grant-date fair value of the unearned TSR Performance Shares will be recognized as compensation expense over the shorter of the cliff-vesting period or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. In the third quarter of 2018, the Company recognized expense associated with the TSR Performance Share awards of approximately $0.9 million.
Stock Options
On June 11, 2018, Holdings awarded 0.9 million stock options to employees. These options expire on March 1, 2028 and have a three-year graded vesting schedule, with one-third vesting on each of the three anniversaries of March 1, 2018. The exercise price for the options is $21.34, which was the closing price of a Holdings’ share on the grant date. The weighted average grant date fair value per option was estimated at $4.61 using a Black-Scholes options pricing model. Key assumptions used in the valuation included expected volatility of 25.4% based on historical selected peer data, a weighted average expected term of 5.7 years as determined by the simplified method, an expected dividend yield of 2.44% based on Holdings’ expected annualized dividend, and a risk-free interest rate of 2.83%. The total fair value of these options of approximately $4.0 million will be charged to expense over the shorter of the vesting period or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. In the third quarter of 2018, the Company recognized expense associated with the June 11, 2018 option grant of approximately $0.7 million.
Director Awards
On May 17, 2018, Holdings awarded 0.03 million unrestricted Holdings’ shares to non-officer directors of Holdings, AXA Equitable Life, and MLOA under the Omnibus Plan. The fair value of these awards was measured using the $21.68 closing price of Holdings’ shares on the grant date. As these awards were immediately vested, their aggregate fair value of $0.6 million was recognized as compensation expense in the second quarter of 2018.


64
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Funding of Awards
The Company used common stock held in Treasury to fund the delivery of the 0.03 million unrestricted shares granted to the non-officer directors in the second quarter of 2018. Holdings may issue new shares or use common stock held in Treasury for the other outstanding awards linked to Holdings’ common stock.
Equity Awards Linked to AXA Ordinary Shares
Grants
On February 15, 2018, AXA Financial granted restricted AXA ordinary shares to non-officer directors of AXA Financial, AXA Equitable Life, and MLOA with a three year vesting period under the Equity Plan for Directors.
Settlement /Payouts
On March 26, 2018, share distributions totaling approximately $20 million were made to active and former employees in settlement of 0.8 million Performance Shares earned under the terms of the AXA Performance Share Plan 2014. On April 6, 2018, cash distributions of approximately $6 million were made to active and former financial professionals in settlement of 0.2 million Performance Units earned under the terms of the AXA Advisor Performance Unit Plan 2014.
AB Long-term Incentive Compensation Plans
During the three and nine months ended September 30, 2018, respectively, AB purchased 1.6 million and 2.9 million units, representing assignments of beneficial ownership of limited partnership interests in AB Holding (“AB Holding Units”), for $48 million and $83 million , respectively (on a trade date basis). These amounts reflect open-market purchases of 1.6 million and 2.8 million AB Holding Units for $48 million and $81 million, respectively, with the remainder relating to purchases of AB Holding Units from employees to allow them to fulfill statutory tax withholding requirements at the time of delivery of long-term incentive compensation awards. During the three and nine months ended September 30, 2017, AB purchased 0.3 million and 5.9 million AB Holding Units for $7 million and $135 million, respectively (on a trade date basis). These amounts reflect open-market purchases of 0.3 million and 5.2 million AB Holding Units for $7 million and $117 million, respectively, with the remainder relating to purchases of AB Holding Units from employees to allow them to fulfill statutory tax withholding requirements at the time of delivery of long-term incentive compensation awards.
During the nine months ended September 30, 2018 and 2017, AB granted to employees and eligible directors 2.5 million and 2.1 million restricted AB Holding Unit awards, respectively. AB used AB Holding Units repurchased during the periods and newly issued AB Holding Units to fund these awards.
During the nine months ended September 30, 2018 and 2017, AB Holding issued 0.6 million and 1.0 million AB Holding Units, respectively, upon exercise of options to buy AB Holding Units. AB Holding used the proceeds of $11 million and $18 million, respectively, received as payment in cash for the exercise price to purchase the equivalent number of newly-issued AB Units.
10)    INCOME TAXES
Income tax expense for the nine months ended September 30, 2018 and 2017 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods.
In the first nine months of 2017, the Company recognized a tax benefit of $221 million related to the conclusion of an Internal Revenue Service (“IRS”) audit for tax years 2008 and 2009.
On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the “Tax Reform Act”), a broad overhaul of the U.S. Internal Revenue Code that changes long-standing provisions governing the taxation of U.S.


65
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

corporations, including life insurance companies. At December 31, 2017, the Company recorded a provisional estimate of the income tax effects related to the Tax Reform Act. During the nine months ended September 30, 2018, there were no changes to this estimate.

11)    RELATED PARTY TRANSACTIONS
The Company’s significant transactions during the nine months ended September 30, 2018 with related parties are summarized below.
Cost Sharing and General Service Agreements 
In the second quarter of 2018, AXA Equitable entered into a general services agreement with Holdings whereby AXA Equitable will benefit from the services received by Holdings from AXA and certain of its subsidiaries for a limited period following the Holdings IPO under a transition services agreement. The general services agreement with Holdings replaces existing cost-sharing and general service agreements with various AXA subsidiaries. AXA Equitable continues to provide services to Holdings and various AXA subsidiaries under a separate existing general services agreement with Holdings.
Insurance Related Transactions
Prior to April 2018, the Company ceded to AXA RE Arizona, an indirect, wholly owned subsidiary of Holdings, a (i) 100% quota share of all liabilities for variable annuities with GMxB riders issued on or after January 1, 2006 and in-force on September 30, 2008 (the “GMxB Business”), (ii) 100% quota share of all liabilities for variable annuities with GMIB riders issued on or after May 1, 1999 through August 31, 2005 in excess of the liability assumed by two unaffiliated reinsurers, which are subject to certain maximum amounts or limitations on aggregate claims, and (iii) 90% quota share of level premium term insurance issued by AXA Equitable on or after March 1, 2003 through December 31, 2008 and lapse protection riders under certain series of universal life insurance policies issued by AXA Equitable on or after June 1, 2003 through June 30, 2007.
On April 12, 2018, the Company completed the unwind of the reinsurance previously provided to the Company by AXA RE Arizona. Accordingly, all of the business previously ceded to AXA RE Arizona, with the exception of the GMxB Business, was novated to EQ AZ Life Re Company (“EQ AZ”), a newly formed captive insurance company organized under the laws of Arizona, which is an indirect wholly owned subsidiary of Holdings. Following the novation of business to EQ AZ, AXA RE Arizona was merged with and into AXA Equitable. Following AXA RE Arizona’s merger with and into AXA Equitable, the GMxB Business is not subject to any new internal or third-party reinsurance arrangements, though in the future AXA Equitable may reinsure the GMxB Business with third parties.
AXA RE Arizona novated the Life Business from AXA RE Arizona to EQ AZ as part of the GMxB Unwind. As a result, EQ AZ reinsures a 90% quota share of level premium term insurance issued by AXA Equitable on or after March 1, 2003 through December 31, 2008 and lapse protection riders under UL insurance policies issued by AXA Equitable on or after June 1, 2003 through June 30, 2007 and the Excess Risks.
The GMxB Unwind was considered a pre-existing relationship required to be effectively settled at fair value. The loss relating to this relationship resulted from the settlement of the reinsurance contracts at fair value and the write-off of previously recorded assets and liabilities related to this relationship recorded in the Company’s historical accounts. The pre-tax loss recognized in the second quarter of 2018 was $2,603 million ($2,056 million net of tax). The Company wrote-off a $1.8 billion Deferred cost of reinsurance asset which was previously reported in Other assets. Additionally, the remaining portion of the loss was determining by calculating the difference between the fair value of the assets received compared to the fair value of the assets and liabilities already recorded within the Company's consolidated financial statements. The Company's primary assets previously recorded were reinsurance recoverables, including the reinsurance recoverable associated with GMDB business. There was an approximate $400 million difference between the fair value of the GMDB recoverable compared to its carrying value which is accounted for under ASC 944.  


66
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The assets received and the assets removed were as follows:
        
 
As of April 12, 2018
 
(in millions)
 
Assets Received
Assets Removed
Assets at fair value:
 
 
Fixed income securities
$
7,442

 
Money Market funds
2

 
Accrued interest
43

 
Derivatives
303

 
Cash
1,098

 
 Total
$
8,888

 
 
 
 
Deferred cost of reinsurance asset
 
$
1,839

GMDB ceded reserves
 
2,317

GMIB reinsurance contract asset
 
7,463

Payable to AXA RE Arizona
 
270

Total
 
$
11,889

Significant non-cash transactions involved in the unwind of the reinsurance previously provided to the Company by AXA RE Arizona included: (a) the increase in total investments includes non-cash activities of $7,790 million for assets received related to the recapture transaction, (b) cancellation of the $300 million surplus note between the Company and AXA RE Arizona, and (c) settlement of the intercompany receivables/payables to AXA RE Arizona of $270 million. In addition, upon merging the remaining assets of AXA Re Arizona into AXA Equitable, $1.2 billion of deferred tax assets were recorded on the balance sheet through an adjustment to Capital in excess of par value.
The reinsurance arrangements with EQ AZ provide important capital management benefits to AXA Equitable. At September 30, 2018, the Company’s GMIB reinsurance contract asset with EQ AZ had carrying value of $189 million, and is reported in GMIB reinsurance contract asset, at fair value in the consolidated balance sheets. Ceded premiums and policy fee income for September 30, 2018 totaled approximately $24 million, Ceded claims paid for September 30, 2018, were $14 million.
AXA Equitable receives statutory reserve credits for reinsurance treaties with EQ AZ to the extent that  EQ AZ holds assets in an irrevocable trust (the “Trust”). At September 30, 2018, EQ AZ held assets of $1.1 billion in the Trust, and had letters of credit of $2.4 billion, which  are guaranteed by Holdings. Under the reinsurance transactions, EQ AZ is permitted to transfer assets from the Trust under certain circumstances. The level of statutory reserves held by EQ AZ fluctuate based on market movements, mortality experience and policyholder behavior. Increasing reserve requirements may necessitate that additional assets be placed in trust and/or securing additional letters of credit, which could adversely impact EQ AZ’s liquidity.
Loans to Affiliates
On April 20, 2018, the Company transferred cash in exchange for an $800 million note from Holdings with an interest rate of 3.69% and maturing on April 20, 2021.
Settlement of Borrowings Between the Company and Affiliates
On April 20, 2018, AXA pre-paid the remaining $650 million of a $700 million note and $50 million of a $500 million term loan and related accrued interest from the Company.


67
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


Insurance Coverage Provided by XL Catlin
Prior to AXA Group’s acquisition of XL Catlin on September 12, 2018, Holdings and the Company had various property and casualty insurance coverages provided by XL Catlin that will be terminated by December 31, 2018. In addition, the Company ceded disability income business to XL Catlin. As of September 30, 2018, the reserves ceded were $92 million.
12)    ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of September 30, 2018 and 2017 follow:
 
September 30,
 
2018
 
2017
 
(in millions)
Unrealized gains (losses) on investments
$
(839
)
 
$
369

Foreign currency translation adjustments
(47
)
 
(57
)
Defined benefit pension plans
(59
)
 
(48
)
Total accumulated other comprehensive income (loss)
(945
)
 
264

Less: Accumulated other comprehensive (income) loss attributable to noncontrolling interest
78

 
67

Accumulated other comprehensive income (loss) attributable to AXA Equitable
$
(867
)
 
$
331

The components of OCI, net of taxes for the three and nine months ended September 30, 2018 and 2017 follow:
 
Three Months Ended September 30,
 
Nine Months Ended
 September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Foreign currency translation adjustments:
 
 
 
 
 
 
 
Foreign currency translation gains (losses) arising during the period
$
1

 
$
6

 
$
(11
)
 
$
20

(Gains) losses reclassified into net income (loss) during the period
—

 
—

 
—

 
—

Foreign currency translation adjustment
1

 
6

 
(11
)
 
20

Net unrealized gains (losses) on investments:
 
 
 
 
 
 
 
Net unrealized gains (losses) arising during the period
(438
)
 
6

 
(1,770
)
 
458

(Gains) losses reclassified into net income (loss) during the period(1)
8

 
8

 
(59
)
 
6

Net unrealized gains (losses) on investments
(430
)
 
14

 
(1,829
)
 
464

Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other
26

 
(85
)
 
373

 
(128
)
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(107) million, $(38) million, $(387) million and $181 million)
(404
)
 
(71
)
 
(1,456
)
 
336



68
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
Three Months Ended September 30,
 
Nine Months Ended
 September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Change in defined benefit plans:
 
 
 
 
 
 
 
Less: reclassification adjustments to net income (loss) for:
 
 
 
 
 
 
 
Amortization of net actuarial (gains) losses included in:
 
 
 
 
 
 
 
Amortization of net prior service cost included in net periodic cost
(3
)
 
(3
)
 
(8
)
 
(2
)
Change in defined benefit plans (net of deferred income tax expense (benefit) of $(1) million, $(2) million, $(2) million and $(1) million)
(3
)
 
(3
)
 
(8
)
 
(2
)
Total other comprehensive income (loss), net of income taxes
(406
)
 
(68
)
 
(1,475
)
 
354

Less: Other comprehensive (income) loss attributable to noncontrolling interest
3

 
(32
)
 
10

 
(19
)
Other comprehensive income (loss) attributable to AXA Equitable
$
(403
)
 
$
(100
)
 
$
(1,465
)
 
$
335

_______________
(1)
See “Reclassification adjustments” in Note 3. Reclassification amounts presented net of income tax expense (benefit) of $2 million, $(16) million, $4 million and $3 million, for the three and nine months ended September 30, 2018 and 2017, respectively.

Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to net income (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.
13)    COMMITMENTS AND CONTINGENT LIABILITIES
Litigation
Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, the use of captive reinsurers, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters.
As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with


69
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters.
The outcome of a litigation or regulatory matter is difficult to predict and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period.
For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of September 30, 2018, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $90 million.
For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews.
In July 2011, a derivative action was filed in the United States District Court for the District of New Jersey entitled Mary Ann Sivolella v. AXA Equitable Life Insurance Company and AXA Equitable Funds Management Group, LLC (“Sivolella Litigation”) and a substantially similar action was filed in January 2013 entitled Sanford et al. v. AXA Equitable FMG (“Sanford Litigation”). These lawsuits were filed on behalf of a total of twelve mutual funds and, among other things, seek recovery under (i) Section 36(b) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), for alleged excessive fees paid to AXA Equitable and AXA Equitable FMG for investment management services and administrative services and (ii) a variety of other theories including unjust enrichment. The Sivolella Litigation and the Sanford Litigation were consolidated and a 25-day trial commenced in January 2016 and concluded in February 2016. In August 2016, the District Court issued its decision in favor of AXA Equitable and AXA Equitable FMG, finding that the plaintiffs had failed to meet their burden to demonstrate that AXA Equitable and AXA Equitable FMG breached their fiduciary duty in violation of Section 36(b) of the Investment Company Act or show any actual damages. In September 2016, the plaintiffs filed a motion to amend the District Court’s trial opinion and to amend or make new findings of fact and/or conclusions of law. In December 2016, the District Court issued an order denying the motion to amend and plaintiffs filed a notice to appeal the District Court’s decision to the U.S. Court of Appeals for the Third Circuit. In July 2018, the U.S. Court of Appeals for the Third Circuit affirmed the District Court’s decision, and that decision is now final because the plaintiffs failed to file a further appeal.
In November 2014, a lawsuit was filed in the Superior Court of New Jersey, Camden County entitled Arlene Shuster, on behalf of herself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all AXA Equitable variable life insurance policyholders who allocated funds from their policy accounts to investments in AXA Equitable’s Separate Accounts, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. The action asserts that AXA Equitable breached its variable life insurance contracts by implementing the volatility management strategy. In February 2016, the Court


70
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

dismissed the complaint. In March 2016, the plaintiff filed a notice of appeal. In April 2018, the Superior Court of New Jersey Appellate Division affirmed the trial court’s decision. In August 2015, another lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from AXA Equitable, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that AXA Equitable implemented the volatility management strategy in violation of applicable law. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted AXA Equitable’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following AXA Equitable’s notification to the court that it would not file a petition for writ of certiorari. We are vigorously defending this matter.
In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to AXA Equitable’s COI increase. In early 2016, AXA Equitable raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated class action complaint alleges the following claims: breach of contract; misrepresentations by AXA Equitable in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek (a) compensatory damages, costs, and, pre- and post-judgment interest, (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class, and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. Five other federal individual actions challenging the COI increase are also pending against AXA Equitable and have been consolidated with the Brach matter for the purposes of coordinating pre-trial activities. They contain similar allegations as those in Brach as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Three state individual actions are also pending against AXA Equitable in New York and Virginia. We are in various stages of motion practice and are vigorously defending each of these matters.
Lease obligations
The liabilities associated with the Company’s lease obligations were as follows:
 
Nine Months Ended September 30,
 
Year Ended December 31,
 
2018
 
2017
 
(in millions)
Leases
 
 
 
Balance, beginning of year
165

 
170

Expense incurred
7

 
29

Deferred rent
2

 
10

Payments made
(40
)
 
(48
)
Interest accretion
3

 
4

Balance, end of period
137

 
165



71
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Obligation under funding agreements
As a member of the FHLBNY, AXA Equitable has access to collateralized borrowings. It also may issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require AXA Equitable to pledge qualified mortgage-backed assets and/or government securities as collateral. AXA Equitable issues short-term funding agreements to the FHLBNY and uses the funds for asset liability and cash management purposes. AXA Equitable issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. For other instruments used for asset liability management purposes see “Derivative and offsetting assets and liabilities” included in Note 3. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets.
 
Outstanding balance at end of period
 
Maturity of Outstanding balance
 
Issued during the period
 
Repaid during the period
September 30, 2018:
(in millions)
Short-term FHLBNY funding agreements
$
500

 
less than one month
 
$
4,500

 
$
4,500

Long-term FHLBNY funding agreements
1,621

 
less than four years
 
—

 
—

 
98

 
Less than five years
 
—

 
—

 
781

 
greater than five years
 
—

 
—

Total long-term funding agreements
2,500

 
 
 
—

 
—

Total FHLBNY funding agreements at September 30, 2018
$
3,000

 
 
 
$
4,500

 
$
4,500

 
 
 
 
 
 
 
 
December 31, 2017:
 
 
 
 
 
 
 
Short-term FHLBNY funding agreements
$
500

 
Less than one month
 
$
6,000

 
$
6,000

Long-term FHLBNY funding agreements
1,244

 
Less than 4 years
 
324

 
—

 
377

 
Less than 5 years
 
303

 
—

 
879

 
Greater than five years
 
135

 
—

Total long-term funding agreements
2,500

 
 
 
762

 
—

Total FHLBNY funding agreements at December 31, 2017
$
3,000

 
 
 
$
6,762

 
$
6,000

Other Commitments
The Company had approximately $18 million of undrawn letters of credit issued in favor of third party beneficiaries primarily, as well as $761 million (including $197 million with affiliates) and $379 million of commitments under equity financing arrangements to certain limited partnership and existing mortgage loan agreements, respectively, at September 30, 2018.
AXA Financial has legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance, and deferred compensation benefits. AXA Equitable remains secondarily liable for its obligations under these plans and would recognize such liability in the event AXA Financial does not perform under the terms of the agreements.
Pursuant to certain assumption agreements (the “Assumption Agreements”), AXA Financial legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance and deferred compensation benefits as well as under the AXA Equitable Retirement plan, a frozen qualified pension plan. AXA Equitable remains secondarily liable for its


72
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

obligations under these plans and would recognize such liabilities in the event AXA Financial does not perform under the terms of the Assumption Agreements. On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity. See Note 16 for further information.
14)    BUSINESS SEGMENT INFORMATION
The Company has four reportable segments: Individual Retirement, Group Retirement, Investment Management and Research and Protection Solutions.
The Company changed its segment presentation in the fourth quarter 2017. The segment disclosures are based on the intention to provide the users of the financial statements with a view of the business from the Company’s perspective. As a result, the Company determined that it is more useful for a user of the financial statements to assess the historical performance on the basis which management currently evaluates the business. The reportable segments are based on the nature of the business activities.
These segments reflect the manner by which the Company’s chief operating decision maker views and manages the business. A brief description of these segments follows:
•
The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.
•
The Group Retirement segment offers tax-deferred investment and retirement plans to be sponsored by educational entities, municipalities and not-for-profit entities as well as small and medium-sized businesses.
•
The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels- Institutional, Retail and Private Wealth Management-and distributes its institutional research products and solutions through Bernstein Research Services.
•
The Protection Solutions segment includes our life insurance and group employee benefits businesses. Our life insurance business offers a variety of variable universal life, universal life and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of dental, vision, life, and short- and long-term disability and other insurance products to small and medium-size businesses across the United States.
Measurement
Operating earnings (loss) is the financial measure which primarily focuses on the Company’s segments’ results of operations as well as the underlying profitability of the Company’s core business. By excluding items that can be distortive and unpredictable such as investment gains (losses) and investment income (loss) from derivative instruments, the Company believes operating earnings (loss) by segment enhances the understanding of the Company’s underlying drivers of profitability and trends in the Company’s segments.
In the second quarter of 2018, the Company revised its Operating earnings definition as it relates to the treatment of certain elements of the profitability of its variable annuity products with indexed-linked features to align to the treatment of its variable annuity products with GMxB features. In addition, adjustments for variable annuity products with index-linked features previously included within Other adjustments in the calculation of Non-GAAP Operating Earnings are now included with the adjustments for variable annuity products with GMxB features in the broader adjustment category, Variable annuity product features. In order to improve the consistency and comparability of the financial statements, management revised the Notes to the Consolidated Financial Statements for the six months ended June 30, 2017, nine months ended September 30, 2017 and the year ended December 31, 2017 to include the revisions discussed herein.


73
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Operating earnings is calculated by adjusting each segment’s Net income (loss) attributable to AXA Equitable for the following items:
•
Items related to Variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features, the effect of benefit ratio unlock adjustments and changes in the fair value of the embedded derivatives reflected within Variable annuity products’ net derivative results;
•
Investment (gains) losses, which includes other-than-temporary impairments of securities, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;
•
Loss on the recapture of GMxB business previously ceded to AXA Arizona;
•
Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations and the one-time impact of the settlement of the defined benefit obligation;
•
Other adjustments, which includes restructuring costs related to severance, lease write-offs related to non-recurring restructuring activities and separation costs; and
•
Income tax expense (benefit) related to the above items and non-recurring tax items which includes the effect of uncertain tax positions for a given audit period and the Tax Reform Act.
Revenues derived from any customer did not exceed 10% of revenues for the three and nine months ended September 30, 2018 and 2017.


74
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The table below presents operating earnings (loss) by segment and Corporate and Other and a reconciliation to Net income (loss) attributable to AXA Equitable for the three and nine months ended September 30, 2018 and 2017, respectively:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Net income (loss) attributable to AXA Equitable
$
(511
)
 
$
21

 
$
(2,858
)
 
$
1,328

Adjustments related to:
 
 
 
 
 
 
 
Variable annuity product features (1)
1,393

 
457

 
2,580

 
(387
)
Investment (gains) losses
9

 
8

 
(73
)
 
9

Loss on the recapture of GMxB business previously ceded to AXA Arizona
(24
)
 
—

 
2,603

 
—

Net actuarial (gains) losses related to pension and other postretirement benefit obligations
17

 
24

 
130

 
72

Other adjustments
33

 
70

 
141

 
76

Income tax expense (benefit) related to above adjustments
(312
)
 
(233
)
 
(1,130
)
 
43

Non-recurring tax items
3

 
(7
)
 
26

 
(225
)
Non-GAAP Operating Earnings
$
608

 
$
340

 
$
1,419

 
$
916

 
 
 
 
 
 
 
 
Operating earnings (loss) by segment:
 
 
 
 
 
 
 
Individual Retirement
$
439

 
$
241

 
$
1,159

 
$
831

Group Retirement
121

 
97

 
255

 
210

Investment Management and Research
39

 
34

 
143

 
99

Protection Solutions
58

 
—

 
12

 
(83
)
Corporate and Other(1)
(49
)
 
(32
)
 
(150
)
 
(141
)
(1)
Includes interest expense of $12 million, $9 million, $34 million, and $20 million, for the three and nine months ended September 30, 2018 and 2017, respectively.
Segment revenues are a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to Total revenues by excluding the following items:
•
Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features;
•
Investment gains (losses), which include other-than-temporary impairments of securities, sales or disposals of securities/investments, realized capital gains/losses, and valuation allowances; and
•
Other adjustments, which includes the impact of adoption of revenue recognition standard ASC 606.


75
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The table below presents segment revenues for the three and nine months ended September 30, 2018 and 2017.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
 
(in millions)
Segment revenues:
 
 
 
 
 
 
 
Individual Retirement(1)
$
1,080

 
$
841

 
$
2,761

 
$
2,679

Group Retirement(1)
259

 
266

 
745

 
704

Investment Management and Research(2)
850

 
788

 
2,602

 
2,303

Protection Solutions(1)
610

 
645

 
1,870

 
1,874

Corporate and Other(1)
185

 
240

 
580

 
710

Adjustments related to:
 
 
 
 
 
 
 
Variable annuity product features
(2,120
)
 
(384
)
 
(3,299
)
 
926

Investment gains (losses)
(9
)
 
(8
)
 
73

 
(9
)
Other adjustments to segment revenues
5

 
24

 
(42
)
 
68

Total revenues
$
860

 
$
2,412

 
$
5,290

 
$
9,255

_____________
(1)
Includes investment expenses charged by AB of approximately $12 million, $18 million, $44 million and $42 million for the three and nine months ended September 30, 2018 and 2017, respectively, for services provided to the Company.
(2)
Inter-segment investment management and other fees of approximately $19 million, $29 million, $65 million and $65 million for the three and nine months ended September 30, 2018 and 2017, respectively, are included in total revenues of the Investment Management and Research segment.

The table below presents Total assets by segment as of September 30, 2018 and December 31, 2017:
 
September 30,
2018
 
December 31,
2017
 
(in millions)
Total assets by segment:
 
 
 
Individual Retirement
$
110,810

 
$
120,608

Group Retirement
43,323

 
40,472

Investment Management and Research
9,052

 
10,079

Protection Solutions
37,272

 
34,296

Corporate and Other
21,047

 
20,475

Total assets
$
221,504

 
$
225,930


15)     REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS
As previously reported, during the preparation of the second quarter 2018 financial statements, management identified errors in its previously issued financial statements related to: (a) a misclassification between interest credited and net derivative gains/losses, (b) an error in an actuarial model used to determine the deferred acquisition cost asset and related amortization for a specific group of insurance products issued by the Company, and (c) the understatement of a charge from Holdings related to partial settlement of a pension plan obligation. The impact of these errors to the Company’s consolidated financial statements for the three months ended March 31, 2018, the nine months ended


76
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

September 30, 2017, the six months ended June 30, 2017, the three months ended March 31, 2017 and the years ended December 31, 2017 and 2016 were not considered to be material.
In addition, during the preparation of its third quarter 2018 financial statements, management identified errors in its previously issued financial statements. These errors primarily relate to the calculation of policyholders’ benefit reserves for the Company’s life and annuity products and the calculation of net derivative gains (losses) and DAC amortization for certain variable and interest sensitive life products. The impact of these errors were not considered to be material to the consolidated financial statements as of and for the three months ended March 31, 2018, the three and six months ended June 30, 2018, the three and nine months ended September 30, 2017, the three and six months ended June 30, 2017, the three months ended March 31, 2017 and the years ended December 31, 2017, 2016 and 2015. However, in order to improve the consistency and comparability of the financial statements, management has determined to revise the Company’s consolidated financial statements for the three and six months ended March 31, 2018 and June 30, 2018, respectively, as well as the three, six and nine months ended March 31, 2017, June 30, 2017 and September 30, 2017, respectively and for the years ended December 31, 2017, 2016 and 2015.


77
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for June 30, 2018 financial information that has been affected by the revisions. This information has been corrected from the information previously presented in the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2018. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revisions, as revised after the revisions and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of June 30, 2018
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
4,786

 
$
(76
)
 
$
4,710

Amounts due from reinsurers
3,088

 
(9
)
 
3,079

Current and deferred taxes
159

 
3

 
162

Total Assets
219,306

 
(82
)
 
219,224

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
28,122

 
(64
)
 
28,058

Total Liabilities
202,196

 
(64
)
 
202,132

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
6,617

 
(18
)
 
6,599

AXA Equitable Equity
13,925

 
(18
)
 
13,907

Equity
16,964

 
(18
)
 
16,946

Total Liabilities and Equity
$
219,306

 
$
(82
)
 
$
219,224

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended June 30, 2018
 
 
 
 
 
Statements of Income (Loss):
 
 
 
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
904

 
$
(21
)
 
$
883

Net derivative gains (losses)
(312
)
 
27

 
(285
)
Total revenues
2,439

 
6

 
2,445

 
 
 
 
 
 
Benefits and other deductions:
 
 
 
 
 
Policyholders' benefits
1,339

 
(38
)
 
1,301

Amortization of deferred policy acquisition costs, net
31

 
5

 
36

Total benefits and other deductions
4,950

 
(33
)
 
4,917

 
 
 
 
 
 
Income (loss) from operations, before income taxes
(2,511
)
 
39

 
(2,472
)
Income tax (expense) benefit
553

 
(9
)
 
544

Net income (loss)
(1,958
)
 
30

 
(1,928
)
Net income (loss) attributable to AXA Equitable
$
(2,114
)
 
$
30

 
$
(2,084
)


78
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended June 30, 2018
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
Net income (loss)
$
(1,958
)
 
$
30

 
$
(1,928
)
Comprehensive income (loss)
(2,278
)
 
30

 
(2,248
)
Comprehensive income (loss) attributable to AXA Equitable
$
(2,420
)
 
$
30

 
$
(2,390
)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2018
 
 
 
 
 
Statements of Income (Loss):
 
 
 
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
1,773

 
$
(29
)
 
$
1,744

Net derivative gains (losses)
(1,172
)
 
72

 
(1,100
)
Total revenues
4,387

 
43

 
4,430

 
 
 
 
 
 
Benefits and other deductions:
 
 
 
 
 
Policyholders' benefits
1,828

 
(47
)
 
1,781

Amortization of deferred policy acquisition costs, net
89

 
21

 
110

Total benefits and other deductions
7,100

 
(26
)
 
7,074

 
 
 
 
 
 
Income (loss) from operations, before income taxes
(2,713
)
 
69

 
(2,644
)
Income tax (expense) benefit
622

 
(15
)
 
607

Net income (loss)
(2,091
)
 
54

 
(2,037
)
Net income (loss) attributable to AXA Equitable
$
(2,401
)
 
$
54

 
$
(2,347
)
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2018
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
Net income (loss)
$
(2,091
)
 
$
54

 
$
(2,037
)
Comprehensive income (loss)
(3,160
)
 
54

 
(3,106
)
Comprehensive income (loss) attributable to AXA Equitable
$
(3,463
)
 
$
54

 
$
(3,409
)


79
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2018
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
9,010

 
$
(72
)
 
$
8,938

Net income (loss) attributable to AXA Equitable
(2,401
)
 
54

 
(2,347
)
Retained earnings, end of period
6,617

 
(18
)
 
6,599

Total AXA Equitable’s equity, end of period
13,925

 
(18
)
 
13,907

Total Equity, End of Period
$
16,964

 
$
(18
)
 
$
16,946

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2018
 
 
 
 
 
Statements of Cash flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
(2,091
)
 
$
54

 
$
(2,037
)
Policy charges and fee income
(1,773
)
 
29

 
(1,744
)
Net derivative (gains) loss
1,172

 
(72
)
 
1,100

Changes in:
 
 
 
 
 
Future policy benefits
396

 
(47
)
 
349

Deferred policy acquisition costs
89

 
21

 
110

Current and deferred income taxes
(645
)
 
15

 
(630
)
Net cash provided by (used in) operating activities
$
1,190

 
$
—

 
$
1,190



80
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for March 31, 2018 financial information that has been affected by the revisions. This information has been corrected from the information previously presented in the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2018. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revisions, and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of March 31, 2018
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
4,826

 
$
(119
)
 
$
4,707

Total Assets
222,424

 
(119
)
 
222,305

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
28,374

 
(10
)
 
28,364

Current and deferred taxes
1,728

 
(38
)
 
1,690

Other liabilities
3,041

 
70

 
3,111

Total Liabilities
202,767

 
22

 
202,789

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
8,824

 
(141
)
 
8,683

AXA Equitable Equity
15,545

 
(141
)
 
15,404

Equity
18,633

 
(141
)
 
18,492

Total Liabilities and Equity
$
222,424

 
$
(119
)
 
$
222,305

 
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2018
 
 
 
 
 
 
Consolidated Statement of Income (Loss):
 
 
 
 
 
 
Revenues:
 
 
 
 
 
 
Policy charges and fee income
 
$
869

 
$
(8
)
 
$
861

Net derivative gains (losses)
 
(777
)
 
(38
)
 
(815
)
Total Revenues
 
2,031

 
(46
)
 
1,985

 
 
 
 
 
 
 
Benefits and other deductions:
 
 
 
 
 
 
Policyholders’ benefits
 
489

 
(9
)
 
480

Interest credited to policyholders’ account balances
 
338

 
(83
)
 
255

Compensation and benefits
 
456

 
70

 
526

Amortization of deferred policy acquisition costs, net
 
10

 
64

 
74

Total benefits and other deductions
 
2,115

 
42

 
2,157

 
 
 
 
 
 
 
Income (loss) from operations, before income taxes
 
(84
)
 
(88
)
 
(172
)
Income tax (expense) benefit
 
44

 
19

 
63

Net income (loss)
 
(40
)
 
(69
)
 
(109
)
Net income (loss) attributable to AXA Equitable
 
$
(194
)
 
$
(69
)
 
$
(263
)


81
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2018
 
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
 
Net income (loss)
 
$
(40
)
 
$
(69
)
 
$
(109
)
Comprehensive income (loss)
 
(789
)
 
(69
)
 
(858
)
Comprehensive income (loss) attributable to AXA Equitable
 
$
(950
)
 
$
(69
)
 
$
(1,019
)
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2018
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
9,010

 
$
(72
)
 
$
8,938

Net income (loss)
(194
)
 
(69
)
 
(263
)
Retained earnings, end of period
8,824

 
(141
)
 
8,683

Total AXA Equitable’s equity, end of period
15,545

 
(141
)
 
15,404

Total Equity, End of Period
$
18,633

 
$
(141
)
 
$
18,492

 
As Previously Reported
 
Impact of Revisions
 
As Revised
Three Months Ended March 31, 2018
(in millions)
Consolidated Statement of Cash Flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
(40
)
 
$
(69
)
 
$
(109
)
Policy charges and fee income
(869
)
 
8

 
(861
)
Interest credited to policyholders’ account balances
338

 
(83
)
 
255

Net derivative (gains) loss
777

 
38

 
815

Changes in:
 
 
 
 
 
DAC
10

 
64

 
74

Future policy benefits
(191
)
 
(9
)
 
(200
)
Current and deferred income taxes
(52
)
 
(19
)
 
(71
)
Other, net
(122
)
 
70

 
(52
)
Net cash provided by (used in) operating activities
$
(21
)
 
$
—

 
$
(21
)



82
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for September 30, 2017 financial information that has been affected by the revisions. This information has been corrected from the information previously presented in the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2017. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the revisions and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of September 30, 2017
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
4,550

 
$
278

 
$
4,828

Amounts due from reinsurers
5,016

 
(12
)
 
5,004

GMIB reinsurance contract asset, at fair value
10,933

 
(33
)
 
10,900

Other Assets
4,258

 
18

 
4,276

Total Assets
219,069

 
251

 
219,320

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
29,423

 
36

 
29,459

Current and deferred taxes
3,148

 
88

 
3,236

Total Liabilities
202,669

 
124

 
202,793

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
7,265

 
158

 
7,423

Accumulated other comprehensive income (loss)
362

 
(31
)
 
331

AXA Equitable Equity
12,990

 
127

 
13,117

Equity
15,959

 
127

 
16,086

Total Liabilities and Equity
$
219,069

 
$
251

 
$
219,320



83
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Nine Months Ended September 30, 2017
 
 
 
 
 
Statements of Income (Loss):
 
 
 
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
2,626

 
$
(110
)
 
$
2,516

Premiums
645

 
20

 
665

Net derivative gains (losses)
1,376

 
(328
)
 
1,048

Total revenues
9,673

 
(418
)
 
9,255

 
 
 
 
 
 
Benefits and other deductions:
 
 
 
 
 
Policyholders' benefits
3,308

 
(124
)
 
3,184

Interest credited to policyholders' account balances
1,008

 
(327
)
 
681

Amortization of deferred policy acquisition costs, net
15

 
27

 
42

Total benefits and other deductions
7,800

 
(424
)
 
7,376

 
 
 
 
 
 
Income (loss) from operations, before income taxes
1,873

 
6

 
1,879

Income tax (expense) benefit
(196
)
 
(2
)
 
(198
)
Net income (loss)
1,677

 
4

 
1,681

Net income (loss) attributable to AXA Equitable
$
1,324

 
$
4

 
$
1,328

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Nine Months Ended September 30, 2017
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
1,677

 
$
4

 
$
1,681

Change in unrealized gains (losses), net of reclassification adjustment
362

 
(26
)
 
336

Other comprehensive income
380

 
(26
)
 
354

Comprehensive income (loss)
2,057

 
(22
)
 
2,035

Comprehensive income (loss) attributable to AXA Equitable
$
1,685

 
$
(22
)
 
$
1,663




84
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Nine Months Ended September 30, 2017
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
5,941

 
$
154

 
$
6,095

Net income (loss)
1,324

 
4

 
1,328

Retained earnings, end of period
7,265

 
158

 
7,423

Accumulated other comprehensive income, beginning of year
1

 
(5
)
 
(4
)
Other comprehensive income (loss)
361

 
(26
)
 
335

Accumulated other comprehensive income, end of period
362

 
(31
)
 
331

Total AXA Equitable’s equity, end of period
12,990

 
127

 
13,117

Total Equity, End of Period
$
15,959

 
$
127

 
$
16,086

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Nine Months Ended September 30, 2017
 
 
 
 
 
Statements of Cash flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
1,677

 
$
4

 
$
1,681

Policy charges and fee income
(2,626
)
 
110

 
(2,516
)
Interest credited to policyholders’ account balances
1,008

 
(327
)
 
681

Net derivative (gains) loss
(1,376
)
 
328

 
(1,048
)
Changes in:
 
 
 
 
 
Deferred Policy Acquisition costs
15

 
27

 
42

Future policy benefits
1,289

 
(143
)
 
1,146

Current and deferred income taxes
639

 
1

 
640

Net cash provided by (used in) operating activities
$
994

 
$
—

 
$
994




85
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for June 30, 2017 financial information that has been affected by the revisions and the change in accounting principle. This information has been corrected from the information previously presented in the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2017. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revisions, as revised after the revisions, the impacts of the change in accounting principle and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
 
As of June 30, 2017
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
4,913

 
$
(63
)
 
$
4,850

Total Assets
215,713

 
(63
)
 
215,650

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
29,679

 
53

 
29,732

Current and deferred taxes
3,267

 
(39
)
 
3,228

Total Liabilities
199,095

 
14

 
199,109

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
7,479

 
(77
)
 
7,402

AXA Equitable Equity
13,273

 
(77
)
 
13,196

Equity
16,257

 
(77
)
 
16,180

Total Liabilities and Equity
$
215,713

 
$
(63
)
 
$
215,650



86
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended June 30, 2017
 
 
 
 
 
Statements of Income (Loss):
 
 
 
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
846

 
$
(12
)
 
$
834

Net derivative gains (losses)
1,763

 
8

 
1,771

Total revenues
4,548

 
(4
)
 
4,544

 
 
 
 
 
 
Benefits and other deductions:
 
 
 
 
 
Policyholders' benefits
1,363

 
(7
)
 
1,356

Amortization of deferred policy acquisition costs, net
(49
)
 
(1
)
 
(50
)
Interest credited to policyholders’ account balances
208

 
(9
)
 
199

Total benefits and other deductions
2,516

 
(17
)
 
2,499

 
 
 
 
 
 
Income (loss) from operations, before income taxes
2,032

 
13

 
2,045

Income tax (expense) benefit
(419
)
 
(5
)
 
(424
)
Net income (loss)
1,613

 
8

 
1,621

Net income (loss) attributable to AXA Equitable
$
1,500

 
$
8

 
$
1,508

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended June 30, 2017
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
Net income (loss)
$
1,613

 
$
8

 
$
1,621

Comprehensive income (loss)
1,887

 
8

 
1,895

Comprehensive income (loss) attributable to AXA Equitable
$
1,794

 
$
8

 
$
1,802




87
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
 
(in millions)
Six Months Ended June 30, 2017
 
 
 
 
 
 
Statements of Income (Loss):
 
 
 
 
 
 
Revenues:
 
 
 
 
 
 
Policy charges and fee income
$
1,698

 
$
(34
)
 
$
1,664

 
Net derivative gains (losses)
1,362

 
54

 
1,416

 
Total revenues
6,823

 
20

 
6,843

 
 
 
 
 
 
 
 
Benefits and other deductions:
 
 
 
 
 
 
Policyholders' benefits
2,338

 
(10
)
 
2,328

 
Amortization of deferred policy acquisition costs, net
(20
)
 
62

 
42

 
Total benefits and other deductions
4,966

 
52

 
5,018

 
 
 
 
 
 
 
 
Income (loss) from operations, before income taxes
1,857

 
(32
)
 
1,825

 
Income tax (expense) benefit
(298
)
 
11

 
(287
)
 
Net income (loss)
1,559

 
(21
)
 
1,538

 
Net income (loss) attributable to AXA Equitable
$
1,328

 
$
(21
)
 
$
1,307

 
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2017
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
1,559

 
$
(21
)
 
$
1,538

Change in unrealized gains (losses), net of reclassification adjustment
386

 
21

 
407

Other comprehensive income
401

 
21

 
422

Comprehensive income (loss)
1,960

 
—

 
1,960

Comprehensive income (loss) attributable to AXA Equitable
$
1,742

 
$
—

 
$
1,742




88
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2017
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
6,151

 
$
(56
)
 
$
6,095

Net income (loss) attributable to AXA Equitable
1,328

 
(21
)
 
1,307

Retained earnings, end of period
7,479

 
(77
)
 
7,402

Accumulated other comprehensive income, beginning of year
17

 
(21
)
 
(4
)
Other comprehensive income (loss)
414

 
21

 
435

Accumulated other comprehensive income, end of period
431

 
—

 
431

Total AXA Equitable’s equity, end of period
13,273

 
(77
)
 
13,196

Total Equity, End of Period
$
16,257

 
$
(77
)
 
$
16,180

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Six Months Ended June 30, 2017
 
 
 
 
 
Statements of Cash flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
1,559

 
$
(21
)
 
$
1,538

Policy charges and fee income
(1,698
)
 
34

 
(1,664
)
Net derivative (gains) loss
(1,362
)
 
(54
)
 
(1,416
)
Changes in:
 
 
 
 
 
Future policy benefits
1,303

 
(10
)
 
1,293

Deferred policy acquisition costs
(20
)
 
62

 
42

Current and deferred income taxes
204

 
(11
)
 
193

Net cash provided by (used in) operating activities
$
(75
)
 
$
—

 
$
(75
)



89
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for March 31, 2017 financial information that has been affected by the revisions and the change in accounting principle. This information has been corrected from the information previously presented in the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2017. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revisions, as revised after the revisions, the impacts of the change in accounting principle and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of March 31, 2017
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
4,961

 
$
(64
)
 
$
4,897

Total Assets
210,013

 
(64
)
 
209,949

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
28,691

 
66

 
28,757

Current and deferred taxes
2,726

 
(46
)
 
2,680

Total Liabilities
195,091

 
20

 
195,111

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
5,978

 
(84
)
 
5,894

AXA Equitable Equity
11,459

 
(84
)
 
11,375

Equity
14,505

 
(84
)
 
14,421

Total Liabilities and Equity
$
210,013

 
$
(64
)
 
$
209,949



90
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2017
 
 
 
 
 
Statements of Income (Loss):
 
 
 
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
852

 
$
(22
)
 
$
830

Net derivative gains (losses)
(362
)
 
7

 
(355
)
Total revenues
2,314

 
(15
)
 
2,299

Benefits and other deductions:
 
 
 
 
 
Policyholders' benefits
975

 
(3
)
 
972

Interest credited to policyholders' account balances
279

 
(30
)
 
249

Amortization of deferred policy acquisition costs, net
29

 
63

 
92

Total benefits and other deductions
2,489

 
30

 
2,519

 
 
 
 
 
 
Income (loss) from operations, before income taxes
(175
)
 
(45
)
 
(220
)
Income tax (expense) benefit
121

 
16

 
137

Net income (loss)
(54
)
 
(29
)
 
(83
)
Net income (loss) attributable to AXA Equitable
$
(172
)
 
$
(29
)
 
$
(201
)
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2017
 
 
 
 
 
Statements of Comprehensive Income (Loss):
 
 
 
 
 
Net income (loss)
$
(54
)
 
$
(29
)
 
$
(83
)
Change in unrealized gains (losses), net of reclassification adjustment
92

 
21

 
113

Total other comprehensive income (loss), net of income taxes
127

 
21

 
148

Comprehensive income (loss)
73

 
(8
)
 
65

Comprehensive income (loss) attributable to AXA Equitable
$
(52
)
 
$
(8
)
 
$
(60
)



91
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2017
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
6,150

 
$
(55
)
 
$
6,095

Net income (loss) attributable to AXA Equitable
(172
)
 
(29
)
 
(201
)
Retained earnings, end of period
5,978

 
(84
)
 
5,894

Accumulated other comprehensive income, beginning of year
17

 
(21
)
 
(4
)
Other comprehensive income (loss)
120

 
21

 
141

Accumulated other comprehensive income, end of period
137

 
—

 
137

Total AXA Equitable’s equity, end of period
11,459

 
(84
)
 
11,375

Total Equity, End of Period
$
14,505

 
$
(84
)
 
$
14,421

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
Three Months Ended March 31, 2017
 
 
 
 
 
Statements of Cash flows:
 
 
 
 
 
Net income (loss)
$
(54
)
 
$
(29
)
 
$
(83
)
Policy charges and fee income
(852
)
 
22

 
(830
)
Interest credited to policyholders’ account balances
279

 
(30
)
 
249

Net derivative (gains) loss
362

 
(7
)
 
355

Changes in:
 
 
 
 
 
Deferred policy acquisition costs
29

 
63

 
92

Future policy benefits
241

 
(3
)
 
238

Current and deferred income taxes
(188
)
 
(16
)
 
(204
)
Net cash provided by (used in) operating activities
$
18

 
$
—

 
$
18





92
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for December 31, 2017 financial information that has been affected by the revisions. This information has been corrected from the information previously presented in the 2017 Form 10-K. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the revisions and the amounts as currently revised.

 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of December 31, 2017
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
4,547

 
$
(55
)
 
$
4,492

Total Assets
225,985

 
(55
)
 
225,930

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Policyholders' account balance
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
29,034

 
36

 
29,070

Current and deferred taxes
1,973

 
(19
)
 
1,954

Total Liabilities
205,795

 
17

 
205,812

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
9,010

 
(72
)
 
8,938

AXA Equitable Equity
16,469

 
(72
)
 
16,397

Equity
19,564

 
(72
)
 
19,492

Total Liabilities and Equity
$
225,985

 
$
(55
)
 
$
225,930




93
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2017
(in millions)
Consolidated Statement of Income (Loss):
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
3,334

 
$
(40
)
 
$
3,294

Premiums
904

 
—

 
904

Net derivative gains (losses)
890

 
(20
)
 
870

Total revenues
11,733

 
(60
)
 
11,673

Benefits and other deductions:
 
 
 
 
 
Policyholders’ benefits
3,462

 
11

 
3,473

Interest credited to Policyholder’s account balances
1,040

 
(119
)
 
921

Amortization of deferred policy acquisition costs
268

 
54

 
322

Total benefits and other deductions
9,478

 
(54
)
 
9,424

 
 
 
 
 
 
Income (loss) from operations, before income taxes
2,255

 
(6
)
 
2,249

Income tax (expense) benefit
1,139

 
(11
)
 
1,128

Net income (loss)
3,394

 
(17
)
 
3,377

Net income (loss) attributable to AXA Equitable
$
2,860

 
$
(17
)
 
$
2,843

 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2017
(in millions)
Statements of Comprehensive Income (Loss):
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
3,394

 
$
(17
)
 
$
3,377

Change in unrealized gains (losses), net of reclassification adjustment
563

 
21

 
584

Total other comprehensive income (loss), net of income taxes
599

 
21

 
620

Comprehensive income (loss)
3,993

 
4

 
3,997

Comprehensive income (loss) attributable to AXA Equitable
$
3,441

 
$
4

 
$
3,445


 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
For the Year ended December 31, 2017
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
6,150

 
$
(55
)
 
$
6,095

Net income (loss) attributable to AXA Equitable
2,860

 
(17
)
 
2,843

Retained earnings, end of period
9,010

 
(72
)
 
8,938

Accumulated other comprehensive income, beginning of year
17

 
(21
)
 
(4
)
Other comprehensive income (loss)
581

 
21

 
602

Total AXA Equitable’s equity, end of period
16,469

 
(72
)
 
16,397

Total Equity, End of Period
$
19,564

 
$
(72
)
 
$
19,492



94
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2017
(in millions)
Consolidated Statement of Cash Flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
3,394

 
$
(17
)
 
$
3,377

Policy charges and fee income
(3,334
)
 
40

 
(3,294
)
Interest credited to policyholders’ account balances
1,040

 
(119
)
 
921

Net derivative (gains) loss
(890
)
 
20

 
(870
)
Deferred Policy Acquisition costs
268

 
54

 
322

Changes in:
 
 
 
 


Future policy benefits
1,511

 
11

 
1,522

Current and deferred income taxes
(664
)
 
11

 
(653
)
Net cash provided by (used in) operating activities
$
1,077

 
$
—

 
$
1,077




95
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for December 31, 2016 financial information that has been affected by the revisions. This information has been corrected from the information previously presented in the 2017 Form 10-K. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the revisions and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of December 31, 2016
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
5,058

 
$
(33
)
 
$
5,025

Total Assets
204,556

 
(33
)
 
204,523

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Policyholders' account balance
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
28,901

 
83

 
28,984

Current and deferred taxes
2,834

 
(40
)
 
2,794

Total Liabilities
189,549

 
43

 
189,592

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
6,150

 
(55
)
 
6,095

Accumulated other comprehensive income (loss)
17

 
(21
)
 
(4
)
AXA Equitable Equity
11,508

 
(76
)
 
11,432

Equity
14,604

 
(76
)
 
14,528

Total Liabilities and Equity
$
204,556

 
$
(33
)
 
$
204,523


 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2016
(in millions)
Consolidated Statement of Income (Loss):
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
3,344

 
$
(33
)
 
$
3,311

Net derivative gains (losses)
(1,211
)
 
(126
)
 
(1,337
)
Total revenues
9,138

 
(159
)
 
8,979

Benefits and other deductions:
 
 
 
 
 
Interest credited to Policyholder’s account balances
1,029

 
(124
)
 
905

Amortization of deferred policy acquisition costs
52

 
(4
)
 
48

Other operating costs and expenses
 
 
 
 


Total benefits and other deductions
8,516

 
(128
)
 
8,388

 
 
 
 
 
 
Income (loss) from operations, before income taxes
622

 
(31
)
 
591

Income tax (expense) benefit
84

 
11

 
95

Net income (loss)
706

 
(20
)
 
686

Net income (loss) attributable to AXA Equitable
$
210

 
$
(20
)
 
$
190



96
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2016
(in millions)
Statements of Comprehensive Income (Loss):
 
 
 
 
 
Net income (loss)
$
706

 
$
(20
)
 
$
686

Change in unrealized gains (losses), net of reclassification adjustment
(194
)
 
(21
)
 
(215
)
Total other comprehensive income (loss), net of income taxes
(215
)
 
(21
)
 
(236
)
Comprehensive income (loss)
491

 
(41
)
 
450

Comprehensive income (loss) attributable to AXA Equitable
$
12

 
$
(41
)
 
$
(29
)
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
For the Year ended December 31, 2016
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
6,990

 
$
(35
)
 
$
6,955

Net income (loss) attributable to AXA Equitable
210

 
(20
)
 
190

Retained earnings, end of period
6,150

 
(55
)
 
6,095

Other comprehensive income (loss)
(198
)
 
(21
)
 
(219
)
Accumulated other comprehensive income, end of period
17

 
(21
)
 
(4
)
Total AXA Equitable’s equity, end of period
11,508

 
(76
)
 
11,432

Total Equity, End of Period
$
14,604

 
$
(76
)
 
$
14,528


 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2016
(in millions)
Consolidated Statement of Cash Flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
706

 
$
(20
)
 
$
686

Policy charges and fee income
(3,344
)
 
33

 
(3,311
)
Interest credited to policyholders’ account balances
1,029

 
(124
)
 
905

Net derivative (gains) loss
1,211

 
126

 
1,337

Deferred Policy Acquisition costs
52

 
(4
)
 
48

Changes in:
 
 
 
 


Current and deferred income taxes
(742
)
 
(11
)
 
(753
)
Net cash provided by (used in) operating activities
$
(461
)
 
$
—

 
$
(461
)



97
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

The following tables present line items for December 31, 2015 financial information that has been affected by the revisions. This information has been corrected from the information previously presented in the 2017 Form 10-K. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the revisions and the amounts as currently revised.
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
As of December 31, 2015
 
 
 
 
 
Assets:
 
 
 
 
 
DAC
$
5,084

 
$
(5
)
 
$
5,079

Total Assets
195,303

 
(5
)
 
195,298

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Future policyholders' benefits and other policyholders' liabilities
28,431

 
49

 
28,480

Current and deferred taxes
3,624

 
(19
)
 
3,605

Total Liabilities
179,705

 
30

 
179,735

 
 
 
 
 
 
Equity:
 
 
 
 
 
Retained Earnings
6,990

 
(35
)
 
6,955

AXA Equitable Equity
12,528

 
(35
)
 
12,493

Equity
15,587

 
(35
)
 
15,552

Total Liabilities and Equity
$
195,303

 
$
(5
)
 
$
195,298

 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2015
(in millions)
Consolidated Statement of Income (Loss):
 
 
Revenues:
 
 
 
 
 
Policy charges and fee income
$
3,291

 
$
(25
)
 
$
3,266

Net derivative gains (losses)
(1,161
)
 
(12
)
 
(1,173
)
Total revenues
8,961

 
(37
)
 
8,924

Benefits and other deductions:
 
 
 
 
 
Policyholders’ benefits
2,474

 
2

 
2,476

Interest credited to Policyholder’s account balances
887

 
(13
)
 
874

Amortization of deferred policy acquisition costs
(243
)
 
(5
)
 
(248
)
Total benefits and other deductions
7,923

 
(16
)
 
7,907

 
 
 
 
 
 
Income (loss) from operations, before income taxes
1,038

 
(21
)
 
1,017

Income tax (expense) benefit
22

 
7

 
29

Net income (loss)
1,060

 
(14
)
 
1,046

Net income (loss) attributable to AXA Equitable
$
662

 
$
(14
)
 
$
648



98
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2015
(in millions)
Statements of Comprehensive Income (Loss):
 
 
 
 
 
Net income (loss)
$
1,060

 
$
(14
)
 
$
1,046

Comprehensive income (loss)
199

 
(14
)
 
185

Comprehensive income (loss) attributable to AXA Equitable
$
(184
)
 
$
(14
)
 
$
(198
)
 
As Previously Reported
 
Impact of Revisions
 
As Revised
 
(in millions)
For the Year ended December 31, 2015
 
 
 
 
 
Statements of Equity:
 
 
 
 
 
Retained earnings, beginning of year
$
7,240

 
$
(21
)
 
$
7,219

Net income (loss) attributable to AXA Equitable
662

 
(14
)
 
648

Retained earnings, end of period
6,990

 
(35
)
 
6,955

Total AXA Equitable’s equity, end of period
12,528

 
(35
)
 
12,493

Total Equity, End of Period
$
15,587

 
$
(35
)
 
$
15,552

 
As Previously Reported
 
Impact of Revisions
 
As Revised
For the Year ended December 31, 2015
(in millions)
Consolidated Statement of Cash Flows:
 
 
 
 
 
Cash flow from operating activities:
 
 
 
 
 
Net income (loss)
$
1,060

 
$
(14
)
 
$
1,046

Policy charges and fee income
(3,291
)
 
25

 
(3,266
)
Net derivative (gains) loss
1,174

 
(1
)
 
1,173

Deferred Policy Acquisition costs
(243
)
 
(5
)
 
(248
)
Changes in:
 
 
 
 
 
Future policy benefits
631

 
2

 
633

Current and deferred income taxes
50

 
(7
)
 
43

Net cash provided by (used in) operating activities
$
(324
)
 
$
—

 
$
(324
)


16)    SUBSEQUENT EVENTS
AXA Financial Merger
On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity (the “Merger”). As a result of the Merger, Holdings assumed all of AXA Financial’s liabilities, including its obligations under the Assumption Agreements.


99
AXA EQUITABLE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


Employee Stock Purchase Plan
On September 21, 2018, Holdings’ Board of Directors approved the AXA Equitable Holdings, Inc. Stock Purchase Plan (the “Plan”), a non-qualified stock purchase plan pursuant to which eligible financial professionals and employees of Holdings and its affiliates may make monthly purchases of common stock. The holder of a majority of the outstanding shares of Holdings’ common stock executed a written consent approving the adoption of the Plan on November 1, 2018.



100

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s discussion and analysis of financial condition and results of operations is presented pursuant to General Instruction (H)(2)(a) of Form 10-Q. The management’s narrative for the Company that follows should be read in conjunction with the consolidated financial statements and the related Notes to Consolidated Financial Statements included elsewhere herein, with the information provided under “Forward-looking Statements” included elsewhere herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) in Part II, Item 7 and “Risk Factors” in Part I, Item 1A included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 (“2017 Form 10-K”). The management’s narrative that follows represents a discussion and analysis of AXA Equitable’s financial condition and results of operations and not the financial condition and results of operations of AXA Equitable Holdings, Inc. (“Holdings”).

Executive Summary
Overview

We are one of America’s leading financial services companies, providing (i) advice and solutions for helping Americans set and meet their retirement goals and protect and transfer their wealth across generations and (ii) a wide range of investment management insights, expertise and innovations to drive better investment decisions and outcomes for clients worldwide.

In the fourth quarter of 2017, we completed the reorganization of our segment results into an expanded segment structure to enhance transparency and accountability. We believe that the additional segments will enhance the transparency of the financial results of our retirement and protection businesses. We have modified the presentation of our business segment results to reflect our new operating structure and prior periods’ presentation has been revised to conform to the new structure.

We manage our business through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. We report certain activities and items that are not included in these segments in Corporate and Other. See Note 14 of Notes to Consolidated Financial Statements for further information on the Company’s segments.

We benefit from our complementary mix of businesses. This business mix provides diversity in our earnings sources, which helps offset fluctuations in market conditions and variability in business results, while offering growth opportunities.

GMxB Unwind

On April 12, 2018, we completed an unwind of the reinsurance provided to the Company by AXA RE Arizona for certain variable annuities with GMxB features (the “GMxB Unwind”). Accordingly, all business previously reinsured to AXA RE Arizona, with the exception of the GMxB Business, was novated to EQ AZ Life Re Company (“EQ AZ”), a newly formed captive insurance company organized under the laws of Arizona, which is an indirect wholly owned subsidiary of Holdings. As of September 30, 2018, the Company’s GMIB reinsurance contract asset with EQ AZ had carrying value of $189 million and is reported in GMIB reinsurance contract asset at fair value in the consolidated balance sheets. Following the novation of this business to EQ AZ, AXA RE Arizona was merged with and into AXA Equitable. Following AXA RE Arizona’s merger with and into AXA Equitable, the GMxB Business is not subject to any internal reinsurance arrangements. See Note 11 of Notes to Consolidated Financial Statements for further information on the GMxB Unwind.

Revenues

Our revenues come from three principal sources:

•
fee income derived from our retirement and protection products and our investment management and research services;

•
premiums from our traditional life insurance and annuity products; and


101


•
investment income from our General Account investment portfolio

Our fee income varies directly in relation to the amount of the underlying account value or benefit base of our retirement and protection products and the amount of assets under management (“AUM”) of our Investment Management and Research business. AV and AUM, each as defined in “-Key Operating Measures,” are influenced by changes in economic conditions, primarily equity market returns, as well as net flows. Our premium income is driven by the growth in new policies written and the persistency of our in-force policies, both of which are influenced by a combination of factors, including our efforts to attract and retain customers and market conditions that influence demand for our products. Our investment income is driven by the yield on our General Account investment portfolio and is impacted by the prevailing level of interest rates as we reinvest cash associated with maturing investments and net flows to the portfolio.

Benefits and Other Deductions

Our primary expenses are:

•
policyholders’ benefits and interest credited to policyholders’ account balances;

•
sales commissions and compensation paid to intermediaries and advisors that distribute our products and services; and

•
compensation and benefits provided to our employees and other operating expenses.

Policyholders’ benefits are driven primarily by mortality, customer withdrawals and benefits which change in response to changes in capital market conditions. In addition, some of our policyholders’ benefits are directly tied to the AV and benefit base of our variable annuity products. Interest credited to policyholders varies in relation to the amount of the underlying AV or benefit base. Sales commissions and compensation paid to intermediaries and advisors vary in relation to premium and fee income generated from these sources, whereas compensation and benefits to our employees are more constant and decline with increases in efficiency. Our ability to manage these expenses across various economic cycles and products is critical to the profitability of our company.

Net Income Volatility

We have offered and continue to offer variable annuity products with variable annuity guaranteed benefits (“GMxB”) features. The future claims exposure on these features is sensitive to movements in the equity markets and interest rates. Accordingly, we have implemented hedging and reinsurance programs designed to mitigate the economic exposure to us from these features due to equity market and interest rate movements. Changes in the values of the derivatives associated with these programs due to equity market and interest rate movements are recognized in the periods in which they occur while corresponding changes in offsetting liabilities are recognized over time. This results in net income volatility as further described below. See “—Significant Factors Impacting Our Results—Impact of Hedging and GMIB Reinsurance on Results.”

In addition to our dynamic hedging strategy, we have recently implemented static hedge positions designed to mitigate the adverse impact of changing market conditions on our statutory capital. We believe this program will continue to preserve the economic value of our variable annuity contracts and better protect our target variable annuity asset level. However, these new static hedge positions increase the size of our derivative positions and may result in higher net income volatility on a period-over-period basis.

Due to the impacts on our net income of equity market and interest rate movements and other items that are not part of the underlying profitability drivers of our business, we evaluate and manage our business performance using Non-GAAP Operating Earnings, a non-GAAP financial measure that is intended to remove these impacts from our results. See “—Key Operating Measures—Non-GAAP Operating Earnings.”



102

Significant Factors Impacting Our Results
The following significant factors have impacted, and may in the future impact, our financial condition, results of operations or cash flows.

Impact of Hedging and GMIB Reinsurance on Results

We have offered and continue to offer variable annuity products with GMxB features. The future claims exposure on these features is sensitive to movements in the equity markets and interest rates.  Accordingly, we have implemented hedging and reinsurance programs designed to mitigate the economic exposure to us from these features due to equity market and interest rate movements. These programs include:

•
Variable annuity hedging programs. We use a dynamic hedging program (within this program, generally, we reevaluate our economic exposure at least daily and rebalance our hedge positions accordingly) to mitigate certain risks associated with the GMxB features that are embedded in our liabilities for our variable annuity products. This program utilizes various derivative instruments that are managed in an effort to reduce the economic impact of unfavorable changes in GMxB features’ exposures attributable to movements in the equity markets and interest rates. Although this program is designed to provide a measure of economic protection against the impact of adverse market conditions, it does not qualify for hedge accounting treatment. Accordingly, changes in value of the derivatives will be recognized in the period in which they occur with offsetting changes in reserves partially recognized in the current period, resulting in net income volatility.
In addition to our dynamic hedging program, in the fourth quarter of 2017 and the first quarter of 2018, we implemented a new hedging program using static hedge positions (derivative positions intended to be held to maturity with less frequent re-balancing) to protect our statutory capital against stress scenarios.  The implementation of this new program in addition to our dynamic hedge program is expected to increase the size of our derivative positions, resulting in an increase in net income volatility. The impacts are most pronounced for variable annuity products in our Individual Retirement segment.
•
GMIB reinsurance contracts.  Historically, GMIB reinsurance contracts were used to cede to affiliated and non-affiliated reinsurers a portion of our exposure to variable annuity products that offer a GMIB feature. We account for the GMIB reinsurance contracts as derivatives and report them at fair value. Gross reserves for GMIB reserves are calculated on the basis of assumptions related to projected benefits and related contract charges over the lives of the contracts. Accordingly, our gross reserves will not immediately reflect the offsetting impact on future claims exposure resulting from the same capital market or interest rate fluctuations that cause gains or losses on the fair value of the GMIB reinsurance contracts. Because changes in the fair value of the GMIB reinsurance contracts are recorded in the period in which they occur and a majority of the changes in gross reserves for GMIB are recognized over time, net income will be more volatile.
Effect of Assumption Updates on Operating Results

During the third quarter 2018, we conducted our annual review of the assumptions underlying the valuation of DAC, deferred sales inducement assets, unearned revenue liabilities, liabilities for future policyholder’s benefits and embedded derivatives for our insurance business (assumption reviews are not relevant for the Investment Management and Research segment). As a result of this review, some assumptions were updated, resulting in increases and decreases in the carrying values of these product liabilities and assets. See “—Consolidated Results of Operation—Assumption Updates and Model Changes” and “—Results of Operations by Segment—Assumption Updates and Model Changes.”
Most of the variable annuity products, variable universal life insurance and universal life insurance products we offer maintain policyholder deposits that are reported as liabilities and classified within either Separate Account liabilities or policyholder account balances. Our products and riders also impact liabilities for future policyholder benefits and unearned revenues and assets for DAC and deferred sales inducements. The valuation of these assets and liabilities (other than deposits) are based on differing accounting methods depending on the product, each of which requires numerous assumptions and


103

professional judgment. The accounting guidance applied in the valuation of these assets and liabilities includes, but is not limited to, the following: (i) traditional life insurance products for which assumptions are locked in at inception; (ii) universal life insurance and variable life insurance secondary guarantees for which benefit liabilities are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments; (iii) certain product guarantees for which benefit liabilities are accrued over the life of the contract in proportion to actual and future expected policy assessments; and (iv) certain product guarantees reported as embedded derivatives at fair value.

Our actuaries oversee the valuation of these product liabilities and assets and review underlying inputs and assumptions. We comprehensively review the actuarial assumptions underlying these valuations and update assumptions when appropriate in the third quarter of each year. Assumptions are based on a combination of company experience, industry experience, management actions and professional judgment and reflect our best estimate as of the date of each financial statement. Changes in assumptions can result in a significant change to the carrying value of product liabilities and assets and, consequently, the impact could be material to earnings in the period of the change.

Macroeconomic and Industry Trends
Our business and consolidated results of operations are significantly affected by economic conditions and consumer confidence, conditions in the global capital markets and the interest rate environment.

Economic Conditions and Consumer Confidence

A wide variety of factors continue to impact economic conditions and consumer confidence. These factors include, among others, concerns over economic growth in the United States, continued low interest rates, falling unemployment rates, the U.S. Federal Reserve’s plans to further raise short-term interest rates, fluctuations in the strength of the U.S. dollar, the uncertainty created by what actions the current administration may pursue, concerns over global trade wars, changes in tax policy, global economic factors including programs by the European Central Bank and the United Kingdom’s vote to exit from the European Union and other geopolitical issues. Additionally, many of the products and solutions we sell are tax-advantaged or tax-deferred. If U.S. tax laws were to change, such that our products and solutions are no longer tax-advantaged or tax-deferred, demand for our products could materially decrease.

Capital Market Conditions

Although extraordinary monetary accommodation has mitigated volatility in interest rate and credit and domestic equity markets for an extended period, global central banks may now be past peak accommodation as the U.S. Federal Reserve continues its gradual pace of policy normalization. As global monetary policy becomes less accommodating, an increase in market volatility could affect our business, including through effects on the yields we earn on invested assets, changes in required reserves and capital and fluctuations in the value of our AUM and AV. These effects could be exacerbated by uncertainty about future fiscal policy, changes in tax policy, the scope of potential deregulation and levels of global trade.

In the short- to medium-term, the potential for increased volatility, coupled with prevailing interest rates remaining below historical averages, could pressure sales and reduce demand for our products as consumers consider purchasing alternative products to meet their objectives. In addition, this environment could make it difficult to consistently develop products that are attractive to customers. Financial performance can be adversely affected by market volatility and equity market declines as fees driven by AV and AUM fluctuate, hedging costs increase and revenues decline due to reduced sales and increased outflows.
 
We monitor the behavior of our customers and other factors, including mortality rates, morbidity rates, annuitization rates and lapse and surrender rates, which change in response to changes in capital market conditions, to ensure that our products and solutions remain attractive and profitable.



104

Interest Rate Environment

We believe the interest rate environment will continue to impact our business and financial performance in the future for several reasons, including the following:

•
Our General Account investment portfolio consists predominantly of fixed income investments. In the near term, and absent further material change in yields available on investments, we expect the yield we earn on new investments will be lower than the yields we earn on maturing investments, which were generally purchased in environments where interest rates were higher than current levels. If interest rates were to rise, we expect the yield on our new money investments would also rise and gradually converge toward the yield of those maturing assets.
•
Certain of our variable annuity and life insurance products pay guaranteed minimum interest crediting rates. We are required to pay these guaranteed minimum rates even if earnings on our investment portfolio decline, with the resulting investment margin compression negatively impacting earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates longer (lower lapse rates) in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio should positively impact earnings. Similarly, we expect policyholders would be less likely to hold policies with existing guaranteed rates (higher lapse rates) as interest rates rise.

•
A prolonged low interest rate environment also may subject us to increased hedging costs or an increase in the amount of statutory reserves that our insurance subsidiaries are required to hold for GMxB features, lowering their statutory surplus, which would adversely affect their ability to pay dividends to us. In addition, it may also increase the perceived value of GMxB features to our policyholders, which in turn may lead to a higher rate of annuitization and higher persistency of those products over time. Finally, low interest rates may continue to cause an acceleration of deferred acquisition costs (“DAC”) amortization or reserve increase due to loss recognition for interest sensitive products, primarily for our Protection Solutions segment.

Regulatory Developments

We are regulated primarily by the NYDFS, with some policies and products also subject to federal regulation. On an ongoing basis, regulators refine capital requirements and introduce new reserving standards. Regulations recently adopted or currently under review can potentially impact our statutory reserve and capital requirements.

•
National Association of Insurance Commissioners (“NAIC”). In 2015, the NAIC Financial Condition (E) Committee established a working group to study and address regulatory issues resulting from variable annuity captive reinsurance transactions, including reforms that would improve the current statutory reserve and risk-based capital (“RBC”) framework for insurance companies that sell variable annuity products. In August 2018, the NAIC adopted the new framework developed and proposed by this working group, to take effect January 2020, and which has now been referred to various other NAIC committees to develop the full implementation details. Among other changes, the new framework includes new prescriptions for reflecting hedge effectiveness, investment returns, interest rates, mortality and policyholder behavior in calculating statutory reserves and RBC. Once effective, it could materially change the level of variable annuity reserves and RBC requirements as well as their sensitivity to capital markets including interest rate, equity markets, volatility and credit spreads. Overall, we believe the NAIC reform is moving variable annuity capital standards towards an economic framework and is consistent with how we manage our business.
•
Fiduciary Rules/“Best Interest” Standards of Conduct. In the wake of the March 2018 federal appeals court decision to vacate the Department of Labor’s 2016 fiduciary rulemaking (the “Rule”), the SEC and NAIC as well as state regulators are currently considering whether to apply an impartial conduct standard similar to the Rule to recommendations made in connection with certain annuities and, in one case, to life insurance policies. For example, in July 2018, the NYDFS issued a final version of Regulation 187 that adopts a “best interest” standard for recommendations regarding the sale of life insurance and annuity products in New York. Regulation 187 takes effect on August 1, 2019 with respect to annuity sales and February 1, 2020 for life insurance sales and is applicable to sales of life insurance and annuity products in New York. We are currently assessing Regulation 187 to determine the impact


105

it may have on our business. Beyond the New York regulation, the likelihood of enactment of any such state-based regulation is uncertain at this time, but if implemented, these regulations could have adverse effects on our business and consolidated results of operations.
•
In April 2018, the SEC released a set of proposed rules that would, among other things, enhance the existing standard of conduct for broker-dealers to require them to act in the best interest of their clients; clarify the nature of the fiduciary obligations owed by registered investment advisers to their clients; impose new disclosure requirements aimed at ensuring investors understand the nature of their relationship with their investment professionals; and restrict certain broker-dealers and their financial professionals from using the terms “adviser” or “advisor”. The SEC accepted public comments on its rulemaking through August 7, 2018. Although the full impact of the proposed rules can only be measured when the implementing regulations are adopted, the intent of this provision is to authorize the SEC to impose on broker-dealers’ fiduciary duties to their customers similar to those that apply to investment advisers under existing law. We are currently assessing these proposed rules to determine the impact they may have on our business.

•
New York Insurance Regulation 210. State regulators are currently considering whether to apply regulatory standards to the determination and/or readjustment of non-guaranteed elements (“NGEs”) within life insurance policies and annuity contracts that may be adjusted at the insurer’s discretion, such as the cost of insurance for universal life insurance policies and interest crediting rates for life insurance policies and annuity contracts. For example, in March 2018, Insurance Regulation 210 went into effect in New York. That regulation establishes standards for the determination and any readjustment of NGEs, including a prohibition on increasing profit margins on existing business or recouping past losses on such business, and requires advance notice of any adverse change in a NGE to both the NYDFS as well as to affected policyholders. We are continuing to assess the impact of Regulation 210 on our business. Beyond the New York regulation, the likelihood of enactment of any such state-based regulation is uncertain at this time, but if implemented, these regulations could have adverse effects on our business and consolidated results of operations.

Impact of Tax Cuts and Jobs Act

On December 22, 2017, President Trump signed into law the Tax Cut and Jobs Act (the “Tax Reform Act”), a broad overhaul of the U.S. Internal Revenue Code that changes long-standing provisions governing the taxation of U.S. corporations, including life insurance companies. See Note 10 of Notes to Consolidated Financial Statements for further information on the impact to the Company’s income taxes.

Productivity Strategies
We continue to build upon our recent productivity improvements through which we have delivered significant efficiency improvements over the last five years. Our productivity strategy includes several initiatives, including relocating some of our real estate footprint away from the New York metropolitan area, replacing or updating less efficient legacy technology infrastructure and expanding existing outsourcing arrangements, which we believe will reduce costs and improve productivity.

AB has announced that it will establish its corporate headquarters in, and relocate approximately 1,050 jobs currently located in the New York metro area to, Nashville, TN. For more detail on the costs and expense savings AB expects to incur as a result of this relocation, see AB’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018.

Key Operating Measures
In addition to our results presented in accordance with U.S. GAAP, we report Non-GAAP Operating Earnings Management believes that the use of these non-GAAP financial measures, together with relevant U.S. GAAP measures, provides a better understanding of our results of operations and the underlying profitability drivers and trends of our business. These non-GAAP financial measures are intended to remove from our results of operations the impact of market changes (where there is mismatch in the valuation of assets and liabilities) as well as certain other expenses which are not part of our underlying profitability drivers or likely to re-occur in the foreseeable future, as such items fluctuate from period-to-period in a manner inconsistent with these drivers. These measure should be considered supplementary to our results that are presented in accordance with U.S.


106

GAAP and should not be viewed as a substitute for the U.S. GAAP measures. Other companies may use similarly titled non-GAAP financial measures that are calculated differently from the way we calculate such measures. Consequently, our non-GAAP financial measures may not be comparable to similar measures used by other companies.

We also discuss certain operating measures, including AUM, AV and certain other operating measures, which management believes provide useful information about our businesses and the operational factors underlying our financial performance.

Non-GAAP Operating Earnings

Non-GAAP Operating Earnings is an after-tax non-GAAP financial measure used to evaluate our financial performance on a consolidated basis that is determined by making certain adjustments to our consolidated after-tax net income attributable to AXA Equitable. The most significant of such adjustments relates to our derivative positions, which protect economic value and statutory capital, and are more sensitive to changes in market conditions than the variable annuity product liabilities as valued under U.S. GAAP. This is a large source of volatility in net income.

In the second quarter of 2018, the Company revised its Non-GAAP Operating Earnings definition as it relates to the treatment of certain elements of the profitability of its variable annuity products with indexed-linked features to align to the treatment of its variable annuity products with GMxB features. In addition, adjustments for variable annuity products with index-linked features previously included within Other adjustments in the calculation of Non-GAAP Operating Earnings are now included with the adjustments for variable annuity products with GMxB features in the broader adjustment category, “Variable annuity product features”. The presentation of Non-GAAP Operating Earnings in prior periods was revised to reflect this change in definition.

Non-GAAP Operating Earnings equals our consolidated after-tax net income attributable to AXA Equitable adjusted to eliminate the impact of the following items:

•
Items related to Variable annuity product features which include certain changes in the fair value of the derivatives and other securities we use to hedge these features, the effect of benefit ratio unlock adjustments and changes in the fair value of the embedded derivatives reflected within Variable annuity products’ net derivative results;
•
Investment (gains) losses, which includes other-than-temporary impairments of securities, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;

•
Loss on the recapture of GMxB business previously ceded to AXA Arizona;

•
Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation;

•
Other adjustments, which includes restructuring costs related to severance, lease write-offs related to non-recurring restructuring activities and separation costs; and

•
Income tax expense (benefit) related to the above items and non-recurring tax items which includes the effect of uncertain tax positions for a given audit period and the Tax Reform Act.

Because Non-GAAP Operating Earnings excludes the foregoing items that can be distortive or unpredictable, management believes that this measure enhances the understanding of the Company’s underlying drivers of profitability and trends in our business, thereby allowing management to make decisions that will positively impact our business.

We use our prevailing corporate federal income tax rate of 21% in 2018 and 35% in 2017, while taking into account any non-recurring differences for events recognized differently in our financial statements and federal income tax returns as well as partnership income taxed at lower rates when reconciling Net income (loss) attributable to AXA Equitable to Non-GAAP Operating Earnings.


107


The table below presents a reconciliation of Net income (loss) attributable to AXA Equitable to Non-GAAP Operating Earnings for the nine months ended September 30, 2018 and 2017:

 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Net income (loss) attributable to AXA Equitable
$
(2,858
)
 
$
1,328

Adjustments related to:
 
 
 
Variable annuity product features (1)
2,580

 
(387
)
Investment (gains) losses
(73
)
 
9

Loss on the recapture of GMxB business previously ceded to AXA Arizona
2,603

 
—

Net actuarial (gains) losses related to pension and other postretirement benefit obligations
130

 
72

Other adjustments
141

 
76

Income tax expense (benefit) related to above adjustments
(1,130
)
 
43

Non-recurring tax items
26

 
(225
)
Non-GAAP Operating Earnings
$
1,419

 
$
916

_______________
(1)
This reconciling item was previously referred to as “GMxB product features”, but is now referred to more broadly as “Variable annuity product features.” See Note 14 to the Notes to Consolidated Financial Statements for details of adjustments related to Variable annuity product features.

Assets Under Management (“AUM”)

AUM means investment assets that are managed by one of our subsidiaries and includes: (i) assets managed by AB, (ii) the assets in our General Account investment portfolio and (iii) the Separate Account assets of our Individual Retirement, Group Retirement and Protection Solutions businesses. Total AUM reflects exclusions between segments to avoid double counting.

Account Value (“AV”)

AV generally equals the aggregate policy account value of our retirement products. General Account AV refers to account balances in investment options that are backed by the General Account while Separate Account AV refers to Separate Account investment assets.

Consolidated Results of Operations
Our consolidated results of operations are significantly affected by conditions in the capital markets and the economy
because we offer market sensitive products. These products have been a significant driver of our results of operations. Because the future claims exposure on these products is sensitive to movements in the equity markets and interest rates, we have in place various hedging and reinsurance programs that are designed to mitigate the economic risks of movements in the equity markets and interest rates. The volatility in Net income attributable to Holdings for the periods presented below results from the mismatch between (i) the change in carrying value of the reserves for GMDB and certain GMIB features that do not fully and immediately reflect the impact of equity and interest market fluctuations and (ii) the change in fair value of products with the GMIB feature that has a no-lapse guarantee, and our hedging and reinsurance programs.
At both September 30, 2018 and September 30, 2017, our economic interest in AB was approximately 29%. Our indirect, wholly owned subsidiary, AllianceBernstein Corporation, is the General Partner of AB. Accordingly, AB is consolidated in our financial statements, and its results are fully reflected in our consolidated financial statements.



108

Assumption Updates and Model Changes

In 2018, we began conducting our annual review of our assumptions and models during the third quarter, consistent with industry practice for public companies in our peer group.

Our annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for our insurance business, liabilities for future policyholder benefits, DAC and deferred sales inducement assets. As a result of this review, some assumptions were updated, resulting in increases and decreases in the carrying values of these product liabilities and assets.

The table below presents the impact of our actuarial assumption updates during the third quarter of 2018 to our Income (loss) from continuing operations, before income taxes and Net income (loss):
 
For the Nine months ended September 30, 2018
 
(in millions)
Impact of assumption updates on Net income (loss):
 
Variable annuity product features related assumption updates
$
(331
)
All other assumption updates
103

Impact of assumption updates on Income (loss) from continuing operations, before income tax

(228
)
Income tax (expense) benefit on assumption updates

41

Net income (loss) impact of assumption updates

$
(187
)

The impact of these assumption updates on Income (loss) from continuing operations, before income taxes was a decrease of $228 million and a decrease to Net income (loss) of $187 million. This includes a $331 million unfavorable impact on the reserves for our Variable annuity product features as a result of unfavorable updates to policyholder behavior, primarily annuitization assumptions, partially offset by favorable updates to economic assumptions.

The net impact of these assumption changes in the third quarter of 2018 decreased Income (loss) from continuing operations, before income taxes by $228 million and consisted of a decrease in Policy charges and fee income of $12 million, a decrease in Policyholders’ benefits of $684 million, an increase in Net derivative losses of $1,065 million, and a decrease in the Amortization of DAC, net of $165 million.

The table below presents the impact of our actuarial assumption updates during the third quarter of 2018 on segment revenues, benefits and other deductions, and Corporate and Other:

 
For the Nine months ended September 30, 2018
 
Segment Revenues
Benefits and Other Deductions
Corporate and Other
Net
 
 
(in millions)
 
 
Impact of assumption updates by segment:
 
 
 
 
Individual Retirement
$
—

$
46

$
—

$
46

Group Retirement
—

31

—

31

Protection Solutions
(12
)
40

—

28

Impact of assumption updates on Corporate and Other

—

—

(2
)
(2
)
Total
 
 
 
$
103


The impact of our annual review on Non-GAAP Operating earnings was favorable by $84 million, or $103 million before taking into consideration the tax impacts.


109


•
For the Individual Retirement segment, the impacts primarily reflect favorable updates to DAC amortization from primarily lower annuitization assumptions and other policyholder behavior updates.

•
For the Group Retirement segment, the impacts primarily reflect a favorable update reflecting lower withdrawal rates.

•
For the Protection Solutions segment, the results primarily reflect favorable updates to surrender rates, expenses and general account investment yields, partially offset by an increase in mortality assumptions. As a result of these changes, the variable and interest sensitive products in the Protection Solutions segment are no longer in loss recognition.

Non-GAAP Operating Earnings excludes items related to Variable annuity product features, such as changes in the fair value of the embedded derivatives associated with the GMIBNLG liability and the effect of benefit ratio unlock adjustments. Accordingly the $331 million unfavorable impact mentioned above, comprised of a $1,065 million increase in the fair value of the GMIBNLG liability and a $734 million decrease in Policyholders’ benefits reflected in Net income (loss) are excluded from Non-GAAP Operating Earnings. After excluding these items, the net impact of assumption changes on Non-GAAP Operating Earnings in the third quarter of 2018 decreased Policy charges and fee income by $12 million, increased Policyholder’ benefits by $50 million, and decreased Amortization of DAC, net by $165 million.



110

The following table summarizes our consolidated statements of income (loss) for the nine months ended September 30, 2018 and 2017:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
REVENUES
 
 
 
Policy charges and fee income
$
2,644

 
$
2,516

Premiums
657

 
665

Net derivative gains (losses)
(3,106
)
 
1,048

Net investment income (loss)
1,748

 
1,993

Total investment gains (losses), net
73

 
(9
)
Investment management and service fees
3,227

 
2,974

Other income
47

 
68

Total revenues
5,290

 
9,255

BENEFITS AND OTHER DEDUCTIONS
 
 
 
Policyholders’ benefits
1,987

 
3,184

Interest credited to policyholders’ account balances
754

 
681

Compensation and benefits (includes $101 and $101 of deferred policy acquisition costs, respectively)
1,459

 
1,324

Commissions and distribution related payments (includes $331 and $332 of deferred policy acquisition costs, respectively)
1,119

 
1,133

Interest expense
34

 
20

Amortization of deferred policy acquisition costs (net of capitalization of $432 and $433 of deferred policy acquisition costs, respectively)
(129
)
 
42

Other operating costs and expenses (includes $1, $2, $2 and $5 of deferred policy acquisition costs, respectively)
3,267

 
992

Total benefits and other deductions
8,491

 
7,376

Income (loss) from continuing operations, before income taxes
(3,201
)
 
1,879

Income tax (expense) benefit
782

 
(198
)
Net income (loss)
(2,419
)
 
1,681

Less: net (income) loss attributable to the noncontrolling interest
(439
)
 
(353
)
Net income (loss) attributable to AXA Equitable
$
(2,858
)
 
$
1,328

The following table summarizes our Non-GAAP Operating Earnings for the nine months ended September 30, 2018 and 2017:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
 Non-GAAP Operating Earnings
$
1,419

 
$
916

Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017
Net Income Attributable to AXA Equitable

Net income (loss) attributable to AXA Equitable decreased by $4,186 million, to a net loss of $2,858 million for the first nine months of 2018 from $1,328 million net income for the first nine months of 2017, primarily driven by the following notable items:


111

•
Net derivative losses increased by $4,154 million mainly due to the unfavorable impact of assumption updates in the third quarter of 2018 compared to the favorable impact of assumption updates in the first nine months of 2017.
•
Decrease in Net investment income of $245 million, mainly due to a change in the market value of trading securities supporting our Individual Retirement products due to higher interest rates.

•
Compensation and benefits increased by $135 million mainly due to our pension settlement in the first quarter of 2018.

•
Interest credited to policyholders’ account balances increased by $73 million mainly driven by higher SCS AV due to new business growth.

•
Interest expense increased by $14 million due to the FHLBNY borrowings during the second quarter of 2018.

•
Other operating costs and expenses increased by $2,275 million mainly due to $1.994 million increase in the amortization of the deferred cost of reinsurance asset including the write-off of $1,839 million of the deferred cost of reinsurance asset as a result of the unwinding of GMxB in the first nine months of 2018 and the absence of a $226 million decrease in amortization of the deferred cost of reinsurance asset driven by the impact of a reserve strengthening in the first nine months of 2017. Also contributing to the higher operating costs and expenses is the settlement of outstanding payments of $273 million related to the GMxB unwind along with an increase in restructuring costs and higher promotion and servicing costs.

Partially offsetting this decrease were the following notable items:

•
Policyholders’ benefits decreased by $1,197 million mainly due to the favorable impact of assumption updates in the third quarter of 2018 compared to the unfavorable impact of assumption updates in the first nine months of 2017.

•
Revenue from fees and related items, including Policy charges and fee income, Premiums, Investment management service fees, and Other income increased by $352 million mainly driven by our Investment Management and Research segment, primarily due to higher base fees reflecting an increase in average AUM of 8% and an increase in performance fees, as well as higher average AV from net flows and higher equity markets.

•
Amortization of DAC, net decreased by $171 million mainly due to the favorable impact of assumption updates in the third quarter of 2018.

•
Net investment gains increased by $82 million, primarily due to the sale of fixed maturities.

•
Income tax benefit increased by $980 million driven by pre-tax losses in the first nine months of 2018 compared to the pre-tax earnings in the first nine months of 2017.

See “Assumption Updates and Model Changes” for more information regarding assumption updates in the third quarter of 2018.

Non-GAAP Operating Earnings

Non-GAAP Operating Earnings increased by $503 million to $1,419 million during the first nine months ended September 30, 2018 from $916 million in the nine months ended September 30, 2017, primarily driven by the following notable items:

•
Policyholders’ benefits decreased by $427 million primarily due to a decrease in our Individual Retirement segment reflecting an improvement in GMxB margins, mainly driven by a reserve strengthening in the second quarter of 2017 (the decrease in Policyholders’ benefits was partially offset by derivative losses).
•
Fee-type revenue increased by $430 million mainly due to our Investment Management and Research segment reflecting higher base fees resulting from an increase in average AUM of 8% from equity markets and the positive impact of


112

adopting a new revenue recognition standard (ASC 606) in 2018, which allows the recognition of certain performance based fees. Insurance segments also increased as a result of higher equity markets.

•
Amortization of DAC, net decreased by $186 million, mainly due to the favorable impact of assumption updates in the third quarter of 2018.

•
Net investment income increased by $138 million mainly due to the General Account portfolio optimization and higher asset balances.

•
Income tax expense decreased by $65 million driven by a lower effective tax rate due to the Tax Reform Act, partially offset by tax expense on higher pre-tax earnings.

Partially offsetting this increase were the following notable items:

•
Investment gains (losses) decreased by $279 million, net including derivative gains (losses) primarily from freestanding derivatives driven by an increase in interest rates in the first nine months of 2018 compared to the first nine months of 2017.

•
Compensation, benefits and other operating costs and expenses increased by $247 million, mainly driven by a decrease in the amortization of the deferred cost of reinsurance driven by the impact of a reserve strengthening in the first nine months of 2017. In addition higher expenses in our Investment Management and Research segment driven by higher compensation resulting from higher fees contributed to the increase in compensation benefits and other operating costs and expenses.

•
Interest credited to policyholders’ account balances increased by $73 million mainly driven by our Individual Retirement segment, reflecting higher SCS AV due to growth in product sales.

•
Interest expense increased by $14 million primarily due to higher interest expense on repurchase agreements.

See “Assumption Updates and Model Changes” for more information regarding assumption updates in the third quarter of 2018.

Results of Operations by Segment
We manage our business through the following four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. We report certain activities and items that are not included in our four segments in Corporate and Other. The following section presents our discussion of Operating earnings (loss) by segment. Consistent with U.S. GAAP guidance for segment reporting, operating earnings (loss) is our U.S. GAAP measure of segment performance. See Note 14 of Notes to Consolidated Financial Statements for further information on the Company’s segments.

Effective Tax Rates by Segment

For interim reporting periods, the Company calculates income tax expense using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. Income tax expense is calculated using the ETR and then allocated to the Company’s business segments using a 18% ETR for our retirement and protection businesses (Individual Retirement, Group Retirement, and Protection Solutions) and a 23% ETR for Investment Management and Research.



113

The following table summarizes Operating earnings (loss) by segment for the periods presented:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Operating earnings (loss)
 
 
 
Individual Retirement
$
1,159

 
$
831

Group Retirement
255

 
210

Investment Management and Research
143

 
99

Protection Solutions
12

 
(83
)
Corporate and Other
(150
)
 
(141
)
Non-GAAP Operating Earnings
$
1,419

 
$
916

Individual Retirement
The Individual Retirement segment includes our variable annuity products which primarily meet the needs of individuals saving for retirement or seeking retirement income.

The following table summarizes Operating earnings of our Individual Retirement segment for the periods presented:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Operating earnings
$
1,159

 
$
831


Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017 for the Individual Retirement Segment
Operating earnings increased by $328 million to $1,159 million in the first nine months of 2018 from $831 million in the first nine months of 2017, primarily attributable to the following:

•
Increase in Net investment income of $211 million resulting from higher asset balances mainly driven by SCS sales and General Account portfolio optimization.

•
Fee-type revenue increased by $165 million due to higher average Separate Account AV from higher equity market performance and higher premium income from payout annuities.

•
Policyholders’ benefits decreased by $350 million primarily due to a reserve strengthening in 2017.

•
Commissions and distribution payments decreased by $17 million driven by lower year-over-year sales.

•
Decrease in Income tax expense of $78 million driven by a lower effective tax rate due to the Tax Reform Act, partially offset by higher pre-tax operating earnings.

This increase was partially offset by:

•
Net Investment losses, including derivative gains (losses), increased by $294 million primarily from freestanding derivatives driven by an increase in interest rates in the first nine months of 2018 compared to the first nine months of 2017.


114


•
Compensation and benefits and other operating costs and expense increased $172 million due to a policyholder behavior update from 2017 which impacted the deferred cost of the reinsurance asset related to the GMxB business.

•
Increase in Interest credited to policyholders’ account balances of $39 million primarily due to SCS products.

Group Retirement
The Group Retirement segment offers tax-deferred investment and retirement plans sponsored by educational entities, municipalities and not-for-profit entities as well as small and medium-sized businesses.

The following table summarizes Operating earnings of our Group Retirement segment for the periods presented:
 
Nine Months Ended September 30,
 
2018

2017
 
(in millions)
Operating earnings
$
255

 
$
210


Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017 for the Group Retirement Segment
Operating earnings increased by $45 million to $255 million in the first nine months of 2018 from $210 million in the first nine months of 2017, primarily attributable to the following:

•
Fee-type revenue increased by $46 million mainly due to an increase in Separate Accounts AV reflecting higher equity markets.

•
Amortization of DAC, net increased by $29 million mainly due to the favorable impact of assumption updates in the third quarter of 2018 related to higher persistency.

•
Decrease in Income tax expense of $10 million driven by a lower effective tax rate due to the Tax Reform Act, partially offset by higher pre-tax operating earnings.

This increase was partially offset by the following:

•
Compensation and benefits and other operating expenses increased by $37 million to support business growth.

•
Net investment income decreased by $10 million mainly driven by lower 2018 income on alternative investments and lower portfolio yields.

See “Assumption Updates and Model Changes” for more information regarding assumption updates in the third quarter of 2018.

Investment Management and Research
The Investment Management and Research segment provides diversified investment management, research and related services to a broad range of clients around the world. Operating earnings (loss) presented here represents our current economic interest, net of tax, in AB of approximately 29% at both September 30, 2018 and September 30, 2017.



115

The following table summarizes Operating earnings of our Investment Management and Research segment for the periods presented:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Operating earnings
$
143

 
$
99


Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017 for the Investment Management and Research Segment
Operating earnings increased by $44 million in the first nine months of 2018 to $143 million from $99 million in the first nine months of 2017 primarily attributable to the following:

•
Increase in fee-type revenue of $297 million was primarily due to higher base fees resulting from an 8% increase in average AUM and additionally an increase in performance fees. Operating earnings includes an increase in revenues of $78 million from the impact of adopting the new revenue recognition standard (ASC 606) in 2018 which allows for the recognition of certain performance based fees.

•
Decrease in Income tax expense of $16 million driven by a lower effective tax rate due to the Tax Reform Act, partially offset by higher pre-tax operating earnings.

This increase was partially offset by the following:

•
Increase in Non-GAAP operating earnings (loss) before noncontrolling interest for the first nine months of 2018 compared to the first nine months of 2017.

•
Higher Compensation, benefits, interest expense and other operating costs of $106 million, including $43 million related to the impact of adoption of revenue recognition standard (ASC 606) in 2018.

•
Higher Commissions and distribution related payments of $18 million.

Protection Solutions
The Protection Solutions segment includes our life insurance and employee benefits businesses. We provide a targeted range of products aimed at serving the financial needs of our clients throughout their lives, including Variable Universal Life (“VUL”), “IUL” and term life products. In 2015, we entered the employee benefits market and currently offer a suite of dental, vision, life, as well as short- and long-term disability insurance products to small and medium-size businesses. In recent years, we have refocused our product offering and distribution towards less capital intensive, higher return accumulation and protection products. We plan to improve our operating earnings over time through earnings generated from sales of our repositioned product portfolio and by proactively managing and optimizing our in-force book.

The following table summarizes Operating earnings (loss) of our Protection Solutions segment for the periods presented:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Operating earnings (loss)
$
12

 
$
(83
)



116

Nine Months Ended September 30, 2018 Compared to the Nine Months Ended September 30, 2017 for the Protection Solutions Segment
Operating earnings

Operating earnings increased $95 million in the first nine months of 2018 to an operating gain of $12 million from an operating loss of $83 million in the first nine months of 2017 primarily attributable to the following:

•
Amortization of DAC, net decreased by $155 million driven by a $151 million decrease in DAC amortization before capitalization. This decrease was mainly driven by the favorable impact of assumption updates in the third quarter of 2018 and lower baseline amortization.

•
Increase of $16 million in Net Investment Income due to the General Account portfolio optimization and higher asset balances.

•
Decrease in Compensation and benefits and other operating costs and expenses of $11 million due to company efficiency plans.

This increase was partially offset by the following:

•
Increase of $45 million in Policyholders’ benefits mainly due to lower reserve accruals, partially offset by higher net death claims.

•
Fee-type revenue decreased by $22 million due to the unfavorable impact of assumption updates in the third quarter of 2018.

See “Assumption Updates and Model Changes” for more information regarding assumption updates in the third quarter of 2018.

Corporate and Other
Corporate and Other includes certain of our financing and investment expenses. It also includes: the Closed Block, run-off group pension business, run-off health business, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Investment Management and Research segment. Accordingly, Corporate and Other does not include any items applicable to AB.

The following table summarizes Operating loss of Corporate and Other for the periods presented:
 
Nine Months Ended September 30,
 
2018
 
2017
 
(in millions)
Operating earnings (loss)
$
(150
)
 
$
(141
)

Supplementary Information
The Company is involved in a number of ventures and transactions with AXA and certain of its affiliates. See Note 11 of the Notes to Consolidated Financial Statements included herein and AXA Equitable’s 2017 Form 10-K as well as AB’s Report on Form 10-K for the year ended December 31, 2017 for information on related party transactions.


117

Adoption and Future Adoption of New Accounting Pronouncements
See Note 2 to the Notes to Consolidated Financial Statements included herein.

Summary of Critical Accounting Policies
The preparation of financial statements in conformity with U.S. GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in our consolidated financial statements included elsewhere herein. For a discussion of our significant accounting policies, see Note 2 of Notes to Consolidated Financial Statements. The most critical estimates include those used in determining:

•
liabilities for future policy benefits;

•
accounting for reinsurance;

•
capitalization and amortization of DAC;

•
estimated fair values of investments in the absence of quoted market values and investment impairments;

•
estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;

•
goodwill and related impairment;

•
measurement of income taxes and the valuation of deferred tax assets; and

•
liabilities for litigation and regulatory matters.

In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries while others are specific to our business and operations. Actual results could differ from these estimates.

A discussion of each of the critical accounting estimates may be found in the Company’s 2017 Form 10-K, under “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Estimates — Application of Critical Accounting Estimates.”



118

Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The management of the Company, with the participation of the Company’s Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of September 30, 2018. This evaluation is performed to determine if our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities and Exchange Act of 1934, as amended, is accumulated and communicated to management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure and are effective to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms.

As previously reported, the Company identified two material weaknesses in the design and operation of the Company’s internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. The Company’s management, including the Company’s CEO and CFO, have concluded that we do not (i) maintain effective controls to timely validate actuarial models are properly configured to capture all relevant product features provide reasonable assurance timely reviews of assumptions and data have occurred, and, as a result, errors were identified in future policyholders’ benefits and deferred policy acquisition costs balances; and (ii) maintain sufficient experienced personnel to prepare the Company’s consolidated financial statements and to verify consolidating and adjusting journal entries are completely and accurately recorded to the appropriate accounts or segments and, as a result, errors were identified in the consolidated financial statements, including in the presentation and disclosure between the operating and financing sections of the statements of cash flows. These material weaknesses resulted in misstatements in the Company’s previously issued annual and interim financial statements and resulted in (i) the revision for the three and six months ended March 31, 2018, and June 30, 2018, respectively, as well as the three, six and nine months ended March 31, 2017, June 30, 2017 and September 30, 2017, respectively and for the years ended December 31, 2017 and 2016 (ii) the revision of the interim financial statements for the three months ended March 31, 2018, the nine months ended September 30, 2017, the six months ended June 30, 2017 and the annual financial statements for the years ended December 31, 2017 and 2016 and (iii) the restatement of the annual financial statements for the year ended December 31, 2016, the revision to each of the quarterly interim periods for 2017 and 2016, and the revision of the annual financial statements for the year ended December 31, 2015. These revisions and restatements were directly related to the material weaknesses described above and not indicative of any new material weaknesses. Until remediated, there is a reasonable possibility that these material weaknesses could result in a material misstatement of the Company's consolidated financial statements or disclosures that would not be prevented or detected.

Due to these material weaknesses, the Company’s management, including the Company’s CEO and CFO, concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2018.

Remediation Status of Material Weaknesses
Management continues to execute its plan moving towards remediation of the material weaknesses. Since identifying the material weaknesses, management has performed the following activities:

Material Weakness Related to Actuarial Models, Assumptions and Data

•
We have developed a three-year rotational schedule to baseline all U.S. GAAP models.

•
We have designed enhanced controls and governance processes for the introduction of new models during the three months ended September 30, 2018.

•
We have implemented enhanced documentation and controls for quarterly model changes and inadvertent change testing during the three months ended September 30, 2018.


119


•
We have developed a comprehensive master assumption inventory risk framework.

•
We have developed and implemented enhanced documentation and control procedures over the assumption review and update process during the three months ended September 30, 2018.

•
We are developing a comprehensive plan for enhancing the process and controls over the reliability of data and inputs into the actuarial models.

Material Weakness Related to Insufficient Personnel and Journal Entry Process

•
With respect to insufficient personnel, we have strengthened the finance team by adding approximately 25 employees to the Accounting and Financial Reporting areas. Of these additional resources, eleven have a CPA license, eight have worked at a “Big 4” public accounting firm and the remainder have worked in a finance area within a public company.

•
To improve controls over journal entries, we have eliminated the secondary process used for consolidating certain entities, reflecting adjustments to prior periods, and generating the business segment disclosures. Beginning with third quarter 2018, all journal entries are recorded in the Company’s general ledger and the secondary process is no longer necessary.

•
We have enhanced the controls over journal entries through the implementation of new standards designed to ensure effective review and approval of journal entries with sufficient supporting documentation during the three months ended September 30, 2018.

•
We are designing new management review controls that will operate at a level of precision sufficient to detect errors that could result in a material misstatement.

While management believes that significant progress has been made in enhancing internal controls as of September 30, 2018 and in the period since, the material weaknesses described herein have not been fully remediated. Management will continue the process to enhance internal controls and will make any further changes that management deems appropriate. Although we plan to complete the remediation process for each material weakness as quickly as possible, we cannot at this time estimate when the remediation will be completed.

Changes in Internal Control Over Financial Reporting
As described above, the Company continues to design and implement additional controls in connection with its remediation plan. These remediation efforts related to the material weaknesses described above represent changes in our internal control over financial reporting (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934. Except as described above, there were no other changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 for the quarter ended September 30, 2018 that have materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.



120

PART II OTHER INFORMATION
Item 1.    Legal Proceedings
See Note 13 of Notes to Consolidated Financial Statements contained herein. Except as disclosed in Note 13 to the Consolidated Financial Statements, there have been no new material legal proceedings and no new material developments in legal proceedings previously reported in the 2017 Form 10-K.

Item 1A. Risk Factors
The following risks should be read in conjunction with, and supplement and amend, the risks that may affect our business, consolidated results of operations or financial condition described in the “Risk Factors” section included in the Annual Report on Form 10-K for the year-ended December 31, 2017. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under “Forward-Looking Statements” above and the risks of our businesses described elsewhere in this Quarterly Report on Form 10-Q.

Equity market declines and volatility may materially and adversely affect our business, results of operations or financial condition.

The S&P 500, the Dow Jones Industrial Average and the Nasdaq Composite are on an eight-year bull market run and are at or near record high levels. A market correction or bear market could materially and adversely affect our business, results of operations or financial condition. Declines or volatility in the equity markets, such as that which we experienced during October 2018, can negatively impact our investment returns as well as our business, results of operations or financial condition. For example, equity market declines or volatility could, among other things, decrease the AV of our annuity and variable life contracts which, in turn, would reduce the amount of revenue we derive from fees charged on those account and asset values. Our variable annuity business in particular is highly sensitive to equity markets, and a sustained weakness or stagnation in equity markets could decrease our revenues and earnings with respect to those products. At the same time, for variable annuity contracts that include GMxB features, equity market declines increase the amount of our potential obligations related to such GMxB features and could increase the cost of executing GMxB-related hedges beyond what was anticipated in the pricing of the products being hedged. This could result in an increase in claims and reserves related to those contracts, net of any reinsurance reimbursements or proceeds from our hedging programs. We may not be able to effectively mitigate, including through our hedging strategies, and we may sometimes choose based on economic considerations and other factors not to fully mitigate the equity market volatility of our portfolio. Equity market declines and volatility may also influence policyholder behavior, which may adversely impact the levels of surrenders, withdrawals and amounts of withdrawals of our annuity and variable life contracts or cause policyholders to reallocate a portion of their account balances to more conservative investment options (which may have lower fees), which could negatively impact our future profitability or increase our benefit obligations particularly if they were to remain in such options during an equity market increase. Market volatility can negatively impact the value of equity securities we hold for investment which could in turn reduce our statutory capital. In addition, equity market volatility could reduce demand for variable products relative to fixed products, lead to changes in estimates underlying our calculations of DAC that, in turn, could accelerate our DAC amortization and reduce our current earnings and result in changes to the fair value of our GMIB reinsurance contracts and GMxB liabilities, which could increase the volatility of our earnings. Lastly, periods of high market volatility or adverse conditions could decrease the availability or increase the cost of derivatives.

Failure to protect the confidentiality of customer information or proprietary business information could adversely affect our reputation and have a material adverse effect on our business, results of operations or financial condition.

Our businesses and relationships with customers are dependent upon our ability to maintain the confidentiality of our and our customers’ proprietary business and confidential information (including customer transactional data and personal data about our employees, our customers and the employees and customers of our customers). Pursuant to federal laws, various federal regulatory and law enforcement agencies have established rules protecting the privacy and security of personal information. In


121

addition, most states, including New York, have enacted laws, which vary significantly from jurisdiction to jurisdiction, to safeguard the privacy and security of personal information.

We and certain of our vendors retain confidential information in information systems and in cloud-based systems (including customer transactional data and personal information about our customers, the employees and customers of our customers, and our own employees). We rely on commercial technologies and third parties to maintain the security of those systems. Anyone who is able to circumvent our security measures and penetrate our information systems or those of our vendors, or the cloud-based systems we use, could access, view, misappropriate, alter or delete any information in the systems, including personally identifiable customer information and proprietary business information. It is possible that an employee, contractor or representative could, intentionally or unintentionally, disclose or misappropriate personal information or other confidential information. Our employees, distribution partners and other vendors may use portable computers or mobile devices which may contain similar information to that in our information systems, and these devices have been and can be lost, stolen or damaged. In addition, an increasing number of states require that customers be notified if a security breach results in the inappropriate disclosure of personally identifiable customer information. Any compromise of the security of our information systems or those of our vendors, or the cloud-based systems we use, through cyber-attacks or for any other reason that results in inappropriate disclosure of personally identifiable customer information could damage our reputation in the marketplace, deter people from purchasing our products, subject us to significant civil and criminal liability and require us to incur significant technical, legal and other expenses any of which could have a material adverse effect on our reputation, business, results of operations or financial condition.

For example, in November 2018, we were notified by one of our third-party vendors of an incident involving unauthorized access to confidential information of certain of our customers, as well as customer information of a number of other institutions. While we are in the early stages of collecting information about this incident, we have begun the process of notifying the appropriate regulators and our affected customers. We continue to monitor this security breach, and, at this time, we cannot provide assurances that all potential causes of the incident have been identified and remediated or that a similar incident will not occur again.

Changes in accounting standards could have a material adverse effect on our business, results of operations or financial condition.

Our consolidated financial statements are prepared in accordance with U.S. GAAP, the principles of which are revised from time to time. Accordingly, from time to time we are required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the Financial Accounting Standards Board (“FASB”). In the future, new accounting pronouncements, as well as new interpretations of existing accounting pronouncements, may have material adverse effects on our business, results of operations or financial condition.

FASB has issued several accounting standards updates which could result in significant changes in U.S. GAAP, including how we account for our financial instruments and how our financial statements are presented. The changes to U.S. GAAP could affect the way we account for and report significant areas of our business, could impose special demands on us in the areas of governance, employee training, internal controls and disclosure and will likely affect how we manage our business. In August 2018, the FASB issued ASU 2018-12 Financial Services—Insurance (Topic 944), which applies to all insurance entities that issue long-duration contracts and revises elements of the measurement models for traditional nonparticipating long-duration and limited payment insurance liabilities and recognition and amortization model for DAC for most long-duration contracts. The new accounting standard also requires product features that have other-than-nominal credit risk, or market risk benefits (“MRBs”), to be measured at fair value. ASU 2018-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. We are currently evaluating the impact that the adoption of this guidance will have on our consolidated financial statements.

In addition, AXA, our parent company, prepares consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”). From time to time, AXA may be required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the International Accounting Standards Board. In the future, new accounting pronouncements, as well as new interpretations of existing accounting pronouncements, may have material adverse effects on


122

AXA’s business, results of operations or financial condition which could impact the way we conduct our business (including, for example, which products we offer), our competitive position, our hedging program and the way we manage capital.

Our investment advisory agreements with clients, and our selling and distribution agreements with various financial intermediaries and consultants, are subject to termination or non-renewal on short notice.

AB derives most of its revenues pursuant to written investment management agreements (or other arrangements) with institutional investors, mutual funds and private wealth clients. In addition, as part of our variable annuity products, AXA Equitable FMG enters into written investment management agreements (or other arrangements) with mutual funds.

Generally, these investment management agreements, including AB’s agreements with AXA and its subsidiaries (AB’s largest client), are terminable without penalty at any time or upon relatively short notice by either party. For example, an investment management contract with an SEC-registered investment company (a “RIC”) may be terminated at any time, without payment of any penalty, by the RIC’s board of directors or by vote of a majority of the outstanding voting securities of the RIC on not more than 60 days’ notice. The investment management agreements pursuant to which AB and AXA Equitable FMG manage RICs must be renewed and approved by the RICs’ boards of directors (including a majority of the independent directors) annually. A significant majority of the directors are independent. Consequently, there can be no assurance that the board of directors of each RIC will approve the investment management agreement each year, or will not condition its approval on revised terms that may be adverse to us.

Also, as required by the Investment Company Act, each investment advisory agreement with a RIC automatically terminates upon its assignment, although new investment advisory agreements may be approved by the RIC’s board of directors or trustees and stockholders. An “assignment” includes a sale of a control block of the voting stock of the investment adviser or its parent company. In the event of a future sale by AXA to a third party of a controlling interest in Holdings’ common stock or if future sales by AXA of Holdings’ common stock were deemed to be an actual or constructive assignment, these termination provisions could be triggered, which may adversely affect AB’s and AXA Equitable FMG’s ability to realize the value of their respective investment advisory agreements. In addition, the actual or constructive transfer of our general partnership interest in AB would constitute an assignment.

The Investment Advisers Act of 1940, as amended (the “Investment Advisers Act”), may also require approval or consent of advisory contracts by clients in the event of an “assignment” of the contract (including a sale of a control block of the voting stock of the investment adviser or its parent company) or a change in control of the investment adviser. Were the sale of Holdings’ common stock by AXA or another transaction to result in an assignment or change in control, the inability to obtain consent or approval from clients or stockholders of RICs or other clients could result in a significant reduction in advisory fees.

AXA has announced its intention to sell all of its interest in the Company over time, subject to any lock-up periods and market conditions. Prior to when such sales trigger an assignment as described above, we and AB will need to seek requisite consents or approvals for such assignment. On October 25, 2018, we obtained shareholder approvals for EQAT and AXA Premier VIP Trust. We and AB are in the process of obtaining shareholder and approvals for AB’s funds and the 1290 Funds, but we may not be successful in obtaining such consents or approvals which would result in terminations of the relevant contracts. Such terminations could have a material adverse effect on our business, results of operations or financial condition.

Similarly, we enter into selling and distribution agreements with securities firms, brokers, banks and other financial intermediaries that are terminable by either party upon notice (generally 30 days) and do not obligate the financial intermediary to sell any specific amount of our products. These intermediaries generally offer their clients investment products that compete with our products. In addition, certain institutional investors rely on consultants to advise them about choosing an investment adviser and some of AB’s services may not be considered among the best choices by these consultants. As a result, investment consultants may advise their clients to move their assets invested with AB to other investment advisers, which could result in significant net outflows.

Finally, AB’s Private Wealth Services relies on referrals from financial planners, registered investment advisers and other professionals. We cannot be certain that we will continue to have access to, or receive referrals from, these third parties.


123


Our reserves could be inadequate due to differences between our actual experience and management’s estimates and assumptions.

We establish and carry reserves to pay future policyholder benefits and claims. Our reserve requirements for our direct and reinsurance assumed business are calculated based on a number of estimates and assumptions, including estimates and assumptions related to future mortality, morbidity, longevity, interest rates, future equity performance, reinvestment rates, persistency, claims experience and policyholder elections (i.e., the exercise or non-exercise of rights by policyholders under the contracts). Examples of policyholder elections include, but are not limited to, lapses and surrenders, withdrawals and amounts of withdrawals, and contributions and the allocation thereof. The assumptions and estimates used in connection with the reserve estimation process are inherently uncertain and involve the exercise of significant judgment. We review the appropriateness of reserves and the underlying assumptions and update assumptions during the third quarter of each year and, if necessary, update our assumptions as additional information becomes available. We cannot, however, determine with precision the amounts that we will pay for, or the timing of payment of, actual benefits and claims or whether the assets supporting the policy liabilities will grow to the level assumed prior to payment of benefits or claims. Our claim costs could increase significantly and our reserves could be inadequate if actual results differ significantly from our estimates and assumptions. We may be required to increase reserves or reduce DAC, which could materially and adversely impact our business, results of operations or financial condition.

Future reserve increases in connection with experience updates could be material and adverse to the results of operations or financial condition of the Company. Future changes as a result of future assumptions reviews could require us to hold additional capital or could otherwise materially and adversely impact our business, results of operations or financial condition.

AB’s revenues and results of operations depend on the market value and composition of AB’s AUM, which can fluctuate significantly based on various factors, including many factors outside of its control.

We derive most of our revenues related to AB’s business from investment advisory and services fees, which typically are calculated as a percentage of the value of AUM as of a specified date, or as a percentage of the value of average AUM for the applicable billing period, and vary with the type of investment service, the size of the account and the total amount of assets AB manages for a particular client. The value and composition of AB’s AUM can be adversely affected by several factors, including:

•
Market Factors. Uncertainties were prevalent throughout 2017. Although U.S. equity markets have advanced to record levels and fixed income risk assets, such as high yield and other credit instruments, have continued to be strong, geopolitical tensions with North Korea, severe hurricanes in the United States and U.S. territories, and new terror attacks in Europe and the United States have kept investors on edge. Many investors are concerned that the U.S. markets are nearly overvalued and are watching closely for Federal Reserve action.
Beyond the United States, economic recovery is unfolding at varying rates throughout the developed and emerging markets. Europe, Asia and the Far East and emerging markets equities have earned high returns year-to-date as a result of improving corporate earnings, greater regulatory clarity, constructive outcomes of various European elections and stabilization in economic growth among the emerging markets. Despite this generally positive backdrop, uncertainty remains over issues like the potential for rising inflation in the United States and President Trump’s ability to pursue his promised pro-growth policies, the impact of Brexit and ongoing concerns about geopolitics, commodity prices and the sustainability of growth in the emerging markets. While the current environment of lower stock correlations, and the potential for lower returns and higher volatility going forward, bode well for active management, investors continue to favor passive management, presenting a significant industry-wide challenge to organic growth.
Market volatility accelerated significantly during October 2018, resulting from increasing concerns about global trade wars, the slowing pace of global growth, inflation and more aggressive monetary policy in the U.S. These factors may adversely impact the global economy and the capital markets, as a result of which AB’s AUM and revenues. would be expected to decline.



124

Additionally, increases in interest rates, particularly if rapid, likely will decrease the total return of many bond investments due to lower market valuations of existing bonds. These factors could have a significant adverse effect on AB’s revenues and results of operations as AUM in AB’s fixed income investments comprise a major component of AB’s total AUM.
•
Client Preferences. Generally, AB’s clients may withdraw their assets at any time and on short notice. Also, changing market dynamics and investment trends, particularly with respect to sponsors of defined benefit plans choosing to invest in less risky investments and the ongoing shift to lower-fee passive services described below, may continue to reduce interest in some of the investment products AB offers, or clients and prospects may continue to seek investment products that AB may not currently offer. Loss of, or decreases in, AUM reduces AB’s investment advisory and services fees and revenues.
•
AB’s Investment Performance. AB’s ability to achieve investment returns for clients that meet or exceed investment returns for comparable asset classes and competing investment services is a key consideration when clients decide to keep their assets with AB or invest additional assets, and when a prospective client is deciding whether to invest with AB. Poor investment performance, both in absolute terms or relative to peers and stated benchmarks, may result in clients withdrawing assets and in prospective clients choosing to invest with competitors.
•
Investing Trends. AB’s fee rates vary significantly among the various investment products and services AB offers to its clients. For example, AB generally earns higher fees from assets invested in its actively-managed equity services than in its actively-managed fixed income services or passive services. Also, AB often earns higher fees from global and international services than AB does from U.S. services. An adverse mix shift would reduce AB’s investment advisory and services fees and revenues.
•
Service Changes. AB may be required to reduce its fee levels, restructure the fees it charges or adjust the services it offers to its clients because of, among other things, regulatory initiatives (whether industry-wide or specifically targeted), changing technology in the asset management business (including algorithmic strategies and emerging financial technology), court decisions and competitive considerations. A reduction in fees would reduce AB’s revenues.

A decrease in the value of AB’s AUM, or a decrease in the amount of AUM AB manages, or an adverse mix shift in its AUM, would adversely affect AB’s investment advisory and services fees and revenues. A reduction in revenues, without a commensurate reduction in expenses, adversely affects AB’s and our business, results of operations or financial condition.

The Tax Reform Act and future changes in U.S. tax laws and regulations or interpretations thereof could reduce our earnings and negatively impact our business, results of operations or financial condition, including by making our products less attractive to consumers.

On December 22, 2017, President Trump signed into law the Tax Reform Act, a broad overhaul of the U.S. Internal Revenue Code that changes long-standing provisions governing the taxation of U.S. corporations, including life insurance companies. While we expect the Tax Reform Act to have a net positive economic impact on us, it contains measures which could have adverse or uncertain impacts on some aspects of our business, results of operations or financial condition.

The Tax Reform Act reduces the federal corporate income tax rate to 21% beginning in 2018. On a GAAP basis, the reduction in the tax rate generally should have a positive impact on our earnings, but resulted in a reduction in the value of our deferred tax assets.

On a statutory basis, we recorded a reduction in the admitted deferred tax assets reported in 2017. In August 2018, the NAIC adopted changes to the RBC calculation, including the C-3 Phase II Total Asset Requirement for variable annuities, to reflect the 21% corporate income tax rate in RBC reported at year-end 2018, which is expected to result in a reduction to our RBC Ratio. We continue to monitor the impact of these and other potential regulatory changes following the Tax Reform Act.

The Tax Reform Act includes provisions that modify the calculation of the dividends received deduction (“DRD”), change how deductions are determined for insurance reserves, increase the amount of policy acquisition expense (also called tax “DAC”)


125

that must be capitalized and amortized for federal income tax purposes, limit the use of net operating losses (“NOLs”) and limit deductions for net interest expense. Some of these changes could adversely affect our business, results of operations or financial condition, notwithstanding the lower corporate income tax rate. These provisions could also impact our investments and investment strategies.

The Tax Reform Act also imposes a one-time transitional tax on some of the accumulated earnings of our foreign subsidiaries and will tax on a current basis earnings of our foreign subsidiaries. These and other changes in the Tax Reform Act could adversely affect our Investment Management and Research business, results of operations or financial condition.

We continue to assess the overall impact that the Tax Reform Act is expected to have on our business, results of operations and financial condition.

Future changes in U.S. tax laws could have a material adverse effect on our business, results of operations or financial condition. We anticipate that, following the Tax Reform Act, we will continue deriving tax benefits from certain items, including but not limited to the DRD, tax credits, insurance reserve deductions and interest expense deductions. However, there is a risk that interpretations of the Tax Reform Act, regulations promulgated thereunder, or future changes to federal, state or other tax laws could reduce or eliminate the tax benefits from these or other items and result in our incurring materially higher taxes.

Many of the products that we sell benefit from one or more forms of tax-favored status under current federal and state income tax regimes. For example, life insurance and annuity contracts currently allow policyholders to defer the recognition of taxable income earned within the contract. While the Tax Reform Act does not change these rules, a future change in law that modifies or eliminates this tax-favored status could reduce demand for our products. Also, if the treatment of earnings accrued inside an annuity contract was changed prospectively, and the tax-favored status of existing contracts was grandfathered, holders of existing contracts would be less likely to surrender or rollover their contracts. Each of these changes could reduce our earnings and negatively impact our business.

Item 4.    Mine Safety Disclosures
NONE.

Item 5.    Other Information
Iran Threat Reduction and Syria Human Rights Act
Holdings, AXA Equitable and their subsidiaries had no transactions or activities requiring disclosure under the Iran Threat Reduction and Syria Human Rights Act (“Iran Act”), nor were they involved in the AXA Group matters described immediately below.

The non-U.S. based subsidiaries of AXA operate in compliance with applicable laws and regulations of the various jurisdictions in which they operate, including applicable international (United Nations and European Union) laws and regulations. While AXA Group companies based and operating outside the United States generally are not subject to U.S. law, as an international group, AXA has in place policies and standards (including the AXA Group International Sanctions Policy) that apply to all AXA Group companies worldwide and often impose requirements that go well beyond local law.

AXA has informed us that AXA Konzern AG, an AXA insurance subsidiary organized under the laws of Germany, provides, accident and health insurance to diplomats based at the Iranian embassy in Berlin, Germany. The total annual premium of these policies is approximately $139,700 before tax and the annual net profit arising from these policies, which is difficult to calculate with precision, is estimated to be $24,272.
AXA has informed us that AXA Belgium, an AXA insurance subsidiary organized under the laws of Belgium, has two policies providing for car insurance for Global Trading NV, who were designated on 17th May 2018 under (E.O.) 13224, and


126

subsequently changed its name to Energy Engineers Procurement & Construction on August 20, 2018. The total annual premium of these policies is approximately $6,559 before tax and the annual net profit arising from these policies, which is difficult to calculate with precision, is estimated to be $983.

In addition, AXA has informed us that AXA Insurance Ireland, an AXA insurance subsidiary, provides statutorily required car insurance under four separate policies to the Iranian Embassy in Dublin, Ireland. AXA has informed us that compliance with the Declined Cases Agreement of the Irish Government prohibits the cancellation of these policies unless another insurer is willing to assume the coverage. The total annual premium for these policies is approximately $7,115 and the annual net profit arising from these policies, which is difficult to calculate with precision, is estimated to be $853.

Also, AXA has informed us that AXA Sigorta, a subsidiary of AXA organized under the laws of Republic of Turkey, provides car insurance coverage for vehicle pools of the Iranian General Consulate and the Iranian Embassy in Istanbul, Turkey. Motor third party liability insurance coverage is compulsory in Turkey and cannot be canceled unilaterally. The total annual premium in respect of these policies is approximately $3,150 and the annual net profit, which is difficult to calculate with precision, is estimated to be $473.

Additionally, AXA has informed us that AXA Winterthur, an AXA insurance subsidiary organized under the laws of Switzerland, provides Naftiran Intertrade, a wholly-owned subsidiary of the Iranian state-owned National Iranian Oil Company, with life, disability and accident coverage for its employees. In addition, AXA Winterthur also provides car and property insurance coverage for the Iranian Embassy in Bern. The provision of these forms of coverage is mandatory in Switzerland. The total annual premium of these policies is approximately $396,597 and the annual net profit arising from these policies, which is difficult to calculate with precision, is estimated to be $59,489.

In addition, AXA has informed us that AXA Egypt, an AXA insurance subsidiary organized under the laws of Egypt, provides the Iranian state-owned Iran Development Bank, two life insurance contracts, covering individuals who have loans with the bank. The total annual premium of these policies is approximately $19,839 and annual net profit arising from these policies, which is difficult to calculate with precision, is estimated to be $2,000.

Furthermore, AXA has informed us that AXA XL, which AXA acquired during the third quarter of 2018, through various non-U.S. subsidiaries, provides insurance to marine policyholders located outside of the U.S. or reinsurance coverage to non-U.S. insurers of marine risks as well as mutual associations of ship owners that provide their members with protection and liability coverage. The provision of these coverages may involve entities or activities related to Iran, including transporting crude oil, petrochemicals and refined petroleum products. AXA XL’s non-U.S. subsidiaries insure or reinsure multiple voyages and fleets containing multiple ships, so they are unable to attribute gross revenues and net profits from such marine policies to activities with Iran. As the activities of these insureds and reinsureds are permitted under applicable laws and regulations, AXA XL intends for its non-U.S. subsidiaries to continue providing such coverage to its insureds and reinsureds to the extent permitted by applicable law.

Lastly, a non-U.S. subsidiary of AXA XL provided accident & health insurance coverage to the diplomatic personnel of the Embassy of Iran in Brussels, Belgium during the third quarter of 2018. AXA XL’s non-U.S. subsidiary received no payments for this insurance during the three months ended September 30, 2018 and the aggregate payments received by this non-U.S. subsidiary for this insurance from inception through the three months ended September 30, 2018 are approximately $73,451. Benefits of approximately $2,994 were paid to beneficiaries during the three months ended September 30, 2018. These activities are permitted pursuant to applicable law. The policy has been cancelled and is no longer in force.

The aggregate annual premium for the above-referenced insurance policies is approximately $646,411, representing approximately 0.0007% of AXA’s 2017 consolidated revenues, which exceed $100 billion. The related net profit, which is difficult to calculate with precision, is estimated to be $88,070, representing approximately 0.002% of AXA’s 2017 aggregate net profit.



127

Item 6.    Exhibits 
 
 
Number
Description and Method of Filing
 
 
Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
Certification of the Registrant’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
Certification of the Registrant’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101.INS
XBRL Instance Document
 
 
101.SCH
XBRL Taxonomy Extension Schema Document
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
____________________________________
# Filed herewith.



128

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, AXA Equitable Life Insurance Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: November 13, 2018
AXA Equitable Life Insurance Company
 
 
 
 
 
By:
/s/ Anders Malmström
 
 
 
Name:
Anders Malmström
 
 
 
Title:
Senior Executive Director
 
 
 
 
and Chief Financial Officer
 
 
 
 
Date: November 13, 2018
 
 
/s/ Andrea Nitzan
 
 
 
Name:
Andrea Nitzan
 
 
 
Title:
Managing Director
 
 
 
 
Chief Accounting Officer and Controller



129